Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Virchow Lab FY 2019

Download as pdf or txt
Download as pdf or txt
You are on page 1of 212

VIRCHOW LABORATORIES LIMITED

Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[700300] Disclosure of general information about company


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Corporate identity number U24232TG1982PLC003368
Permanent account number of entity AAACV7245F
PLOT NO.4,
S.V.CO-OP.INDUSTRIALESTATE
Address of registered office of company , JEEDIMETLA , Hyderabad
Andhra Pradesh ,
TELANGANA , INDIA - 000000
Commercial and
Type of industry Industrial
Date of board meeting when final accounts were approved 31/08/2019
Date of start of reporting period 01/04/2018 01/04/2017
Date of end of reporting period 31/03/2019 31/03/2018
Nature of report standalone consolidated Standalone
Content of report Financial Statements
Description of presentation currency INR
Level of rounding used in financial statements Lakhs
Type of cash flow statement Indirect Method
Whether company is maintaining books of account and other relevant
No
books and papers in electronic form

Disclosure of principal product or services [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Types of principal product or services [Axis] 1
01/04/2018
to
31/03/2019
Disclosure of general information about company [Abstract]
Disclosure of principal product or services [Abstract]
Disclosure of principal product or services [LineItems]
Product or service category (ITC 4 digit) code 3003
MEDICAMENTS (EXCL
GOODS HDG NO 3002
3005 OR 3006) CNSISTNC
OF TWO/MORE
Description of product or service category CONSTUNTS MXD
TOGETHER FOR HMN
MEDCNE NT FR RTL
SALE
Turnover of product or service category 37,187.57
Highest turnover contributing product or service (ITC 8 digit) code 30032000
Description of product or service SULPHAMETHOXAZOLE
Turnover of highest contributing product or service 37,187.57
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[700600] Disclosures - Directors report

Details of directors signing board report [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Directors signing board report [Axis] 1 2
01/04/2018 01/04/2018
to to
31/03/2019 31/03/2019
Details of signatories of board report [Abstract]
Details of directors signing board report [LineItems]
Name of director signing board report [Abstract]
NANDIGALA NARAYANA
First name of director VENKATA REDDY REDDY MUNDLA
Designation of director Managing Director Managing Director
Director identification number of director 01740424 00064392
Date of signing board report 31/08/2019 31/08/2019

Details of principal business activities contributing 10% or more of total turnover of company [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Product/service 1 Product/service 2
Principal business activities of company [Axis]
[Member] [Member]
01/04/2018 01/04/2018
to to
31/03/2019 31/03/2019
Details of principal business activities contributing 10% or more of total turnover
of company [Abstract]
Details of principal business activities contributing 10% or more of total
turnover of company [LineItems]
Name of main product/service SULPHAMETHOXAZOLE Oxalic Acid
Description of main product/service SULPHAMETHOXAZOLE Oxalic Acid
NIC code of product/service 3003 3003
Percentage to total turnover of company 74.00% 12.00%

2
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018
to
31/03/2019
Textual information (1)
Disclosure in board of directors report explanatory [TextBlock] [See below]
Textual information (2)
Description of state of companies affair [See below]
TRANSFER TO
RESERVES: During
Disclosure relating to amounts if any which is proposed to carry to any the period, the Company
reserves has transferred Rs. 17.87
lakhs to capital
redemption reserve.
Textual information (3)
Disclosures relating to amount recommended to be paid as dividend [See below]
Textual information (4)
Details regarding energy conservation [See below]
Textual information (5)
Details regarding technology absorption [See below]
Textual information (6)
Details regarding foreign exchange earnings and outgo [See below]
Textual information (7)
Disclosures in director’s responsibility statement [See below]
Details of material changes and commitment occurred during period Textual information (8)
affecting financial position of company [See below]
Textual information (9)
Particulars of loans guarantee investment under section 186 [TextBlock] [See below]
Particulars of contracts/arrangements with related parties under section Textual information (10)
188(1) [TextBlock] [See below]
Details of contracts/arrangements/transactions not at arm's length
basis [Abstract]
Whether there are contracts/arrangements/transactions not at arm's
No
length basis
Details of material contracts/arrangements/transactions at arm's
length basis [Abstract]
Whether there are material contracts/arrangements/transactions at
No
arm's length basis

Details of statement indicating manner in which formal N o t


Applicable
annual evaluation made by board of its performance and of its
committees and individual directors [TextBlock]

Date of board of directors' meeting in which board's report referred


31/08/2019
to under section 134 was approved
Disclosure of extract of annual return as provided under section 92(3) Textual information (11)
[TextBlock] [See below]
Details of principal business activities contributing 10% or more
of total turnover of company [Abstract]
Particulars of holding, subsidiary and associate companies [Abstract]
VIRCHOW LABORATORIES
Name of company LIMITED
Details of shareholding pattern of top 10 shareholders [Abstract]

N o t
Disclosure of statement on declaration given by independent directors Applicable
under section 149(6) [TextBlock]

Reappointment of independent directors as per section 149(10) [TextBlock] N o t


Applicable

Disclosure for companies covered under section 178(1) on


Textual information (12)
directors appointment and remuneration including other matters [See below]
provided under section 178(3) [TextBlock]
Disclosure of statement on development and implementation of risk Textual information (13)
management policy [TextBlock] [See below]
Details on policy development and implementation by company on
Textual information (14)
corporate social responsibility initiatives taken during year [See below]
[TextBlock]

3
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Report on highlights on performance of subsidiaries,


associates and joint venture companies and their Textual information (15)
contribution to overall performance of the companies [See below]
during the period under report [TextBlock]
Textual information (16)
Disclosure as per rule 8(5) of companies accounts rules 2014 [TextBlock] [See below]
Textual information (17)
Disclosure of financial summary or highlights [TextBlock] [See below]

CHANGE IN THE NATURE


OF BUSINESS, IF
ANY:

Disclosure of change in nature of business [TextBlock] D u r i n g


the period under review
and the date of Board’s
Report there was no change
in the nature of
Business.

Details of directors or key managerial personnels who were Textual information (18)
appointed or have resigned during year [TextBlock] [See below]
Disclosure of companies which have become or ceased to be its
Textual information (19)
subsidiaries, joint ventures or associate companies during [See below]
year [TextBlock]
Details relating to deposits covered under chapter v of companies act Textual information (20)
[TextBlock] [See below]
Details of deposits which are not in compliance with requirements Textual information (21)
of chapter v of act [TextBlock] [See below]
Details of significant and material orders passed by
Textual information (22)
regulators or courts or tribunals impacting going concern [See below]
status and company’s operations in future [TextBlock]
Details regarding adequacy of internal financial controls with Textual information (23)
reference to financial statements [TextBlock] [See below]
Disclosure of contents of corporate social responsibility policy Textual information (24)
[TextBlock] [See below]
Disclosure of reasons if company fails to spend prescribed amount on CSR Others
We spend the money on need
base. However, we will
spend the balance unspent
Disclosure of other reasons if company fails to spend prescribed amount amount in future as per our
on CSR company CSR policy by
considering the present
provisions as per
Companies Act.
Disclosure of appointment and remuneration of director or Textual information (25)
managerial personnel if any, in the financial year [TextBlock] [See below]
Details of remuneration of director or managerial personnel [Abstract]
Number of meetings of board [pure] 0
Details of signatories of board report [Abstract]
Name of director signing board report [Abstract]

4
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (1)

Disclosure in board of directors report explanatory [Text Block]


DIRECTORS’ REPORT

To

The Members of

Virchow Laboratories Limited.

Your Directors have pleasure in presenting the 37th Directors’ Report on the business and operations of the Company together with the audited
Financial Statements for the year ended 31st March, 2019.

FINANCIAL SUMMARY/HIGHLIGHTS, OPERATIONS, STATE OF AFFAIRS:

The financial results for the financial year 2018-19 and for the previous financial year 2017-18 are given as under

Particulars (Rs. in Lakhs)

Standalone

2018-19 2017-18

Income from operations 37187.57 33553.81

Other Income 814.42 635.40

Profit/ (Loss) before Interest, Depreciation & tax 5209.53 3978.97

5
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Depreciation 501.89 480.05

Financial charges 59.96 49.41

Profit / (Loss) Before Tax 4647.68 3449.01

Provision for Tax (including deferred Tax ) 1551.70 1205.34

Comprehensive Income –As per


3112.76 2269.72
Ind AS

Net Profit/(Loss) 3095.98 2243.68

PERFORMANCE REVIEW:

Standalone:

The Company has recorded a turnover of Rs. 37187.57 Lakhs and earned a Net Profit of Rs 3095.98 Lakhs in the financial year 2018-19 as
against the turnover of Rs. 33353.81 Lakhs and net Profit of Rs. 2243.68 Lakhs in the financial year 2017-18.

TRANSFER TO RESERVES:

6
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

During the period, the Company has transferred Rs. 17.87 lakhs to capital redemption reserve.

DIVIDEND:

During the year, the Directors do not recommend payment of any dividend.

CHANGE IN THE NATURE OF BUSINESS, IF ANY:

During the period under review and the date of Board’s Report there was no change in the nature of Business.

MATERIAL CHANGES AND COMMITMENTS, IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY WHICH HAVE
OCCURRED BETWEEN THE END IF THE FINANCIAL YEAR OF THE COMPANY TO WHICH THE FINANCIAL STATEMENTS
RELATE AND THE DATE OF THE REPORT:

There are no material changes and commitments affecting financial position of the company between 31st March, 2019 and the date of Boards’
Report. (i.e. 21.08.2019)

NUMBER OF MEETINGS OF THE BOARD:

The Board of Directors met 4 times during the year on 02.06.2018, 18.07.2018, 06.09.2018 and 29.12.2018 the maximum gap between any two
meetings was less than four months, as stipulated under the provisions of Companies Act, 2013.

PUBLIC DEPOSITS:

The Company has not accepted any deposits falling within the meaning of Sec.73 of the Companies Act, 2013 read with the Companies
(Acceptance of Deposits) Rules, 2014 during the financial year under review.

7
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

CAPITAL OF THE COMPANY:

During the period under review, the Company’s Authorized Share capital of the company stand at Rs. 1,50,00,000 divided into 1,50,000 equity
shares of Rs.100/- each.

The company bought back 17,867 equity shares at a price of Rs. 24,900/- each aggregating to Rs.44.49 crores and accordingly the Paid up capital
of the Company stands reduced to Rs. 71,47,000 divided into 71,470 equity shares of Rs. 100/- each.

INFORMATION ABOUT THE FINANCIAL PERFORMANCE OF SUBSIDIARIES / ASSOCIATES/ JOINT VENTURES:

As on 31st March, 2019, the Company has three (3) Subsidiary Companies namely Andhra Organics Limited (wholly- owned subsidiary),
Virchow Drugs Limited, Virchow Healthcare private Limited and one Associated company that is Virchow Bio-tech Private Limited respectively.
The Financial performance of the subsidiary companies and associate company are mentioned in FORM AOC- 1 in accordance with Section
129(3) of the Companies Act, 2013 which is annexed as ANNEXURE 1.

NAMES OF THE COMPANIES WHICH HAVE BECOME OR CEASED TO BE ITS SUBSIDIARIES, JOINT VENTURES OR ASSOCIATE
COMPANIES DURING THE YEAR:

During the period under review, there are no companies who ceased or became the subsidiaries, joint ventures or associate companies.

INSURANCE:

The company's properties have been adequately insured against major risks. All the insurable interests of your Company including inventories,
buildings, plant and machinery, stock and receivables under legislative enactments are adequately insured.

A STATEMENT INDICATING DEVELOPMENT AND IMPLEMENTATION OF A RISK MANAGEMENT POLICY FOR THE COMPANY

8
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

INCULDING IDENTIFICATION THEREIN OF ELEMENTS OF RISK, IF ANY, WHICH IN THE OPINION OF THE BOARD MAY
THREATEN THE EXISTENCE OF THE COMPANY:

Company follows a comprehensive system of Risk Management. Company has adopted a procedure for assessment and minimization of probable
risks. It ensures that all the risks are timely defined and mitigated in accordance with the well-structured risk management process. The company
also adopted the Risk Management Policy.

DIRECTORS AND KEY MANAGERIAL PERSONNEL APPOINTED OR RESIGNED:

· In accordance with Section 152 of the Act, Mr. L.V. Subash and Mr. M. Maha Vishnu Directors of the Company retire by rotation at the
ensuing Annual General Meeting and being eligible, offer themselves for re-appointment.

· Pursuant to sections 196 and 197 of Companies Act, 2013, continuation of Dr. N. Venkata Reddy as Managing Director of the Company is
proposed for the approval of shareholders.

· During the period under review, Mr. D. Ravinder Reddy resigned from the Board on 18.07.2018. The Board has place on records its sincere
appreciation for the valuable contributions made by him.

DIRECTORS RESPONSIBILITY STATEMENT:

Pursuant to the provisions of Sec. 134(5) of the Companies Act, 2013 the Board of Directors of your Company hereby certifies and confirms that:

a. In the preparation of the Annual Accounts, the applicable accounting standards have been followed along with proper explanation relating to
material departures;

9
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

b. The Directors have selected such accounting policies and applied them consistently and made judgment and estimates that are reasonable and
prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit and loss of the
Company for that period;

c. The Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of
the Companies Act, 2013 for safeguarding the Assets of the Company and for preventing and detecting fraud and other irregularities;

d. The Directors have prepared the Annual accounts on a going concern basis.

e. The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were
adequate and operating effectively and

f. The Directors had laid down internal financial controls to be followed by the company and that such internal financial controls are adequate
and were operating effectively.

INDIAN ACCOUNTING STANDARDS (IndAS)

The Ministry of Corporate Affairs vide its notification dated 16th February, 2015 has notified the Companies (Indian Accounting Standards)
Rules, 2015. In pursuance of the said notification, the Company has adopted Indian Accounting Standards (IndAS) with effect from 01st April,
2017.

DETAILS IN REPECT OF FRAUDS REPORTED BY AUDITORS UNDER SUB-SECTION (12) OF SECTION 143 OTHER THAN THOSE
WHICH ARE REPORTABLE TO CENTRAL GOVERNMENT.

There were no frauds reported by the auditors as per section 143 (12) other than those which are reportable to Central Government.

10
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

STATUTORY AUDITORS:

M/s Ramana Reddy & Associates, Chartered Accountants, Hyderabad was appointed as Statutory Auditors in the AGM held on 30.09.2014 upto
31.03.2019. Therefore their re-appointment as statutory auditors for a period of five (5) years commencing from 01.04.2019 to 31.03.2024. .

COST AUDITOR:

Sri P. Srinivas, Cost Accountant, Hyderabad (Registration No. 100309), acting as cost auditor to audit the cost records maintained by the
company for the financial year 2019-2020, on a remuneration of Rs. 1,00,000./-

SECRETARIAL AUDITOR:

Pursuant to the provisions of Section 134(3) (f) & Section 204 of the Companies Act, 2013, Secretarial audit report as provided by M/s. S. S.
Reddy & Associates, Practicing Company Secretaries is annexed to this Report as an ANNEXURE 2.

EXPLANATIONS OR COMMENTS BY THE BOARD ON EVERY QUALIFICATIONS, RESERVATIONS OR ADVERSE REMARK OR


DISCLAIMER MADE-

The Board has duly reviewed the Statutory Auditor’s Report and Secretarial Audit Report for the year ended March 31, 2019 and has noted that
the same does not have any reservation, qualification or adverse remarks.

EXTRACT OF ANNUAL RETURN:

As required pursuant to section 92(3) of the Companies Act, 2013 and rule 12(1) of the Companies (Management and Administration) Rules,
2014, an extract of annual return in MGT 9 as a part of this Annual Report as ANNEXURE 3.

11
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHNAGE OUTGO:

The required information as per Section 134(3)(m) of the Companies Act, 2013 is provided in ANNEXURE 4.

DISCLOSURE OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS

The Internal Financial Controls with reference to financial statements as designed and implemented by the Company are adequate. The Company
maintains appropriate system of internal control, including monitoring procedures, to ensure that all assets are safeguarded against loss from
unauthorized use or disposition. Company policies, guidelines and procedures provide for adequate checks and balances, and are meant to ensure
that all transactions are authorized, recorded and reported correctly.

During the period under review, there is no material or serious observations have been noticed for inefficiency or inadequacy of such controls.

SIGNIFICANT & MATERIAL ORDERS PASSED BY THE REGULATORS:

During the period under review there are no significant and material orders passed by the regulators or Courts or Tribunals impacting the going
concern status and the company’s operations in future.

IN CASE OF A COMPANY COVERED UNDER SUB-SECTION (1) OF SECTION 178, COMPANY’S POLICY ON DIRECTORS”
APPOINTMENT AND REMUNERATION INCULDING CRITERIA FOR DETERMING QUALIFICATIONS, POSITIVE ATTRIBUTES,
INDEPENDENCE OF A DIRECTOR AND OTHER MATTERS PROVIDED UNDER SUB-SECTION (3) OF SECTION 178:

The Nomination & Remuneration Committee constituted and the Policy framed and adopted by the Company is in line with the provisions of with
Section 178 of the Companies Act, 2013 and the details of the composition of the Committee are given below:

12
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

1. Mr. K.V. Ravindra Reddy - Chairman

2. Mr. A. Venkata Reddy - Member

3. Mr. M. Narayana Reddy - Member

The Policy adopted by the Company is placed on website of the company i.e., www.virchows.com.

PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS:

The Company has not given any loan or guarantee as specified under section 186 of the Companies Act, 2013. The Investments made by the
Company under section 186 of the companies Act, 2013 were within the limits of section 186(2) of the Companies Act, 2013.

AUDIT COMMITTEE:

The Audit Committee of the Company is constituted in line with the provisions of with Section 177 of the Companies Act, 2013 and the details of
the composition of the Committee are given below:

1. Mr. K.V. Ravindra Reddy - Chairman

2. Mr. A. Venkata Reddy - Member

3. Mr. M. Narayana Reddy - Member

COMPOSITION OF CSR AND THE DETAILS ABOUT THE POLICY DEVELOPED AND IMPLEMENTED BY THE COMPANY ON
CORPORATE SOCIAL RESPONSIBILITY INITIATIVES TAKEN DURING THE YEAR:

In terms of section 135 and schedule VII of the Companies Act, 2013, the Board of Directors of the company has constituted a CSR committee.

13
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

The CSR committee of the Board has developed CSR policy. The details of the composition of the committee are given below:

1. Mr. A. Venkata Reddy - Chairman

2. Mr. N. Prasanth - Member

3. Mr. M. Vishnu Mundla - Member

The Policy adopted by the Company is placed on website of the company i.e. www.virchows.com. The details on amount spent on CSR activities
is attached in ANNEXURE - 5

RELATED PARTY TRANSACTIONS:

All contracts/arrangements/transactions entered by the Company during the financial year with related parties were in the ordinary course of
business on arm’s length basis and were in compliance with the applicable provisions of the Companies Act, 2013. The Company has not entered
into any transaction of a material nature with any of the related parties which are in conflict with the interest of the Company.

Particulars of contracts or arrangements with related parties are provided in the notes of accounts as part of financial statements and also in
FORM AOC – 2 which is annexed as ANNEXURE - 6.

STATEMENT SHOWING THE NAMES OF THE TOP TEN EMPLOYEES IN TERMS OF REMUNERATION DRAWN AND THE NAME
OF EVERY EMPLOYEE:

A statement showing the names of the top ten employees in terms of remuneration drawn and the name of every employee is not applicable.

SECRETARIAL STANDARDS:

The company is in compliance with the applicable secretarial standards.

14
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND
REDRESSAL) ACT, 2013:

The Company always endeavors to create and provide an environment that is free from discrimination and harassment including sexual
harassment. Directors further states that during the year under review, there were no cases filed pursuant to the Sexual Harassment of Women at
Workplace (Prevention, Prohibition and Redressal) Act, 2013.

ACKNOWLEDGEMENTS:

The directors would like to express their grateful appreciation for assistance and co-operation received from clients, banks, investors,
Government, other statutory authorities and all others associated with the company. Your directors also wish to place on record their deep sense
of appreciation for the excellent contribution made by the employees at all levels, which enabled the company to achieve sustained growth in the
operational performance during the year under review.

For and on behalf of the Board

Virchow Laboratories Limited

M. Narayana Reddy Dr. N. Venkata Reddy

Managing Director (Technical) Managing Director (Commercial)

(DIN: 00064392) (DIN : 01740424)

15
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Date: 31.08.2019

Place: Hyderabad

Textual information (2)

Description of state of companies affair


FINANCIAL SUMMARY/HIGHLIGHTS, OPERATIONS, STATE OF AFFAIRS: The financial results for the financial year 2018-19 and for
the previous financial year 2017-18 are given as under Particulars (Rs. in Lakhs) Standalone 2018-19 2017-18 Income from
operations 37187.57 33553.81 Other Income 814.42 635.40 Profit/ (Loss) before Interest, Depreciation & tax 5209.53 3978.97
Depreciation 501.89 480.05 Financial charges 59.96 49.41 Profit / (Loss) Before Tax 4647.68 3449.01 Provision for Tax (including
deferred Tax ) 1551.70 1205.34 Comprehensive Income –As per Ind AS 3112.76 2269.72 Net Profit/(Loss) 3095.98 2243.68
PERFORMANCE REVIEW: Standalone: The Company has recorded a turnover of Rs. 37187.57 Lakhs and earned a Net Profit of Rs 3095.98
Lakhs in the financial year 2018-19 as against the turnover of Rs. 33353.81 Lakhs and net Profit of Rs. 2243.68 Lakhs in the financial year
2017-18.

Textual information (3)

Disclosures relating to amount recommended to be paid as dividend


DIVIDEND: During the year, the Directors do not recommend payment of any dividend.

Textual information (4)

Details regarding energy conservation


ANNEXURE 4 Disclosure of Particulars with respect to conservation of Energy, Technology Absorption and Foreign Exchange earnings and
outgo: 1 Energy Conservation: 31.03.2019 31.03.2018 A 1. Power & Fuel Consumption Electricity: a) Purchased: Units 9092900
80,58,155 Total amount (Rs in Lakhs) 674.48 613.21 b) Own Generation: Through Diesel Generator Units 1039085 7,32,997
Units per ltr. of Diesel oil 3.12 3.12 Cost/Unit (Rs) 22.41 19.05 2. Coal used in Boiler: Quantity (Tonnes) 44816 47541 Cost
(Rs in Lakhs) 2428.29 2461.28 Average Rate (Rs) 5418.29 5177.15 3. Furnace Oil (HSD): Quantity (K. Litre) - Total Amount
(Rs) - Average Unit/Litres - 4. Others/Internal generation: Quantity (Tonnes) - Total Cost (Rs) - Average Rate (Rs) - 2.
Technology Absorption: Expenditure incurred on research and development (including capital expenditure) (rupees in Lakhs) 127.95
151.40 3. Foreign Exchange earnings and outgo Earnings (Rs in lakhs)` 25461.16 20595.16 Outgo (Rs in lakhs) 3002.69 2115.47

Textual information (5)

Details regarding technology absorption


ANNEXURE 4 Disclosure of Particulars with respect to conservation of Energy, Technology Absorption and Foreign Exchange earnings and
outgo: 1 Energy Conservation: 31.03.2019 31.03.2018 A 1. Power & Fuel Consumption Electricity: a) Purchased: Units 9092900
80,58,155 Total amount (Rs in Lakhs) 674.48 613.21 b) Own Generation: Through Diesel Generator Units 1039085 7,32,997
Units per ltr. of Diesel oil 3.12 3.12 Cost/Unit (Rs) 22.41 19.05 2. Coal used in Boiler: Quantity (Tonnes) 44816 47541 Cost
(Rs in Lakhs) 2428.29 2461.28 Average Rate (Rs) 5418.29 5177.15 3. Furnace Oil (HSD): Quantity (K. Litre) - Total Amount
(Rs) - Average Unit/Litres - 4. Others/Internal generation: Quantity (Tonnes) - Total Cost (Rs) - Average Rate (Rs) - 2.
Technology Absorption: Expenditure incurred on research and development (including capital expenditure) (rupees in Lakhs) 127.95
151.40 3. Foreign Exchange earnings and outgo Earnings (Rs in lakhs)` 25461.16 20595.16 Outgo (Rs in lakhs) 3002.69 2115.47

16
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (6)

Details regarding foreign exchange earnings and outgo


ANNEXURE 4 Disclosure of Particulars with respect to conservation of Energy, Technology Absorption and Foreign Exchange earnings and
outgo: 1 Energy Conservation: 31.03.2019 31.03.2018 A 1. Power & Fuel Consumption Electricity: a) Purchased: Units 9092900
80,58,155 Total amount (Rs in Lakhs) 674.48 613.21 b) Own Generation: Through Diesel Generator Units 1039085 7,32,997
Units per ltr. of Diesel oil 3.12 3.12 Cost/Unit (Rs) 22.41 19.05 2. Coal used in Boiler: Quantity (Tonnes) 44816 47541 Cost
(Rs in Lakhs) 2428.29 2461.28 Average Rate (Rs) 5418.29 5177.15 3. Furnace Oil (HSD): Quantity (K. Litre) - Total Amount
(Rs) - Average Unit/Litres - 4. Others/Internal generation: Quantity (Tonnes) - Total Cost (Rs) - Average Rate (Rs) - 2.
Technology Absorption: Expenditure incurred on research and development (including capital expenditure) (rupees in Lakhs) 127.95
151.40 3. Foreign Exchange earnings and outgo Earnings (Rs in lakhs)` 25461.16 20595.16 Outgo (Rs in lakhs) 3002.69 2115.47

Textual information (7)

Disclosures in director’s responsibility statement


DIRECTORS RESPONSIBILITY STATEMENT: Pursuant to the provisions of Sec. 134(5) of the Companies Act, 2013 the Board of Directors
of your Company hereby certifies and confirms that: a. In the preparation of the Annual Accounts, the applicable accounting standards have
been followed along with proper explanation relating to material departures; b. The Directors have selected such accounting policies and applied
them consistently and made judgment and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the
Company at the end of the financial year and of the profit and loss of the Company for that period; c. The Directors have taken proper and
sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013 for safeguarding
the Assets of the Company and for preventing and detecting fraud and other irregularities; d. The Directors have prepared the Annual accounts
on a going concern basis. e. The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that
such systems were adequate and operating effectively and f. The Directors had laid down internal financial controls to be followed by the
company and that such internal financial controls are adequate and were operating effectively.

Textual information (8)

Details of material changes and commitment occurred during period affecting financial position of company
MATERIAL CHANGES AND COMMITMENTS, IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY WHICH HAVE
OCCURRED BETWEEN THE END IF THE FINANCIAL YEAR OF THE COMPANY TO WHICH THE FINANCIAL STATEMENTS
RELATE AND THE DATE OF THE REPORT: There are no material changes and commitments affecting financial position of the company
between 31st March, 2019 and the date of Boards’ Report. (i.e. 21.08.2019)

Textual information (9)

Particulars of loans guarantee investment under section 186 [Text Block]


PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS:

The Company has not given any loan or guarantee as specified under section 186 of the Companies Act, 2013. The Investments made by the
Company under section 186 of the companies Act, 2013 were within the limits of section 186(2) of the Companies Act, 2013.

17
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (10)

Particulars of contracts/arrangements with related parties under section 188(1) [Text Block]
RELATED PARTY TRANSACTIONS:

All contracts/arrangements/transactions entered by the Company during the financial year with related parties were in the ordinary course of
business on arm’s length basis and were in compliance with the applicable provisions of the Companies Act, 2013. The Company has not entered
into any transaction of a material nature with any of the related parties which are in conflict with the interest of the Company.

Particulars of contracts or arrangements with related parties are provided in the notes of accounts as part of financial statements and also in
FORM AOC – 2 which is annexed as ANNEXURE - 6.

18
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (11)

Disclosure of extract of annual return as provided under section 92(3) [Text Block]
FORM NO. MGT.9

EXTRACT OF ANNUAL RETURN

as on the financial year ended on 31.03.2019

[Pursuant to section 92(3) of the Companies Act, 2013 and rule 12(1) of the Companies (Management and Administration) Rules, 2014]

I. REGISTRATION AND OTHER DETAILS:

i) CIN U24232TG1982PLC003368

ii) Registration Date 20/01/1982

iii) Name of the Company VIRCHOW LABORATORIES LIMITED

iv) Category / Sub-Category of the Company Non-Government/Public Company

PlotNo.4,S.V.Co- Operative Indl, Estate, Jeedimetla , Hyderabad-


500055
v) Address of the Registered office and contact details
Contact details: 040-44445608

vi) Whether listed company Yes / No No

Name, Address and Contact details of Registrar and Transfer Agent,


vii) Not Applicable
if any

II. PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY

All the business activities contributing 10 % or more of the total turnover of the company shall be stated:-

Name and
NIC Code of % to total
Description of

19
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Sl. No. the Product/ turnover of the


main products/
service company
services

1 Sulphamethoxazole 74.12

2 Oxalic Acid 12.44

III. PARTICULARS OF HOLDING, SUBSIDIARY AND ASSOCIATE COMPANIES :

NAME AND ADDRESS OF


S.
THE HOLDING/ % of shares Applicable
CIN/GLN
SUBSIDIARY/ASSOCIATE held Section
NO
COMPANY

1 Andhra Organics Limited U24116TG1991PLC012314 Subsidiary 100% 2(87)

2 Virchow Drugs Limited U24239TG2004PLC042949 Subsidiary 51% 2(87)

3 Virchow Healthcare Pvt. Ltd. U24230MH2007PTC176048 Subsidiary 85% 2(87)

Virchow Bio- tech


4. U24210TG2001PTC036520 Associate 49% 2(6)
Private Limited

IV. SHARE HOLDING PATTERN (Equity Share Capital Breakup as percentage of Total Equity)

i) Category-wise Share Holding

20
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

%
No. of Shares held at No. of Shares held Change
Category of Shareholders the beginning of the at the end of the during
year year the
year

% of % of
Demat Physical Total Total Demat Physical Total Total
Shares Shares

A. Promoters

Indian

Individual/ HUF
-- 89337 89337 100 -- 71470 71470 100 --

Central Govt
-- -- -- -- -- -- -- -- --

State Govt (s)


-- -- -- -- -- -- -- -- --

Bodies Corp.
-- -- -- -- -- -- -- -- --

Banks/FI
-- -- -- -- -- -- -- -- --

Any Other..
-- -- -- -- -- -- -- -- --

Sub-total (A) (1):-


-- 89337 89337 100 -- 71470 71470 100 --

(2) Foreign

a) NRIs – Individuals -- -- -- -- -- -- -- -- --

21
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

b) Other – Individuals
-- -- -- -- -- -- -- -- --

c) Bodies Corp.
-- -- -- -- -- -- -- -- --

d) Banks / FI
-- -- -- -- -- -- -- -- --

e) Any Other....
-- -- -- -- -- -- -- -- --

Sub-total (A) (2):-


-- -- -- -- -- -- -- -- --

Total shareholding of Promoter

(A) = -- 89337 89337 100 -- 71470 71470 100 --

(A)(1)+(A)( 2)

B. Public Shareholding

1. Institutions
-- -- -- -- -- -- -- -- --

a) Mutual Funds
-- -- -- -- -- -- -- -- --

b) Banks/FI
-- -- -- -- -- -- -- -- --

c) Central Govt
-- -- -- -- -- -- -- -- --

d) State Govt(s)
-- -- -- -- -- -- -- -- --

e) Venture Capital Funds


-- -- -- -- -- -- -- -- --

22
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

f) Insurance Companies
-- -- -- -- -- -- -- -- --

g) FIIs
-- -- -- -- -- -- -- -- --

h) Foreign Venture Capital Funds


-- -- -- -- -- -- -- -- --

i) Others (specify)
-- -- -- -- -- -- -- -- --

Sub-total (B)(1):-
-- -- -- -- -- -- -- -- --

2. Non-Institutions

a) Bodies Corp.
-- -- -- -- -- -- -- -- --

i) Indian
-- -- -- -- -- -- -- -- --

ii) Overseas
-- -- -- -- -- -- -- -- --

b) Individuals
-- -- -- -- -- -- -- -- --

i) Individual shareholders holding


nominal share capital uptoRs. 1 lakh
-- -- -- -- -- -- -- -- --

ii) Individual shareholders holding


nominal share capital in excess of Rs 1
lakh -- -- -- -- -- -- -- -- --

23
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

c) Others (specify)
-- -- -- -- -- -- -- -- --

Sub-total (B)(2):-
-- -- -- -- -- -- -- -- --

Total Public Shareholding (B) = (B)(1) +


(B)(2)
-- -- -- -- -- -- -- -- --

C. Shares held by Custodian for GDRs &


-- -- -- -- -- -- -- -- --
ADRs

Grand Total (A+B+C)


-- 89337 89337 100 -- 71470 71470 100

(ii) Shareholding of Promoters

Shareholding at Shareholding
SlN
Shareholder's Name the beginning of at the end of
o.
the year the year

%of Shares
% of total Pledged/ % of total %of Shares Pledged/ % change in share
No. of Shares Shares of the encumbered No. of Shares Shares of the encumbered to total holding during
company to total company shares the year
shares

Dr. N. Venkata
1 3779 4.23 -- 3024 4.23 --
Reddy

2 Dr. T. Teena 3641 4.08 -- 2913 4.08 -- --

3 M. Narayana Reddy 6017 6.74 -- 4814 6.74 -- --

Sri. D. Ravindra
Reddy
4 6379 7.14 -- 5103 7.14 -- --

Dr. L. V. Subba
Reddy

24
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

5 6922 7.75 -- 5538 7.75 -- -

Dr. Nandigala
6 7419 8.30 -- 5935 8.30 -- --
Hemanth

Sri. Nandigala
7 7419 8.30 -- 5935 8.30 -- --
Prashanth

Sri. M. Maha
8 8322 9.32 -- 6658 9.32 -- --
Vishnu

9 Smt. M. Sudha 8322 9.32 -- 6658 9.32 -- --

10 Sri. L. V. Sunil 6734 7.54 -- 5387 7.54 -- --

11 Sri. L. V. Subash 6250 7.00 -- 5000 7.00 -- --

Smt. M. Lakshmi
Prasanna
12 1907 2.13 -- 1524 2.13 -- --

Smt. L. Naga
Amma
13 0 0 -- 0 0 -- 0

Smt. N.
Anasuyamma
14 895 1.00 -- 716 1.00 -- --

15 Dr. P. Gargi 2256 2.52 -- 1805 2.53 -- --

16 Smt. N. Sudarshana 1786 2.00 -- 1429 2.00 -- --

Sri. N. Vijaya
17 1786 2.00 -- 1429 2.00 -- --
Bhaskar Reddy

Sri. G.
18 Chandramouleswara 1430 1.60 -- 1144 1.60 -- --
Reddy

19 Smt. G. Vedavati 1482 1.66 -- 1186 1.66 -- --

Sri. C. Sudhakar
20 76 0.09 -- 61 0.09 -- --
Reddy

Dr. L. Sunita

25
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

21 4283 4.79 -- 3426 4.79 -- --

Sri. N.L. Narsimha


22 1786 2.00 -- 1429 2.00 -- --
Reddy

23 Smt. C. Saraswathi 370 0.41 -- 296 0.41 -- --

Sri. N. Rama Subba


0.04
Reddy
24 38 -- 30 0.04 -- --

Sri. N. Pareswara
0.04
Reddy
25 38 -- 30 0.04 -- --

89337
Total 100 -- 71470 100 -- --

(iii) Change in Promoters' Shareholding

Cumulative
Sl. Shareholding at the beginning
Shareholding
No. of the year
during the year

% of total % of total
No. of shares shares of the No. of shares shares of the
company company

At the beginning of the year 89337 100 89337 100

Due to buy back of 17,867


Date wise Increase/ Decrease in Promoters Shareholding during
equity shares at
the year specifying the reasons for increase/decrease (e.g.
Rs. 25000 per
allotment/transfer/bonus/ sweat equity etc):
share.

At the End of the year 71470 100 71470 100

26
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

(iv) Shareholding Pattern of top ten Shareholders (other than Directors, Promoters and Holders of GDRs and ADRs):

Cumulative
Sl. Shareholding at the
Shareholding during
No. beginning of the year
the year

% of total shares % of total shares


For Each of the Top 10 Shareholders No. of shares No. of shares
of the company of the company

At the beginning of the year -- -- -- --

Date wise Increase/Decrease in Share holding during


the year
-- -- -- --
specifying the reasons for increase/decrease (e.g.
allotment/ transfer/ bonus/sweat equity etc):

At the End of the year (or on the date of separation,


-- -- -- --
if separated during the year)

(v) Shareholding of Directors and Key Managerial Personnel:

Date wise Increase / Decrease in Share holding during


the year
For Each of the Shareholding at the Shareholding at
Sl.
Directors and beginning of the the end of the
No. specifying the reasons for increase / decrease (e.g.
KMP year year
allotment / transfer / bonus/ sweat equity etc):

% of total shares of
Date of
the No. of % of total shares
No. of shares increase/ Reason
shares of the company
decrease
company

The date of change is 31.07.2018 due to buy back of


Dr. N. Venkata

27
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

1 Reddy 3779 4.23 17867 equity shares at Rs. 25,000 per 3024 4.23
share.

M. Narayana
2 6017 6.74 4714 6.74
Reddy

Sri M. Maha
3 8322 9.32 6658 9.32
Vishnu

Dr. L. V. Subba
4 6922 7.74 5538 7.75
Reddy

Dr. Nandigala
5 7419 8.30 5935 8.30
Hemanth-

Sri. Nandigala
6 719 8.30 5935 8.30
Prasanth

7 M. Sudha 8322 9.32 6658 9.32

8 L. V. Subash 6250 7.00 5000 7.00

9 Dr. P. Gargi 2256 2.53 1805 2.53

10 S. Swetha - - - - - -

K. V. Ravindra
11 - - - -
Reddy

A. Venkata
12 - - - -
Reddy

28
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

V. INDEBTEDNESS:

Indebtedness of the Company including interest outstanding/accrued but not due for payment:

(Rs. In lakhs)

Secured Loans
Total
excluding Unsecured Loans Deposits
Indebtedness
deposits

Indebtedness at the beginning of the financial year

i) Principal Amount
1761.99
ii) Interest due but not paid - - 1761.99
-
iii) Interest accrued but not due - - -
-
- - -

1761.99 1761.99
Total (i+ii+iii) - -

Change in Indebtedness during the financial year

• Addition
425.05 - - 425.05
• Reduction
- - - -

Net Change 425.05 - - 425.05

Indebtedness at the end of the financial year

i) Principal Amount 2187.04


2187.04 - -
ii) Interest due but not paid -
- - -
iii) Interest accrued but not due -
- - -

Total (i+ii+iii) 2187.04 - - 2187.04

29
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

VI. REMUNERATION OF DIRECTORS AND KEY MANAGERIAL PERSONNEL:

A. Remuneration to Managing Director, Whole-time Directors and/or Manager:

Sl. Name of MD/WTD/


Particulars of Remuneration Total Amount
no. Manager

M. Narayana Reddy- MD
N. Venkata Reddy-
MD

Gross salary

(b) Value of perquisites u/s 17(2) Income-tax Act, 1961


1. 12,00,000 12,00,000 24,00,000
(c) Profits in lieu of salary under section 17(3) Income- tax Act,
1961

2. Stock Option -- -- --

3. Sweat Equity -- -- --

Commission

4. - as % of profit 2,45,00,000 2,45,00,000 4,90,00,000

- others, specify...

5. Others, please specify -- -- --

Total (A) 2,57,00,000 2,57,00,000 5,14,00,000

Companies Act,
Ceiling as per the Act Companies Act, 2013 Companies Act, 2013
2013

2,58,47,000 2,58,47,000 5,16,94,000

B. Remuneration to other directors:

Sl. no. Particulars of Remuneration Name of Directors Total Amount

30
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

3. Independent Directors -- -- --

• Fee for attending board committee meetings

• Commission

• Others, please specify

Total (1) -- -- --

4. Other Non-Executive Directors

• Fee for attending board committee meetings

• Commission -- -- --

• Others, please specify

Total (2) -- -- --

Total (B) = (1 + 2)

Total Managerial Remuneration 2,57,00,000 2,57,00,000 5,14,00,000

Overall Ceiling as per the Act Companies Act, 2013 Companies Act, 2013 Companies Act, 2013

2,58,47,000 2,58,47,000 5,14,00,000

C. REMUNERATION TO KEY MANAGERIAL PERSONNEL OTHER THAN MD/MANAGER/WTD:

Sl. Key Managerial


Particulars of Remuneration
no. Personnel

Company
CEO CFO Total
Secretary

Gross salary

(a) Salary as per provisions contained in section 17(1) of the Income-tax Act,
1961
1. -- -- -- --
(b) Value of perquisites u/s 17(2) Income-tax Act, 1961

(c) Profits in lieu of salary under section 17(3) Income-tax Act, 1961

2. Stock Option -- -- -- --

31
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

3. Sweat Equity -- -- -- --

Commission

4. - as % of profit -- -- -- --

- others, specify...

5. Others, please specify -- -- -- --

Total -- -- -- --

VII. PENALTIES/PUNISHMENT/COMPOUNDING OF OFFENCES:

Details of Penalty/
Section of the Brief Punishment/ Authority Appeal made, if any (give
Type
Companies Act Description Compounding fees [RD/NCLT/COURT] Details)
imposed

A. COMPANY

Penalty -- -- -- --

Punishment -- -- -- --

Compounding -- -- -- --

B. DIRECTORS

Penalty -- -- -- --

Punishment -- -- -- --

Compounding -- -- -- --

C. OTHER OFFICERS IN
DEFAULT

Penalty -- -- -- --

Punishment -- -- -- --

32
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Compounding -- -- -- --

For and on behalf of the Board

Virchow Laboratories Limited

M. Narayana Reddy Dr. N. Venkata Reddy

Managing Director (Technical) Managing Director (Commercial)

(DIN: 00064392) (DIN : 01740424)

Date: 31.08.2019

Place: Hyderabad

33
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (12)

Disclosure for companies covered under section 178(1) on directors appointment and remuneration including other
matters provided under section 178(3) [Text Block]
DIRECTORS AND KEY MANAGERIAL PERSONNEL APPOINTED OR RESIGNED:

· In accordance with Section 152 of the Act, Mr. L.V. Subash and Mr. M. Maha Vishnu Directors of the Company retire by rotation at the
ensuing Annual General Meeting and being eligible, offer themselves for re-appointment.

· Pursuant to sections 196 and 197 of Companies Act, 2013, continuation of Dr. N. Venkata Reddy as Managing Director of the Company is
proposed for the approval of shareholders.

· During the period under review, Mr. D. Ravinder Reddy resigned from the Board on 18.07.2018. The Board has place on records its sincere
appreciation for the valuable contributions made by him.

Textual information (13)

Disclosure of statement on development and implementation of risk management policy [Text Block]
A STATEMENT INDICATING DEVELOPMENT AND IMPLEMENTATION OF A RISK MANAGEMENT POLICY FOR THE COMPANY
INCULDING IDENTIFICATION THEREIN OF ELEMENTS OF RISK, IF ANY, WHICH IN THE OPINION OF THE BOARD MAY
THREATEN THE EXISTENCE OF THE COMPANY:

Company follows a comprehensive system of Risk Management. Company has adopted a procedure for assessment and minimization of probable
risks. It ensures that all the risks are timely defined and mitigated in accordance with the well-structured risk management process. The company
also adopted the Risk Management Policy.

34
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (14)

Details on policy development and implementation by company on corporate social responsibility initiatives taken
during year [Text Block]
COMPOSITION OF CSR AND THE DETAILS ABOUT THE POLICY DEVELOPED AND IMPLEMENTED BY THE COMPANY ON
CORPORATE SOCIAL RESPONSIBILITY INITIATIVES TAKEN DURING THE YEAR:

In terms of section 135 and schedule VII of the Companies Act, 2013, the Board of Directors of the company has constituted a CSR committee.
The CSR committee of the Board has developed CSR policy. The details of the composition of the committee are given below:

1. Mr. A. Venkata Reddy - Chairman

2. Mr. N. Prasanth - Member

3. Mr. M. Vishnu Mundla - Member

The Policy adopted by the Company is placed on website of the company i.e. www.virchows.com. The details on amount spent on CSR activities
is attached in ANNEXURE - 5

Textual information (15)

Report on highlights on performance of subsidiaries, associates and joint venture companies and their contribution to
overall performance of the companies during the period under report [Text Block]
INFORMATION ABOUT THE FINANCIAL PERFORMANCE OF SUBSIDIARIES / ASSOCIATES/ JOINT VENTURES:

As on 31st March, 2019, the Company has three (3) Subsidiary Companies namely Andhra Organics Limited (wholly- owned subsidiary),
Virchow Drugs Limited, Virchow Healthcare private Limited and one Associated company that is Virchow Bio-tech Private Limited respectively.
The Financial performance of the subsidiary companies and associate company are mentioned in FORM AOC- 1 in accordance with Section
129(3) of the Companies Act, 2013 which is annexed as ANNEXURE 1.

35
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (16)

Disclosure as per rule 8(5) of companies accounts rules 2014 [Text Block]
DIRECTORS’ REPORT

To

The Members of

Virchow Laboratories Limited.

Your Directors have pleasure in presenting the 37th Directors’ Report on the business and operations of the Company together with the audited
Financial Statements for the year ended 31st March, 2019.

FINANCIAL SUMMARY/HIGHLIGHTS, OPERATIONS, STATE OF AFFAIRS:

The financial results for the financial year 2018-19 and for the previous financial year 2017-18 are given as under

Particulars (Rs. in Lakhs)

Standalone

2018-19 2017-18

Income from operations 37187.57 33553.81

Other Income 814.42 635.40

Profit/ (Loss) before Interest, Depreciation & tax 5209.53 3978.97

36
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Depreciation 501.89 480.05

Financial charges 59.96 49.41

Profit / (Loss) Before Tax 4647.68 3449.01

Provision for Tax (including deferred Tax ) 1551.70 1205.34

Comprehensive Income –As per


3112.76 2269.72
Ind AS

Net Profit/(Loss) 3095.98 2243.68

PERFORMANCE REVIEW:

Standalone:

The Company has recorded a turnover of Rs. 37187.57 Lakhs and earned a Net Profit of Rs 3095.98 Lakhs in the financial year 2018-19 as
against the turnover of Rs. 33353.81 Lakhs and net Profit of Rs. 2243.68 Lakhs in the financial year 2017-18.

TRANSFER TO RESERVES:

37
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

During the period, the Company has transferred Rs. 17.87 lakhs to capital redemption reserve.

DIVIDEND:

During the year, the Directors do not recommend payment of any dividend.

CHANGE IN THE NATURE OF BUSINESS, IF ANY:

During the period under review and the date of Board’s Report there was no change in the nature of Business.

MATERIAL CHANGES AND COMMITMENTS, IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY WHICH HAVE
OCCURRED BETWEEN THE END IF THE FINANCIAL YEAR OF THE COMPANY TO WHICH THE FINANCIAL STATEMENTS
RELATE AND THE DATE OF THE REPORT:

There are no material changes and commitments affecting financial position of the company between 31st March, 2019 and the date of Boards’
Report. (i.e. 21.08.2019)

NUMBER OF MEETINGS OF THE BOARD:

The Board of Directors met 4 times during the year on 02.06.2018, 18.07.2018, 06.09.2018 and 29.12.2018 the maximum gap between any two
meetings was less than four months, as stipulated under the provisions of Companies Act, 2013.

PUBLIC DEPOSITS:

The Company has not accepted any deposits falling within the meaning of Sec.73 of the Companies Act, 2013 read with the Companies
(Acceptance of Deposits) Rules, 2014 during the financial year under review.

38
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

CAPITAL OF THE COMPANY:

During the period under review, the Company’s Authorized Share capital of the company stand at Rs. 1,50,00,000 divided into 1,50,000 equity
shares of Rs.100/- each.

The company bought back 17,867 equity shares at a price of Rs. 24,900/- each aggregating to Rs.44.49 crores and accordingly the Paid up capital
of the Company stands reduced to Rs. 71,47,000 divided into 71,470 equity shares of Rs. 100/- each.

INFORMATION ABOUT THE FINANCIAL PERFORMANCE OF SUBSIDIARIES / ASSOCIATES/ JOINT VENTURES:

As on 31st March, 2019, the Company has three (3) Subsidiary Companies namely Andhra Organics Limited (wholly- owned subsidiary),
Virchow Drugs Limited, Virchow Healthcare private Limited and one Associated company that is Virchow Bio-tech Private Limited respectively.
The Financial performance of the subsidiary companies and associate company are mentioned in FORM AOC- 1 in accordance with Section
129(3) of the Companies Act, 2013 which is annexed as ANNEXURE 1.

NAMES OF THE COMPANIES WHICH HAVE BECOME OR CEASED TO BE ITS SUBSIDIARIES, JOINT VENTURES OR ASSOCIATE
COMPANIES DURING THE YEAR:

During the period under review, there are no companies who ceased or became the subsidiaries, joint ventures or associate companies.

INSURANCE:

The company's properties have been adequately insured against major risks. All the insurable interests of your Company including inventories,
buildings, plant and machinery, stock and receivables under legislative enactments are adequately insured.

A STATEMENT INDICATING DEVELOPMENT AND IMPLEMENTATION OF A RISK MANAGEMENT POLICY FOR THE COMPANY

39
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

INCULDING IDENTIFICATION THEREIN OF ELEMENTS OF RISK, IF ANY, WHICH IN THE OPINION OF THE BOARD MAY
THREATEN THE EXISTENCE OF THE COMPANY:

Company follows a comprehensive system of Risk Management. Company has adopted a procedure for assessment and minimization of probable
risks. It ensures that all the risks are timely defined and mitigated in accordance with the well-structured risk management process. The company
also adopted the Risk Management Policy.

DIRECTORS AND KEY MANAGERIAL PERSONNEL APPOINTED OR RESIGNED:

· In accordance with Section 152 of the Act, Mr. L.V. Subash and Mr. M. Maha Vishnu Directors of the Company retire by rotation at the
ensuing Annual General Meeting and being eligible, offer themselves for re-appointment.

· Pursuant to sections 196 and 197 of Companies Act, 2013, continuation of Dr. N. Venkata Reddy as Managing Director of the Company is
proposed for the approval of shareholders.

· During the period under review, Mr. D. Ravinder Reddy resigned from the Board on 18.07.2018. The Board has place on records its sincere
appreciation for the valuable contributions made by him.

DIRECTORS RESPONSIBILITY STATEMENT:

Pursuant to the provisions of Sec. 134(5) of the Companies Act, 2013 the Board of Directors of your Company hereby certifies and confirms that:

a. In the preparation of the Annual Accounts, the applicable accounting standards have been followed along with proper explanation relating to
material departures;

40
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

b. The Directors have selected such accounting policies and applied them consistently and made judgment and estimates that are reasonable and
prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit and loss of the
Company for that period;

c. The Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of
the Companies Act, 2013 for safeguarding the Assets of the Company and for preventing and detecting fraud and other irregularities;

d. The Directors have prepared the Annual accounts on a going concern basis.

e. The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were
adequate and operating effectively and

f. The Directors had laid down internal financial controls to be followed by the company and that such internal financial controls are adequate
and were operating effectively.

INDIAN ACCOUNTING STANDARDS (IndAS)

The Ministry of Corporate Affairs vide its notification dated 16th February, 2015 has notified the Companies (Indian Accounting Standards)
Rules, 2015. In pursuance of the said notification, the Company has adopted Indian Accounting Standards (IndAS) with effect from 01st April,
2017.

DETAILS IN REPECT OF FRAUDS REPORTED BY AUDITORS UNDER SUB-SECTION (12) OF SECTION 143 OTHER THAN THOSE
WHICH ARE REPORTABLE TO CENTRAL GOVERNMENT.

There were no frauds reported by the auditors as per section 143 (12) other than those which are reportable to Central Government.

41
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

STATUTORY AUDITORS:

M/s Ramana Reddy & Associates, Chartered Accountants, Hyderabad was appointed as Statutory Auditors in the AGM held on 30.09.2014 upto
31.03.2019. Therefore their re-appointment as statutory auditors for a period of five (5) years commencing from 01.04.2019 to 31.03.2024. .

COST AUDITOR:

Sri P. Srinivas, Cost Accountant, Hyderabad (Registration No. 100309), acting as cost auditor to audit the cost records maintained by the
company for the financial year 2019-2020, on a remuneration of Rs. 1,00,000./-

SECRETARIAL AUDITOR:

Pursuant to the provisions of Section 134(3) (f) & Section 204 of the Companies Act, 2013, Secretarial audit report as provided by M/s. S. S.
Reddy & Associates, Practicing Company Secretaries is annexed to this Report as an ANNEXURE 2.

EXPLANATIONS OR COMMENTS BY THE BOARD ON EVERY QUALIFICATIONS, RESERVATIONS OR ADVERSE REMARK OR


DISCLAIMER MADE-

The Board has duly reviewed the Statutory Auditor’s Report and Secretarial Audit Report for the year ended March 31, 2019 and has noted that
the same does not have any reservation, qualification or adverse remarks.

EXTRACT OF ANNUAL RETURN:

As required pursuant to section 92(3) of the Companies Act, 2013 and rule 12(1) of the Companies (Management and Administration) Rules,
2014, an extract of annual return in MGT 9 as a part of this Annual Report as ANNEXURE 3.

42
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHNAGE OUTGO:

The required information as per Section 134(3)(m) of the Companies Act, 2013 is provided in ANNEXURE 4.

DISCLOSURE OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS

The Internal Financial Controls with reference to financial statements as designed and implemented by the Company are adequate. The Company
maintains appropriate system of internal control, including monitoring procedures, to ensure that all assets are safeguarded against loss from
unauthorized use or disposition. Company policies, guidelines and procedures provide for adequate checks and balances, and are meant to ensure
that all transactions are authorized, recorded and reported correctly.

During the period under review, there is no material or serious observations have been noticed for inefficiency or inadequacy of such controls.

SIGNIFICANT & MATERIAL ORDERS PASSED BY THE REGULATORS:

During the period under review there are no significant and material orders passed by the regulators or Courts or Tribunals impacting the going
concern status and the company’s operations in future.

IN CASE OF A COMPANY COVERED UNDER SUB-SECTION (1) OF SECTION 178, COMPANY’S POLICY ON DIRECTORS”
APPOINTMENT AND REMUNERATION INCULDING CRITERIA FOR DETERMING QUALIFICATIONS, POSITIVE ATTRIBUTES,
INDEPENDENCE OF A DIRECTOR AND OTHER MATTERS PROVIDED UNDER SUB-SECTION (3) OF SECTION 178:

The Nomination & Remuneration Committee constituted and the Policy framed and adopted by the Company is in line with the provisions of with
Section 178 of the Companies Act, 2013 and the details of the composition of the Committee are given below:

43
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

1. Mr. K.V. Ravindra Reddy - Chairman

2. Mr. A. Venkata Reddy - Member

3. Mr. M. Narayana Reddy - Member

The Policy adopted by the Company is placed on website of the company i.e., www.virchows.com.

PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS:

The Company has not given any loan or guarantee as specified under section 186 of the Companies Act, 2013. The Investments made by the
Company under section 186 of the companies Act, 2013 were within the limits of section 186(2) of the Companies Act, 2013.

AUDIT COMMITTEE:

The Audit Committee of the Company is constituted in line with the provisions of with Section 177 of the Companies Act, 2013 and the details of
the composition of the Committee are given below:

1. Mr. K.V. Ravindra Reddy - Chairman

2. Mr. A. Venkata Reddy - Member

3. Mr. M. Narayana Reddy - Member

COMPOSITION OF CSR AND THE DETAILS ABOUT THE POLICY DEVELOPED AND IMPLEMENTED BY THE COMPANY ON
CORPORATE SOCIAL RESPONSIBILITY INITIATIVES TAKEN DURING THE YEAR:

In terms of section 135 and schedule VII of the Companies Act, 2013, the Board of Directors of the company has constituted a CSR committee.

44
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

The CSR committee of the Board has developed CSR policy. The details of the composition of the committee are given below:

1. Mr. A. Venkata Reddy - Chairman

2. Mr. N. Prasanth - Member

3. Mr. M. Vishnu Mundla - Member

The Policy adopted by the Company is placed on website of the company i.e. www.virchows.com. The details on amount spent on CSR activities
is attached in ANNEXURE - 5

RELATED PARTY TRANSACTIONS:

All contracts/arrangements/transactions entered by the Company during the financial year with related parties were in the ordinary course of
business on arm’s length basis and were in compliance with the applicable provisions of the Companies Act, 2013. The Company has not entered
into any transaction of a material nature with any of the related parties which are in conflict with the interest of the Company.

Particulars of contracts or arrangements with related parties are provided in the notes of accounts as part of financial statements and also in
FORM AOC – 2 which is annexed as ANNEXURE - 6.

STATEMENT SHOWING THE NAMES OF THE TOP TEN EMPLOYEES IN TERMS OF REMUNERATION DRAWN AND THE NAME
OF EVERY EMPLOYEE:

A statement showing the names of the top ten employees in terms of remuneration drawn and the name of every employee is not applicable.

SECRETARIAL STANDARDS:

The company is in compliance with the applicable secretarial standards.

45
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND
REDRESSAL) ACT, 2013:

The Company always endeavors to create and provide an environment that is free from discrimination and harassment including sexual
harassment. Directors further states that during the year under review, there were no cases filed pursuant to the Sexual Harassment of Women at
Workplace (Prevention, Prohibition and Redressal) Act, 2013.

ACKNOWLEDGEMENTS:

The directors would like to express their grateful appreciation for assistance and co-operation received from clients, banks, investors,
Government, other statutory authorities and all others associated with the company. Your directors also wish to place on record their deep sense
of appreciation for the excellent contribution made by the employees at all levels, which enabled the company to achieve sustained growth in the
operational performance during the year under review.

For and on behalf of the Board

Virchow Laboratories Limited

M. Narayana Reddy Dr. N. Venkata Reddy

Managing Director (Technical) Managing Director (Commercial)

(DIN: 00064392) (DIN : 01740424)

46
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Date: 31.08.2019

Place: Hyderabad

47
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (17)

Disclosure of financial summary or highlights [Text Block]


FINANCIAL SUMMARY/HIGHLIGHTS, OPERATIONS, STATE OF AFFAIRS:

The financial results for the financial year 2018-19 and for the previous financial year 2017-18 are given as under

Particulars (Rs. in Lakhs)

Standalone

2018-19 2017-18

Income from operations 37187.57 33553.81

Other Income 814.42 635.40

Profit/ (Loss) before Interest, Depreciation & tax 5209.53 3978.97

Depreciation 501.89 480.05

Financial charges 59.96 49.41

Profit / (Loss) Before Tax 4647.68 3449.01

Provision for Tax (including deferred Tax ) 1551.70 1205.34

Comprehensive Income –As per


3112.76 2269.72
Ind AS

Net Profit/(Loss) 3095.98 2243.68

PERFORMANCE REVIEW:

48
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Standalone:

The Company has recorded a turnover of Rs. 37187.57 Lakhs and earned a Net Profit of Rs 3095.98 Lakhs in the financial year 2018-19 as
against the turnover of Rs. 33353.81 Lakhs and net Profit of Rs. 2243.68 Lakhs in the financial year 2017-18.

Textual information (18)

Details of directors or key managerial personnels who were appointed or have resigned during year [Text Block]
DIRECTORS AND KEY MANAGERIAL PERSONNEL APPOINTED OR RESIGNED:

· In accordance with Section 152 of the Act, Mr. L.V. Subash and Mr. M. Maha Vishnu Directors of the Company retire by rotation at the
ensuing Annual General Meeting and being eligible, offer themselves for re-appointment.

· Pursuant to sections 196 and 197 of Companies Act, 2013, continuation of Dr. N. Venkata Reddy as Managing Director of the Company is
proposed for the approval of shareholders.

· During the period under review, Mr. D. Ravinder Reddy resigned from the Board on 18.07.2018. The Board has place on records its sincere
appreciation for the valuable contributions made by him.

49
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (19)

Disclosure of companies which have become or ceased to be its subsidiaries, joint ventures or associate companies
during year [Text Block]
NAMES OF THE COMPANIES WHICH HAVE BECOME OR CEASED TO BE ITS SUBSIDIARIES, JOINT VENTURES OR ASSOCIATE
COMPANIES DURING THE YEAR:

During the period under review, there are no companies who ceased or became the subsidiaries, joint ventures or associate companies.

Textual information (20)

Details relating to deposits covered under chapter v of companies act [Text Block]
PUBLIC DEPOSITS:

The Company has not accepted any deposits falling within the meaning of Sec.73 of the Companies Act, 2013 read with the Companies
(Acceptance of Deposits) Rules, 2014 during the financial year under review.

Textual information (21)

Details of deposits which are not in compliance with requirements of chapter v of act [Text Block]
PUBLIC DEPOSITS:

The Company has not accepted any deposits falling within the meaning of Sec.73 of the Companies Act, 2013 read with the Companies
(Acceptance of Deposits) Rules, 2014 during the financial year under review.

Textual information (22)

Details of significant and material orders passed by regulators or courts or tribunals impacting going concern status
and company’s operations in future [Text Block]
SIGNIFICANT & MATERIAL ORDERS PASSED BY THE REGULATORS:

During the period under review there are no significant and material orders passed by the regulators or Courts or Tribunals impacting the going
concern status and the company’s operations in future.

50
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (23)

Details regarding adequacy of internal financial controls with reference to financial statements [Text Block]
DISCLOSURE OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS

The Internal Financial Controls with reference to financial statements as designed and implemented by the Company are adequate. The Company
maintains appropriate system of internal control, including monitoring procedures, to ensure that all assets are safeguarded against loss from
unauthorized use or disposition. Company policies, guidelines and procedures provide for adequate checks and balances, and are meant to ensure
that all transactions are authorized, recorded and reported correctly.

51
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (24)

Disclosure of contents of corporate social responsibility policy [Text Block]


REPORT ON CSR ACTIVITIES

[Pursuant to section 135 of the Companies Act, 2013 and Rule 9 of the Companies (Corporate Social Responsibility) Rules, 2014]

1. A brief Outline of Company’s CSR Policy, including overview of projects or programmes undertaken/ proposed to be undertaken:

The CSR committee of the Board has developed CSR Policy consist of

a) Eradicating poverty, promoting health care & sanitation and making available safe drinking water

b) Promoting education

c) Rural development projects

d) Sports promotion

2. Composition of CSR Committee:

The details of the composition of the committee are given below:

1. Mr. A. Venkata Reddy - Chairman

2. Mr. N. Prasanth - Member

3. Mr. M. Vishnu Mundla - Member

3. Average net profits of the company for last three financial years

The average net profit of the Company for the last three financial years was Rs. 59,58,09,750

52
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

4. Prescribed CSR Expenditure (two per cent of above)

The Company has allocated 2% of the average net profits of the last three financial years for the CSR initiative which amounts to Rs. 1,19,16,195

5. Details of CSR spent during the financial year:

(a)Total amount spent for the financial year: Rs. 91,73,565

(b) Amount unspent, if any: (Rs)

2016-17 34,81,066

2017-18 – 1,33,42,522

2018-19 - 1,19,16,195

2,87,39,783

(c) Manner in which the amount spent during the financial year is detailed below:

(1) (2) (3) (4) (5) (6) (7) (8)

Amount spent on the


CSR project or Location of Cumul-ative expenditure Amount spent Direct or
Sl. Sector in which the Amount projects or Programs
activity Project / upto to the reporting through implementing
No Project is covered outlay
identified Programs period agency
(rupees in lakhs)

Promotion of
1 32.92
education

Promotion of
2 7.20
sports

Promotion of
3 28.42
health care

Providing safe
4 4.87
drinking water

Rural
5 18.33
development

TOTAL 91.74

53
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

6. In case the company has failed to spend the 2% of the average net profits of the last three financial years or any part thereof, the company shall
provide the reasons for not spending the amount in its board report:

We spend the money on need base. However, we will spend the balance unspent amount in future as per our company CSR policy by considering
the present provisions as per Companies Act.

Textual information (25)

Disclosure of appointment and remuneration of director or managerial personnel if any, in the financial year [Text
Block]
DIRECTORS AND KEY MANAGERIAL PERSONNEL APPOINTED OR RESIGNED:

· In accordance with Section 152 of the Act, Mr. L.V. Subash and Mr. M. Maha Vishnu Directors of the Company retire by rotation at the
ensuing Annual General Meeting and being eligible, offer themselves for re-appointment.

· Pursuant to sections 196 and 197 of Companies Act, 2013, continuation of Dr. N. Venkata Reddy as Managing Director of the Company is
proposed for the approval of shareholders.

· During the period under review, Mr. D. Ravinder Reddy resigned from the Board on 18.07.2018. The Board has place on records its sincere
appreciation for the valuable contributions made by him.

54
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[700500] Disclosures - Signatories of financial statements

Details of directors signing financial statements [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Directors signing financial statements [Axis] 1 2
01/04/2018 01/04/2018
to to
31/03/2019 31/03/2019
Details of signatories of financial statements [Abstract]
Details of directors signing financial statements [Abstract]
Details of directors signing financial statements [LineItems]
Name of director signing financial statements [Abstract]
NANDIGALA NARAYANA
First name of director VENKATA REDDY REDDY MUNDLA
Designation of director Managing Director Managing Director
Director identification number of director 01740424 00064392
Date of signing of financial statements by director 31/08/2019 31/08/2019

55
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[700400] Disclosures - Auditors report

Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Auditor's Clause not
Auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Axis] favourable remark applicable
[Member] [Member]
01/04/2018 01/04/2018
to to
31/03/2019 31/03/2019
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in
auditors' report [Abstract]
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in
auditors' report [LineItems]
Textual information
Disclosure in auditors report relating to fixed assets (26) [See below]
(i) (a) The company
has maintained
proper records
showing full
Disclosure relating to quantitative details of fixed assets particulars including
quantitative details
and situation of fixed
assets.
Disclosure relating to physical verification and material discrepancies of fixed Textual information
assets (27) [See below]
Textual information
Disclosure relating to title deeds of immovable properties (28) [See below]
(ii) Physical
verification of
inventory has been
conducted at
Disclosure in auditors report relating to inventories reasonable intervals
by the management
and no material
discrepancies were
noticed.
Textual information
Disclosure in auditors report relating to loans (29) [See below]
Disclosure about loans granted to parties covered under section 189 of companies Textual information
act (30) [See below]
Textual information
Disclosure relating to terms and conditions of loans granted (31) [See below]
Textual information
Disclosure regarding receipt of loans granted (32) [See below]
Textual information
Disclosure regarding terms of recovery of loans granted (33) [See below]
Disclosure in auditors report relating to compliance with Section 185 and 186 of Textual information
Companies Act, 2013 (34) [See below]
Textual information
Disclosure in auditors report relating to deposits accepted (35) [See below]
Textual information
Disclosure in auditors report relating to maintenance of cost records (36) [See below]
Textual information
Disclosure in auditors report relating to statutory dues [TextBlock] (37) [See below]
Disclosure relating to regularity in payment of undisputed statutory dues Textual information
[TextBlock] (38) [See below]
(b) According to the
information and
explanations given
to us, there are no
dues of income tax,
Disclosure relating to disputed statutory dues [TextBlock] customs duty, goods
and service tax and
cess which have not
been deposited on
account of any
dispute.

56
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

(viii) The company


has not availed any
loans or borrowings
from a financial
Disclosure in auditors report relating to default in repayment of financial dues institution or banks.
Accordingly,
paragraph 3(viii) of
the Order is no
applicable.
Disclosure in auditors report relating to public offer and term loans used for Textual information
purpose for which those were raised (39) [See below]
Disclosure in auditors report relating to fraud by the company or on the Textual information
company by its officers or its employees reported during period (40) [See below]
Textual information
Disclosure in auditors report relating to managerial remuneration (41) [See below]
(xii) In our opinion
and according to the
information and
explanations given
Disclosure in auditors report relating to Nidhi Company to us, the company is
not a nidhi company.
Accordingly,
paragraph 3 (xii) is
not applicable.
Textual information
Disclosure in auditors report relating to transactions with related parties (42) [See below]
Disclosure in auditors report relating to preferential allotment or private Textual information
placement of shares or convertible debentures (43) [See below]
Disclosure in auditors report relating to non-cash transactions with directors Textual information
or persons connected with him (44) [See below]
(xvi) The company
is not required to be
Disclosure in auditors report relating to registration under section 45-IA of registered under
Reserve Bank of India Act, 1934 section 45-IA of the
Reserve Bank of
India Act, 1934.

Details regarding auditors [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Auditors [Axis] 1
01/04/2018
to
31/03/2019
Details regarding auditors [Abstract]
Details regarding auditors [LineItems]
Category of auditor Auditors firm
RAMANA REDDY
Name of audit firm & ASSOCIATES
AGASTHYA
REDDY
Name of auditor signing report RAJASEKHAR
REDDY
Firms registration number of audit firm 003246S
Membership number of auditor 227799
Unit No.406, 4th
Floor, “Ashoka
Capitol”, Opp : KBR
Address of auditors Park Road No.2,
Banjara
Hills,Hyderabad –
500 034.
Permanent account number of auditor or auditor's firm AADFA6113F
SRN of form ADT-1 Z99999999
Date of signing audit report by auditors 31/08/2019
Date of signing of balance sheet by auditors 31/08/2019

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018
to
31/03/2019
Textual information (45)
Disclosure in auditor’s report explanatory [TextBlock] [See below]
Whether companies auditors report order is applicable on company Yes
Whether auditors' report has been qualified or has any reservations or
No
contains adverse remarks

57
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (26)

Disclosure in auditors report relating to fixed assets


(i) (a) The company has maintained proper records showing full particulars including quantitative details and situation of fixed assets. (b) The
fixed assets of the company have been physically verified by the management during the year as per a programme of verification, which in our
opinion is reasonable having regard to the size of the company and the nature of its fixed assets. No material discrepancies were noticed on such
verification. (c) According to the information and explanations given to us and on the basis of our examination of the records of the Company, the
title deeds of immovable properties are held in the name of the company.

Textual information (27)

Disclosure relating to physical verification and material discrepancies of fixed assets


(b) The fixed assets of the company have been physically verified by the management during the year as per a programme of verification, which
in our opinion is reasonable having regard to the size of the company and the nature of its fixed assets. No material discrepancies were noticed on
such verification.

Textual information (28)

Disclosure relating to title deeds of immovable properties


(c) According to the information and explanations given to us and on the basis of our examination of the records of the Company, the title deeds
of immovable properties are held in the name of the company.

Textual information (29)

Disclosure in auditors report relating to loans


(iii) The company has not granted any loans, secured or unsecured to companies, firms or other parties covered in the register maintained under
section 189 of the Companies Act during the year. Accordingly, the sub-clauses (a) (b) and (c) are not applicable to the company.

Textual information (30)

Disclosure about loans granted to parties covered under section 189 of companies act
(iii) The company has not granted any loans, secured or unsecured to companies, firms or other parties covered in the register maintained under
section 189 of the Companies Act during the year. Accordingly, the sub-clauses (a) (b) and (c) are not applicable to the company.

Textual information (31)

Disclosure relating to terms and conditions of loans granted


(iii) The company has not granted any loans, secured or unsecured to companies, firms or other parties covered in the register maintained under
section 189 of the Companies Act during the year. Accordingly, the sub-clauses (a) (b) and (c) are not applicable to the company.

Textual information (32)

Disclosure regarding receipt of loans granted


(iii) The company has not granted any loans, secured or unsecured to companies, firms or other parties covered in the register maintained under
section 189 of the Companies Act during the year. Accordingly, the sub-clauses (a) (b) and (c) are not applicable to the company.

58
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (33)

Disclosure regarding terms of recovery of loans granted


(iii) The company has not granted any loans, secured or unsecured to companies, firms or other parties covered in the register maintained under
section 189 of the Companies Act during the year. Accordingly, the sub-clauses (a) (b) and (c) are not applicable to the company.

Textual information (34)

Disclosure in auditors report relating to compliance with Section 185 and 186 of Companies Act, 2013
(iv) According to the information and explanations given to us and on the basis of our examination of the records of the Company, the Company
has not provided any loans, investments, guarantees, and security during the year as referred to in sections 185 and 186 of the Companies Act,
2013.

Textual information (35)

Disclosure in auditors report relating to deposits accepted


(v) In our opinion and according to the information and explanations given to us, the company has not accepted any deposits in terms of directives
issued by Reserve Bank of India and the provisions of sections 73 to 76 or any other relevant provisions of the Companies Act and the rules
framed there under are not applicable.

Textual information (36)

Disclosure in auditors report relating to maintenance of cost records


(vi) In our opinion and according to the information and explanations given to us, the company has maintained the cost records as prescribed by
the Central Government in accordance with the provisions of Section 148(1) of the Act. However, we have not made detailed examination of the
same.

Textual information (37)

Disclosure in auditors report relating to statutory dues [Text Block]


(vii) (a) The company is generally regular in depositing with appropriate authorities undisputed statutory dues including provident fund,
employees’ state insurance, income tax, goods and service tax, custom duty, cess and other material statutory dues as applicable to it. According
to the information and explanations given to us, no undisputed amounts payable in respect of income tax, goods and service tax, customs duty,
and cess were in arrears, wherever applicable, as at 31st March, 2019 for a period of more than six months from the date they became payable.

Textual information (38)

Disclosure relating to regularity in payment of undisputed statutory dues [Text Block]


(vii) (a) The company is generally regular in depositing with appropriate authorities undisputed statutory dues including provident fund,
employees’ state insurance, income tax, goods and service tax, custom duty, cess and other material statutory dues as applicable to it. According
to the information and explanations given to us, no undisputed amounts payable in respect of income tax, goods and service tax, customs duty,
and cess were in arrears, wherever applicable, as at 31st March, 2019 for a period of more than six months from the date they became payable.

Textual information (39)

Disclosure in auditors report relating to public offer and term loans used for purpose for which those were raised
(ix) The company did not raise any money by way of initial public offer or further public offer (including debt instruments) and term loans during
the year. Accordingly, paragraph 3 (ix) of the Order is not applicable.

59
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (40)

Disclosure in auditors report relating to fraud by the company or on the company by its officers or its employees
reported during period
(x) To the best of our knowledge and according to the information and explanations given to us, no material fraud by the company or on the
company by its officers or employees has been noticed or reported during the course of our audit.

Textual information (41)

Disclosure in auditors report relating to managerial remuneration


(xi) According to the information and explanations given to us and basis on our examination of the records of the company, the company has
paid/provided for managerial remuneration in accordance with requisite approvals mandated by the provisions of section 197 read with schedule
V to the act.

Textual information (42)

Disclosure in auditors report relating to transactions with related parties


(xiii) According to the information and explanations given to us and based on our examination of the records of the company, transactions with
related parties are in compliance with section 188 of the Companies Act and details of such transactions have been disclosed in the standalone Ind
AS financial statements as required by the applicable accounting standards.

Textual information (43)

Disclosure in auditors report relating to preferential allotment or private placement of shares or convertible
debentures
(xiv) According to the information and explanations given to us and based on our examination of the records of the company, the company has
not made any preferential allotment or private placement of shares or fully or partly convertible debentures during the year.

Textual information (44)

Disclosure in auditors report relating to non-cash transactions with directors or persons connected with him
(xv) According to the information and explanations given to us and based on our examination of the records of the company, the company has not
entered into any non-cash transactions with directors or persons connected with him. Accordingly, paragraph 3 (xv) is not applicable.

60
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (45)

Disclosure in auditor’s report explanatory [Text Block]

Unit No.406, 4th Floor,

Ashoka Capitol, Opp:KBR Park,

Road No.2,Banjara Hills,


Ramana Reddy & Associates
Hyderabad – 500 034
Chartered Accountants
Ph: 23316426/23316912

Email:rr.associates83@gmail.com

INDEPENDENT AUDITOR’S REPORT

To

The Members of

VIRCHOW LABORATORIES LIMITED

Report on the Standalone Ind AS Financial Statements

Opinion

We have audited the accompanying Ind AS financial statements of VIRCHOW LABORATORIES LIMITED (“the Company”), which comprise
the Balance Sheet as at 31st March, 2019, the Statement of Profit and Loss (including Other Comprehensive Income), the Statement of Cash
Flows and the Statement of Changes in Equity for the year then ended, and a summary of the significant accounting policies and other
explanatory information.

In our opinion and to the best of our information and according to the explanations given to us, the aforesaid Ind AS financial statements give the

61
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

information required by the Companies Act, 2013 (“the Act”) in the manner so required and give a true and fair view in conformity with the
Indian Accounting Standards prescribed under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015, as
amended, (“Ind AS”) and other accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2019, the
profit and total comprehensive income, changes in equity and its cash flows for the year ended on that date

Basis for Opinion

We conducted our audit of the Ind AS financial statements in accordance with the Standards on Auditing (SAs) specified under section 143(10) of
the Companies Act, 2013. Our responsibilities under those Standards are further described in the Auditor’s Responsibilities for the Audit of the
Ind AS Financial Statements section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the
Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the Ind AS financial statements
under the provisions of the Companies Act, 2013 and the Rules there under, and we have fulfilled our other ethical responsibilities in accordance
with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a
basis for our audit opinion on the separate Ind AS financial statements.

Management’s Responsibility for the Standalone Ind AS Financial Statements

The Company’s Board of Directors is responsible for the matters stated in Section 134(5) of the Companies Act, 2013 (“the Act”) with respect to
the preparation of these Standalone Ind AS financial statements that give a true and fair view of the state of affairs (financial position), profit or
loss (financial performance including other comprehensive income), cash flows and changes in equity of the Company in accordance with the
accounting principles generally accepted in India. This responsibility also includes maintenance of adequate accounting records in accordance
with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities;
selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design,
implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and
completeness of the accounting records, relevant to the preparation and presentation of the Standalone Ind AS financial statements that give a true
and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the Standalone Ind AS financial statements, management is responsible for assessing the Company’s ability to continue as a going
concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either
intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

The Board of Directors are also responsible for overseeing the company’s financial reporting process.

Auditor’s Responsibilities for the Audit of the Standalone Ind AS Financial Statements

Our objectives are to obtain reasonable assurance about whether the Standalone Ind AS financial statements as a whole are free from material
misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of

62
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists.
Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to
influence the economic decisions of users taken on the basis of these standalone Ind AS financial statements.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We
also:

· Identify and assess the risks of material misstatement of the standalone Ind AS financial statements, whether due to fraud or error, design
and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our
opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve
collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

· Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the
circumstances. Under section 143(3)(i) of the Companies Act, 2013, we are also responsible for expressing our opinion on whether the company
has adequate internal financial controls system in place and the operating effectiveness of such controls.

· Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by
management.

· Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained,
whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability to continue as a
going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures
in the Ind AS financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence
obtained up to the date of our auditor’s report. However, future events or conditions may cause the Company to cease to continue as a going
concern.

· Evaluate the overall presentation, structure and content of the standalone Ind AS financial statements, including the disclosures, and
whether the standalone Ind AS financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant
audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding
independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and
where applicable, related safeguards.

63
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of
the standalone Ind AS financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor’s
report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter
should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public
interest benefits of such communication.

Report on Other Legal and Regulatory Requirements

1. As required by the Companies (Auditor’s Report) Order, 2016 (“the Order”) issued by the Central Government in terms of Section 143(11)
of the Act, we give in “Annexure A” a statement on the matters specified in paragraphs 3 and 4 of the Order.

2. As required by Section 143(3) of the Act, we report that:

a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the
purposes of our audit.

b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of
those books.

c) The Balance Sheet, the Statement of Profit and Loss including Other Comprehensive Income, Statement of Changes in Equity and the
Statement of Cash Flow dealt with by this Report are in agreement with the relevant books of account.

d) In our opinion, the aforesaid standalone Ind AS financial statements comply with the Indian Accounting Standards prescribed under
section 133 of the Act, read with Rule 7 of the Companies (Accounts) Rules, 2014.

e) On the basis of the written representations received from the directors as on 31st March, 2019 taken on record by the Board of Directors,
none of the directors is disqualified as on 31st March, 2019 from being appointed as a director in terms of Section 164(2) of the Act.

f) With respect to the adequacy of the internal financial controls over financial reporting of the Company and the operating effectiveness of
such controls, refer to our Report in “Annexure B”.

64
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

g) With respect to the other matters to be included in the Auditor’s Report in accordance with the requirements of section 197(16) of the Act,
as amended:

In our opinion and to the best of our information and according to the explanations given to us, the remuneration paid by the Company to its
directors during the year is in accordance with the provisions of section 197 of the Act.

h) With respect to the other matters to be included in the Auditor’s Report in accordance with Rule 11 of the Companies (Audit and Auditors)
Rules, 2014, in our opinion and to the best of our information and according to the explanations given to us:

i. The Company does not have any pending litigations which would impact its financial position.

ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses.

iii. There were no amounts required to be transferred, to the Investor Education and Protection Fund by the Company.

For RAMANA REDDY & ASSOCIATES

CHARTERED ACCOUNTANTS

Firm Regn. No. 003246S

65
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

(CA.RAJASEKHAR REDDY A.)

PARTNER

Membership No.227799

PLACE: HYDERABAD

DATE: 31.08.2019

ANNEXURE - A TO THE INDEPENDENT AUDITOR’S REPORT

(Referred to in paragraph 1 of Report on Other Legal and Regulatory

Requirements, of our report of even date)

(i) (a) The company has maintained proper records showing full particulars including quantitative details and situation of fixed assets.

(b) The fixed assets of the company have been physically verified by the management during the year as per a programme of verification,
which in our opinion is reasonable having regard to the size of the company and the nature of its fixed assets. No material discrepancies were
noticed on such verification.

(c) According to the information and explanations given to us and on the basis of our examination of the records of the Company, the title
deeds of immovable properties are held in the name of the company.

(ii) Physical verification of inventory has been conducted at reasonable intervals by the management and no material discrepancies were
noticed.

(iii) The company has not granted any loans, secured or unsecured to companies, firms or other parties covered in the register maintained
under section 189 of the Companies Act during the year. Accordingly, the sub-clauses (a) (b) and (c) are not applicable to the company.

66
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

(iv) According to the information and explanations given to us and on the basis of our examination of the records of the Company, the
Company has not provided any loans, investments, guarantees, and security during the year as referred to in sections 185 and 186 of the
Companies Act, 2013.

(v) In our opinion and according to the information and explanations given to us, the company has not accepted any deposits in terms of
directives issued by Reserve Bank of India and the provisions of sections 73 to 76 or any other relevant provisions of the Companies Act and the
rules framed there under are not applicable.

(vi) In our opinion and according to the information and explanations given to us, the company has maintained the cost records as
prescribed by the Central Government in accordance with the provisions of Section 148(1) of the Act. However, we have not made detailed
examination of the same.

(vii) (a) The company is generally regular in depositing with appropriate authorities undisputed statutory dues including provident fund,
employees’ state insurance, income tax, goods and service tax, custom duty, cess and other material statutory dues as applicable to it.

According to the information and explanations given to us, no undisputed amounts payable in respect of income tax, goods and service tax,
customs duty, and cess were in arrears, wherever applicable, as at 31st March, 2019 for a period of more than six months from the date they
became payable.

(b) According to the information and explanations given to us, there are no dues of income tax, customs duty, goods and service tax and cess
which have not been deposited on account of any dispute.

(viii) The company has not availed any loans or borrowings from a financial institution or banks. Accordingly, paragraph 3(viii) of the
Order is no applicable.

(ix) The company did not raise any money by way of initial public offer or further public offer (including debt instruments) and term
loans during the year. Accordingly, paragraph 3 (ix) of the Order is not applicable.

(x) To the best of our knowledge and according to the information and explanations given to us, no material fraud by the company or on
the company by its officers or employees has been noticed or reported during the course of our audit.

67
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

(xi) According to the information and explanations given to us and basis on our examination of the records of the company, the company
has paid/provided for managerial remuneration in accordance with requisite approvals mandated by the provisions of section 197 read with
schedule V to the act.

(xii) In our opinion and according to the information and explanations given to us, the company is not a nidhi company. Accordingly,
paragraph 3 (xii) is not applicable.

(xiii) According to the information and explanations given to us and based on our examination of the records of the company, transactions
with related parties are in compliance with section 188 of the Companies Act and details of such transactions have been disclosed in the
standalone Ind AS financial statements as required by the applicable accounting standards.

(xiv) According to the information and explanations given to us and based on our examination of the records of the company, the company
has not made any preferential allotment or private placement of shares or fully or partly convertible debentures during the year.

(xv) According to the information and explanations given to us and based on our examination of the records of the company, the company
has not entered into any non-cash transactions with directors or persons connected with him. Accordingly, paragraph 3 (xv) is not applicable.

(xvi) The company is not required to be registered under section 45-IA of the Reserve Bank of India Act, 1934.

For RAMANA REDDY & ASSOCIATES

CHARTERED ACCOUNTANTS

Firm Regn. No.003246S

PLACE: HYDERABAD

DATE: 31.08.2019

(CA.RAJASEKHAR REDDY A)

PARTNER

Membership No.227799

68
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

ANNEXURE - B TO THE INDEPENDENT AUDITOR’S REPORT

Report on the Internal Financial Controls under Clause (i) of Sub-section 3 of Section 143 of the

Companies Act, 2013 (“the Act”)

We have audited the internal financial controls over financial reporting of VIRCHOW LABORATORIES LIMITED (“the Company”) as of 31
March 2019 in conjunction with our audit of the standalone Ind AS financial statements of the Company for the year ended on that date.

Management’s Responsibility for Internal Financial Controls

The Company’s management is responsible for establishing and maintaining internal financial controls based on the internal control over financial
reporting criteria established by the Company considering the essential components of internal control stated in the Guidance Note on Audit of
Internal Financial Controls over Financial Reporting issued by the Institute of Chartered Accountants of India (‘ICAI’). These responsibilities
include the design, implementation and maintenance of adequate internal financial controls that were operating effectively for ensuring the
orderly and efficient conduct of its business, including adherence to company’s policies, the safeguarding of its assets, the prevention and
detection of frauds and errors, the accuracy and completeness of the accounting records, and the timely preparation of reliable financial
information, as required under the Companies Act, 2013.

Auditors’ Responsibility

Our responsibility is to express an opinion on the Company's internal financial controls over financial reporting based on our audit. We conducted
our audit in accordance with the Guidance Note on Audit of Internal Financial Controls over Financial Reporting (the “Guidance Note”) and the
Standards on Auditing, issued by ICAI and deemed to be prescribed under section 143(10) of the Companies Act, 2013, to the extent applicable to
an audit of internal financial controls, both applicable to an audit of Internal Financial Controls and, both issued by the Institute of Chartered
Accountants of India. Those Standards and the Guidance Note require that we comply with ethical requirements and plan and perform the audit to
obtain reasonable assurance about whether adequate internal financial controls over financial reporting was established and maintained and if
such controls operated effectively in all material respects.

69
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Our audit involves performing procedures to obtain audit evidence about the adequacy of the internal financial controls system over financial
reporting and their operating effectiveness. Our audit of internal financial controls over financial reporting included obtaining an understanding of
internal financial controls over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and
operating effectiveness of internal control based on the assessed risk. The procedures selected depend on the auditor’s judgment, including the
assessment of the risks of material misstatement of the financial statements, whether due to fraud or error.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion on the Company’s
internal financial controls system over financial reporting.

Meaning of Internal Financial Controls over Financial Reporting

A company's internal financial control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
A company's internal financial control over financial reporting includes those policies and procedures that(1) pertain to the maintenance of
records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide
reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorisations of
management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorised
acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Inherent Limitations of Internal Financial Controls Over Financial Reporting

Because of the inherent limitations of internal financial controls over financial reporting, including the possibility of collusion or improper
management override of controls, material misstatements due to error or fraud may occur and not be detected. Also, projections of any evaluation
of the internal financial controls over financial reporting to future periods are subject to the risk that the internal financial control over financial
reporting may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may
deteriorate.

Opinion

70
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

In our opinion, the Company has, in all material respects, an adequate internal financial controls system over financial reporting and such internal
financial controls over financial reporting were operating effectively as at 31 March 2019, based on the internal control over financial reporting
criteria established by the Company considering the essential components of internal control stated in the Guidance Note on Audit of Internal
Financial Controls Over Financial Reporting issued by the Institute of Chartered Accountants of India.

For RAMANA REDDY & ASSOCIATES

CHARTERED ACCOUNTANTS

Firm Regn. No.003246S

PLACE: HYDERABAD

DATE: 31.08.2019

(CA.RAJASEKHAR REDDY A.)

PARTNER

Membership No.227799

[700700] Disclosures - Secretarial audit report

Details of signatories of secretarial audit report [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Signatories of secretarial audit report [Axis] 1
01/04/2018
to
31/03/2019
Details of signatories of secretarial audit report [Abstract]
Details of signatories of secretarial audit report [LineItems]
Category of secretarial auditor Individual
Name of secretarial auditor signing report AAKANKSHA
Membership number of secretarial auditor 49041
Certificate of practice number of secretarial auditor 20064
P l o t
No.8-2-603/23/3 &
8-2-603/23, 15, 2nd
Floor, HSR Summit,
Address of secretarial auditors Road No.10 Banjara
Hills, Beside No. 1
News channel office,
Hyderabad-500034.
Permanent account number of secretarial auditor or secretarial auditors firm AWRPA9608B
Date of signing secretarial audit report 31/08/2019

71
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018
to
31/03/2019
Disclosure in secretarial audit report explanatory [TextBlock]
Whether secretarial audit report is applicable on company Yes
Whether secretarial audit report has been qualified or has any
No
observation or other remarks

72
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[110000] Balance sheet


Unless otherwise specified, all monetary values are in Lakhs of INR
31/03/2019 31/03/2018 31/03/2017
Balance sheet [Abstract]
Assets [Abstract]
Non-current assets [Abstract]
Property, plant and equipment 4,223.02 4,577.9
Other intangible assets 0 0
Non-current financial assets [Abstract]
Non-current investments 3,057.13 3,054.24
Loans, non-current 0 0
Other non-current financial assets 0 599.74
Total non-current financial assets 3,057.13 3,653.98
Other non-current assets 345.51 143.78
Total non-current assets 7,625.66 8,375.66
Current assets [Abstract]
Inventories 2,979.53 2,603.06
Current financial assets [Abstract]
Current investments 3,564.54 4,289.66
Trade receivables, current 6,596.83 7,771.59
Cash and cash equivalents 1,446.94 26.66
Loans, current 0 0
Other current financial assets 134.51 165.33
Total current financial assets 11,742.82 12,253.24
Current tax assets 27.82 0
Other current assets 658.2 2,160.95
Total current assets 15,408.37 17,017.25
Total assets 23,034.03 25,392.91
Equity and liabilities [Abstract]
Equity [Abstract]
Equity attributable to owners of parent [Abstract]
Equity share capital 71.47 89.34 117.55
Other equity 19,869.36 22,241.9
Total equity attributable to owners of parent 19,940.83 22,331.24
Non controlling interest 0 0
Total equity 19,940.83 22,331.24
Liabilities [Abstract]
Non-current liabilities [Abstract]
Non-current financial liabilities [Abstract]
Borrowings, non-current 0 0
Other non-current financial liabilities 45.36 43.96
Total non-current financial liabilities 45.36 43.96
Provisions, non-current 378.08 348.87
Deferred tax liabilities (net) 86.01 173.53
Total non-current liabilities 509.45 566.36
Current liabilities [Abstract]
Current financial liabilities [Abstract]
Borrowings, current 2,187.04 1,761.99
Trade payables, current 98.73 118.07
Other current financial liabilities 217.7 373.9
Total current financial liabilities 2,503.47 2,253.96
Other current liabilities 52.49 151.06
Provisions, current 27.79 34.17
Current tax liabilities 0 56.12
Total current liabilities 2,583.75 2,495.31
Total liabilities 3,093.2 3,061.67
Total equity and liabilities 23,034.03 25,392.91

73
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[210000] Statement of profit and loss

Earnings per share [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Statement of profit and loss [Abstract]
Earnings per share [Abstract]
Earnings per share [Line items]
Basic earnings per share [Abstract]
[INR/shares]
Basic earnings (loss) per share from continuing operations 4,175.19
[INR/shares] 2,465.96

Basic earnings (loss) per share from discontinued operations [INR/shares] 0 [INR/shares] 0
[INR/shares]
Total basic earnings (loss) per share 4,175.19
[INR/shares] 2,465.96

Diluted earnings per share [Abstract]


[INR/shares]
Diluted earnings (loss) per share from continuing operations 4,175.19
[INR/shares] 2,465.96

Diluted earnings (loss) per share from discontinued operations [INR/shares] 0 [INR/shares] 0
[INR/shares]
Total diluted earnings (loss) per share 4,175.19
[INR/shares] 2,465.96

74
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Statement of profit and loss [Abstract]
Income [Abstract]
Revenue from operations 37,187.57 33,553.81
Other income 814.42 635.4
Total income 38,001.99 34,189.21
Expenses [Abstract]
Cost of materials consumed 22,578.79 19,691.36
Purchases of stock-in-trade 479.34 453.11
Changes in inventories of finished goods, work-in-progress and
135.37 863.28
stock-in-trade
Employee benefit expense 2,833.54 2,497.17
Finance costs 59.96 49.41
Depreciation, depletion and amortisation expense 501.9 480.56
Other expenses 6,765.41 6,705.31
Total expenses 33,354.31 30,740.2
Profit before exceptional items and tax 4,647.68 3,449.01
Total profit before tax 4,647.68 3,449.01
Tax expense [Abstract]
Current tax 1,648.24 1,257.33
Deferred tax -96.54 -51.99
Total tax expense 1,551.7 1,205.34
Total profit (loss) for period from continuing operations 3,095.98 2,243.67
Total profit (loss) for period 3,095.98 2,243.67
Comprehensive income OCI components presented net of tax [Abstract]
Whether company has other comprehensive income OCI components
No No
presented net of tax
Other comprehensive income net of tax [Abstract]
Components of other comprehensive income that will not be
reclassified to profit or loss, net of tax [Abstract]
Other comprehensive income, net of tax, gains (losses) on
-9.02 -13.99
revaluation
Other comprehensive income, net of tax, gains (losses) on
22.92 33.72
remeasurements of defined benefit plans
Other comprehensive income, net of tax, change in fair
value of financial liability attributable to change 2.88 6.3
in credit risk of liability
Other comprehensive income, net of tax, net
movement in regulatory deferral account
0 0
balances related to items that will not be
reclassified to profit or loss
Total other comprehensive income that will not be reclassified
16.78 26.03
to profit or loss, net of tax
Total other comprehensive income 16.78 26.03
Total comprehensive income 3,112.76 2,269.7
Comprehensive income OCI components presented before tax [Abstract]
Whether company has comprehensive income OCI components presented
No No
before tax
Other comprehensive income before tax [Abstract]
Total other comprehensive income 16.78 26.03
Total comprehensive income 3,112.76 2,269.7
Earnings per share explanatory [TextBlock]
Earnings per share [Abstract]
Basic earnings per share [Abstract]
Diluted earnings per share [Abstract]

75
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[400200] Statement of changes in equity

Statement of changes in equity [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Equity attributable
to the equity
Components of equity [Axis] Equity [Member]
holders of the
parent [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Other equity [Abstract]
Statement of changes in equity [Line items]
Equity [Abstract]
Changes in equity [Abstract]
Comprehensive income [Abstract]
Profit (loss) for period 3,095.98 2,243.67 3,095.98
Changes in comprehensive income components 16.78 26.04 16.78
Total comprehensive income 3,112.76 2,269.71 3,112.76
Other changes in equity [Abstract]
Other additions to reserves -5,485.3 -8,256.52 -5,485.3
Total other changes in equity -5,485.3 -8,256.52 -5,485.3
Total increase (decrease) in equity -2,372.54 -5,986.81 -2,372.54
Other equity at end of period 19,869.36 22,241.9 28,228.71 19,869.36

Statement of changes in equity [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Equity attributable to the equity holders
Components of equity [Axis] Reserves [Member]
of the parent [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Other equity [Abstract]
Statement of changes in equity [Line items]
Equity [Abstract]
Changes in equity [Abstract]
Comprehensive income [Abstract]
Profit (loss) for period 2,243.67 3,095.98 2,243.67
Changes in comprehensive income components 26.04 16.78 26.04
Total comprehensive income 2,269.71 3,112.76 2,269.71
Other changes in equity [Abstract]
Other additions to reserves -8,256.52 -5,485.3 -8,256.52
Total other changes in equity -8,256.52 -5,485.3 -8,256.52
Total increase (decrease) in equity -5,986.81 -2,372.54 -5,986.81
Other equity at end of period 22,241.9 28,228.71 19,869.36 22,241.9

76
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Statement of changes in equity [Table] ..(3)


Unless otherwise specified, all monetary values are in Lakhs of INR
Components of equity [Axis] Reserves [Member] Capital redemption reserves [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Other equity [Abstract]
Statement of changes in equity [Line items]
Equity [Abstract]
Changes in equity [Abstract]
Comprehensive income [Abstract]
Profit (loss) for period 0 0
Total comprehensive income 0 0
Other changes in equity [Abstract]
Other additions to reserves 17.87 0
Total other changes in equity 17.87 0
Total increase (decrease) in equity 17.87 0
Other equity at end of period 28,228.71 46.08 28.21 28.21

Statement of changes in equity [Table] ..(4)


Unless otherwise specified, all monetary values are in Lakhs of INR
Retained earnings
Components of equity [Axis] General reserve [Member]
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Other equity [Abstract]
Statement of changes in equity [Line items]
Equity [Abstract]
Changes in equity [Abstract]
Comprehensive income [Abstract]
Profit (loss) for period 0 0 3,095.98
Changes in comprehensive income components 16.78
Total comprehensive income 0 0 3,112.76
Other changes in equity [Abstract]
Other additions to reserves -5,503.16
Total other changes in equity -5,503.16
Total increase (decrease) in equity 0 0 -2,390.4
Other equity at end of period 4,598.59 4,598.59 4,598.59 15,211.11

Statement of changes in equity [Table] ..(5)


Unless otherwise specified, all monetary values are in Lakhs of INR
Remeasurements of defined benefit plans
Components of equity [Axis] Retained earnings [Member]
[Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Other equity [Abstract]
Statement of changes in equity [Line items]
Equity [Abstract]
Changes in equity [Abstract]
Comprehensive income [Abstract]
Profit (loss) for period 2,243.67 3,095.98 2,243.67
Changes in comprehensive income components 26.04 16.78 26.04
Total comprehensive income 2,269.71 3,112.76 2,269.71
Other changes in equity [Abstract]
Other additions to reserves -8,256.52 -5,503.16 -8,256.52
Total other changes in equity -8,256.52 -5,503.16 -8,256.52
Total increase (decrease) in equity -5,986.81 -2,390.4 -5,986.81
Other equity at end of period 17,601.51 23,588.32 15,211.11 17,601.51

77
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Statement of changes in equity [Table] ..(6)


Unless otherwise specified, all monetary values are in Lakhs of INR
Remeasurements
Components of equity [Axis] of defined benefit Other reserves [Member]
plans [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Other equity [Abstract]
Statement of changes in equity [Line items]
Equity [Abstract]
Changes in equity [Abstract]
Comprehensive income [Abstract]
Profit (loss) for period 0 0
Total comprehensive income 0 0
Other changes in equity [Abstract]
Other additions to reserves -0.01 0
Total other changes in equity -0.01 0
Total increase (decrease) in equity -0.01 0
Other equity at end of period 23,588.32 13.58 13.59 13.59
State Subsidy and State Subsidy and
Description of nature of other reserves Investment Allowance Investment Allowance
Utilised Reserve Utilised Reserve

78
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[320000] Cash flow statement, indirect


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to 31/03/2017
31/03/2019 31/03/2018
Statement of cash flows [Abstract]
Whether cash flow statement is applicable on company Yes Yes
Cash flows from used in operating activities [Abstract]
Profit before tax 4,647.68 3,449.01
Adjustments for reconcile profit (loss) [Abstract]
Adjustments for decrease (increase) in inventories -376.47 1,151.75
Adjustments for decrease (increase) in trade receivables, current 1,174.76 -1,623.33
Adjustments for decrease (increase) in other current assets 1,533.56 -287.59

Adjustments for decrease (increase) in other non-current assets 0


(A) -0.05
Adjustments for other financial assets, current (B) 725.12 (C) 5,515.58
Adjustments for increase (decrease) in other current liabilities -330.85 -246.34
Adjustments for depreciation and amortisation expense 501.89 480.55
Adjustments for provisions, current 22.83 13.48

Other adjustments to reconcile profit (loss) (D) -17.87 (E) -28.21


Total adjustments for reconcile profit (loss) 3,232.97 4,975.84
Net cash flows from (used in) operations 7,880.65 8,424.85
Income taxes paid (refund) 1,648.23 1,225.24
Net cash flows from (used in) operating activities 6,232.42 7,199.61
Cash flows from used in investing activities [Abstract]
Proceeds from sales of property, plant and equipment 2.14 2.44
Purchase of property, plant and equipment 149.15 651.5

Other inflows (outflows) of cash (F) 395.12 (G) -27.14


Net cash flows from (used in) investing activities 248.11 -676.2
Cash flows from used in financing activities [Abstract]
Proceeds from borrowings (H) 425.04 (I) 453.57
Other inflows (outflows) of cash (J) -5,485.29
-8,221.7

Net cash flows from (used in) financing activities -5,060.25 -7,768.13
Net increase (decrease) in cash and cash equivalents before effect of
1,420.28 -1,244.72
exchange rate changes
Net increase (decrease) in cash and cash equivalents 1,420.28 -1,244.72
Cash and cash equivalents cash flow statement at end of period 1,446.94 26.66 1,271.38

Footnotes
(A) Loss on sale of Fixed Assets
(B) Increase/Decrease in Current Investments
(C) Increase/Decrease in Current Investments
(D) Increase/Decrease in Equity
(E) Increase/Decrease in Equity
(F) Increase/Decrease in Investments
(G) Increase/Decrease in Investments
(H) Increase/Decrease in Borrowings
(I) Increase/Decrease in Borrowings
(J) Buy back of equity premium and its Tax paid - (8228.31) Transitional Reserve - 6.61

79
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[610100] Notes - List of accounting policies


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018
to
31/03/2019
Textual information (46)
Disclosure of significant accounting policies [TextBlock] [See below]

80
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (46)

Disclosure of significant accounting policies [Text Block]

NOTES FORMING PART OF FINANCIAL STATEMENTS

NOTE 1

DESCRIPTION OF THE COMPANY AND SINGNIFICANT ACCOUNTING POLICIES:

1. Background:

Virchow Laboratories Limited (“the company”) was Incorporated in 1982 and its registered office in Hyderabad, Telangana, India. Virchow
Laboratories Limited is the largest producer of Sulfamethoxazole in the world. Virchow also undertakes custom synthesis and manufacture of
drug intermediates and bulk chemicals.

2. Significant Accounting Policies:

This note provides a list of the significant accounting policies adopted in the preparation of these financial statements. These policies have been
consistently applied to all the years presented, unless otherwise stated.

a) Basis of preparation of financial statements:

The financial statements of the company have been prepared and presented in accordance with the Indian Accounting Standards (“Ind AS”)
notified under the Companies ( Indian Accounting Standards) Rules, 2015 and as amended from time to time.

81
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:

· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;

· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.

b) Use of Estimates and Judgments:

The preparation of financial statements in conformity with Ind AS required management to make judgments, estimates and assumptions that
affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Accounting estimates may
change from period to period. Actual results may differ from these estimates.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which
the estimates are revised and if material, their effects are disclosed in the notes to the standalone financial statements.

c) Functional and Presentation Currency:

Items included in the financial statements are measured using the currency of the primary economic environment in which the entity operates ('the
functional currency'). These financial statements are prepared in Indian rupee, which is also the functional currency of the Company. All financial
information presented in Indian rupees has been rounded to the nearest Lakhs.

82
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

d) Current and Non- Current classification:

The Company presents assets and liabilities in the balance sheet based on current/ non-current classification.

An asset is treated as current when it is:

• Expected to be realized or intended to be sold or consumed in normal operating cycle

• Held primarily for the purpose of trading

• Expected to be realized within twelve months after the reporting period or

• Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period

All other assets are classified as non-current.

A liability is current when:

• It is expected to be settled in normal operating cycle

• It is due to be settled within twelve months after the reporting period, or

• There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period

83
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

The Company classifies all other liabilities as non-current.

Deferred tax assets and liabilities are classified as non-current assets and liabilities.

The operating cycle is the time between the acquisition of assets for processing and their realization in cash and cash equivalents. The Company
has identified twelve months as its operating cycle.

e) Foreign Currency transactions:

Transactions in foreign currencies are translated to the functional currencies of the Company at exchange rates at the dates of the transactions.
Monetary assets and liabilities denominated in foreign currencies at the reporting date are translated into the functional currency at the exchange
rate at that date. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at that date when
the fair value was measured. Exchange differences arising on settlements of monetary items or on translating monetary items at rates difference
from those at which they were translated on initial recognition during the period or in the previous financial statements are recognized in the
statement of profit and loss in the period in which they arise with.

f) Revenue Recognition:

· Sale of Goods:

Revenue is recognized when significant risks and rewards of ownership have been transferred to the buyer, recovery of consideration is probable,
the associated costs and possible return of goods can be estimated reliably, there is no continuing management involvement with the goods and
the amount of revenue can be measured reliably. Revenue from the sale of goods is measured at fair value of the consideration received or
receivable, net of returns, Goods and Service tax (GST), applicable trade discounts, allowances and amounts collected on behalf of third parties.

Revenue from export sales and other sales outside of India is recognized when the significant risks and rewards of ownership of products are
transferred to the customers, which occurs upon delivery of the products to the customers unless the terms of the applicable contract provide
specific revenue generating activities to be completed, in which case revenue is recognized once all such activities are completed.

· Sales Returns:

84
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

The Company accounts for sales returns accrual by recording an allowance for sales returns concurrent with the recognition of revenue at the time
of a product sale.

Interest Income:

Interest income primarily comprises of interest from term deposits and electricity deposits. Interest income is recorded using the effective rate of
interest. Interest income is included in other income in the statement of profit and loss.

· Dividend Income:

Dividend income is recognized when the Company’s right to receive the payment is established, which is generally when shareholders approve
the dividend.

· Export incentives:

Export incentives are recognized as income when the right to receive credit as per the terms of the scheme is established in respect of the exports
made and where there is no significant uncertainty regarding the ultimate collection of the relevant export proceeds.

g) Government Grants:

Grants from the government are recognized at fair value where there is a reasonable assurance that the grant will be received and the company
will comply with the attached conditions.

h) Income tax:

The income tax expense or credit for the period is the tax payable on the current period's taxable income based on the applicable income tax rate
for each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses.

The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period.

85
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Deferred income tax provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities
and their carrying amounts in the financial statements. Deferred income tax is determined using tax rates (and laws) that have been enacted or
substantially enacted by the end of the reporting period and are expected to apply when the related deferred income tax asset is realized or the
deferred income tax liability is settled.

Deferred tax assets are recognized for all deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilize those temporary differences and losses.

Current and deferred tax is recognized in profit or loss, except to the extent that it relates to items recognized in other comprehensive income or
directly in equity, In this case, the tax is also recognized in other comprehensive income or directly in equity, respectively

i) Earnings per share:

The Company presents basic and diluted earnings per share (“EPS”) data for its ordinary shares.

Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of
ordinary shares outstanding during the period.

Diluted EPS is determined by adjusting the profit or loss attributable to ordinary shareholders and the weighted average number of ordinary
shares outstanding for the effects of all dilutive potential ordinary shares.

j) Property, Plant and equipment:

Items of property, plant and equipment are measured at cost less accumulated depreciation and accumulated impairment losses, if any.

Cost includes expenditures that are directly attributable to the asset. The cost of self- constructed assets includes the cost of materials and other
costs directly attributable to bringing the asset to a working condition for its intended use. General and Specific borrowing costs that are
attributable to the construction of a qualifying asset are capitalized as part of the cost of the asset during the period of time that is required to
complete and prepare the asset for its intended use or sale.

86
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Gains and losses upon disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the
carrying amount of property, plant and equipment and are recognized in the statement of profit and loss. The costs of repairs and maintenance are
recognized in the statement of profit and loss as incurred.

Advances paid towards the acquisition of property, plant and equipment outstanding at each reporting date is disclosed as Capital Advances under
other non-current assets.

k) Depreciation/Amortization methods, estimated useful lives and residual value

Depreciation is recognized in the statement of profit and loss on a Written Down Value (WDV) basis over the estimated useful lives of property,
plant and equipment. Leased assets are depreciated over the shorter of the lease term and their useful lives. Land is not depreciated.

Description of the Asset Useful Life in Years

Building 30 to 60 years

Plant & Machinery, Electrical Installations etc 10 to 20 years

Computers 3 years

Furniture 10 years

Office Equipment 5 years

Vehicles 8 to 10 years

The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period.

Gains or losses on disposal are determined by comparing proceeds with carrying amount.

87
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

l) Intangible assets:

i) Recognition:

In-tangible assets consist of software licenses etc. which are measured at cost on initial recognition and amortized over their estimated useful life.

ii) Amortization methods and periods:

The Company amortizes intangible assets on a straight line method over a period of six years.

m) Borrowings:

Borrowings are initially recognized at fair value, net of transaction cost incurred. Borrowings are subsequently measured at amortized cost. Any
difference between the proceeds (net of transaction costs) and the redemption amount is recognized in profit or loss over the period of the
borrowings using the effective interest method.

Borrowings are removed from the balance sheet when the obligation specified in the contract is discharged, cancelled or expired. The difference
between the carrying amount of a financial liability that has been extinguished or transferred to another party and the consideration paid,
including any non-cash assets transferred or liabilities assumed, is recognized in profit or loss.

Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least 12
months after the reporting period.

n) Borrowing Costs:

General and specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying asset are
capitalized during the period of time that is required to complete and prepare the asset for its intended use or sale. Qualifying assets are assets that
necessarily take a substantial period of time to get ready for their intended use or sale. Investment income earned on the temporary investment of
specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing cost eligible for capitalization. Other
borrowings costs are expensed in the period in which they are incurred.

o) Leases:

88
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

At the inception of each lease, the lease arrangement is classified as either a finance lease or operating lease, based on the substance of the lease
arrangement. A lease that transfers substantially all the risks and rewards incidental to ownership to the lessee is classified as a finance lease. All
other leases are classified as operating leases.

As a lessee:

Operating lease payments are recognized as an expense in the statement of profit & loss over lease term.

p) Inventories:

Inventories consists of raw materials, stores and spares, work-in-progress and finished goods and are measured at the lower of cost and net
realizable value. Net realizable value is the estimated selling price in the ordinary course of business less estimated costs of completion and the
estimated costs necessary to make the sale.

Cost includes expenditures incurred in acquiring the inventories, production or conversion costs and other costs incurred in bringing them to their
existing location and condition. In the case of finished goods and work-in-progress, cost includes an appropriate share of overheads based on
normal operating capacity. Stores and spares, that do not qualify to be recognized as property, plant and equipment, consists of packing materials,
engineering spares (such as machinery spare parts) and consumables which are used for operating machines are consumed as indirect materials in
the manufacturing process.

q) Investments and other financial assets:

89
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

i) Classification

The Company classifies its financial assets in the following measurement categories:

- Those to be measured subsequently at fair value (either through other comprehensive income, or through profit or loss), and

- those measured at amortized cost.

The classification depends on the entity's business model for managing the financial assets and the contractual terms of the cash flows. For assets
measured at fair value, gains and losses will either be recorded in profit or loss or other comprehensive income.

ii) Measurement

At initial recognition, the company measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit
or loss, transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at fair
value through profit or loss are expensed in profit or loss.

Debt instruments: Subsequent measurement of debt instruments depends on the Company's business model for managing the asset and the cash
flow characteristics of the asset. There are three measurement categories into which the Company classifies its debt instruments:

Amortized cost: Assets that are held for collection of contractual cash flows where those cash flows represent solely payments of principal and
interest are measured at amortized cost. A gain or loss on a debt investment that is subsequently measured at amortized cost and is not part of a
hedging relationship is recognized in profit or loss when the asset is derecognized or impaired. Interest income from these financial assets is
included in finance income using the effective interest rate method.

90
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Fair value through other comprehensive income (FVOCI): Assets that are held for collection of contractual cash flows and for selling the financial
assets, where the assets' cash flows represent solely payments of principal and interest, are measured at fair value through other comprehensive
income (FVOCI). Movements in the carrying amount are taken through OCI, except for the recognition of impairment gains or losses, interest
revenue and foreign exchange gains and losses which are recognized in profit and loss. When the financial asset is derecognized, the cumulative
gain or loss previously recognized in OCI is reclassified from equity to profit or loss and recognized in other gains/(losses). Interest income from
these financial assets is included in other income using the effective interest rate method.

Fair value through profit or loss: Assets that do not meet the criteria for amortized cost or FVOCI are measured at fair value through profit or loss.
A gain or loss on a debt investment that is subsequently measured at fair value through profit or loss and is not part of a hedging relationship is
recognized in profit or loss and presented net in the statement of profit and loss within other gains/(losses) in the period in which it arises. Interest
income from these financial assets is included in other income.

Equity instruments: The Company subsequently measures all equity investments at fair value. Where the company's management has elected to
present fair value gains and losses on equity investments in other comprehensive income, there is no subsequent reclassification of fair value
gains and losses to profit or loss. Dividends from such investments are recognized in profit or loss as other income when the Company's right to
receive payments is established.

Changes in the fair value of financial assets at fair value through profit or loss are recognized in other gain/(losses) in the statement of profit and
loss. Impairment losses (and reversal of impairment losses) on equity investments measured at FVOCI are not reported separately from other
changes in fair value.

iii) Impairment of financial assets:

The Company assesses on a forward looking basis the expected credit losses associated with its assets carried at amortized cost and FVOCI debt
instruments. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The company applies
the simplified approach permitted by Ind AS 109 Financial Instruments, which requires expected lifetime losses to be recognized from initial
recognition of the receivables.

iv) De-recognition of financial assets:

A financial asset is derecognized only when

· the company has transferred the rights to receive cash flow from the financial asset or

· retains the contractual rights to receive the cash flows of the financial assets, but assumes a contractual obligation to pay cash flows to one
or more recipients.

91
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Where the entity has transferred an asset, the Company evaluates whether it has transferred substantially all risks and rewards of ownership of the
financial asset. In such cases, the financial asset is derecognized. Where the entity has not transferred substantially all risks and rewards of
ownership of the financial asset is not derecognized.

Where the entity has neither transferred a financial asset nor retains substantially all risks and rewards of ownership of the financial asset, the
financial asset is derecognized if the Company has not retained control of the financial asset. Where the Company retains control of the financial
asset, the asset is continued to be recognized to the extent of continuing involvement in the financial asset.

r) Impairment of non-financial assets:

The carrying amounts of the Company’s non-financial assets, other than inventories and deferred tax assets are reviewed at each reporting date to
determine whether there is any indication of impairment.

s) Offsetting financial instruments:

Financial assets and liabilities are offset and the net amount is reported in the balance sheet where there is a legally enforceable right to offset the
recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously. The legally
enforceable right must not be contingent on future events and must be enforceable in the normal course of business and in the event of default,
insolvency or bankruptcy of the Company or the counterparty.

t) Employee benefits:

i) Short-term employee benefits:

Liabilities for wages and salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after the end of the
period in which the employees render the related service are recognized in respect of employees’ services up to the end of the reporting period
and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit
obligations in the balance sheet.

92
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

ii) Other long-term employee benefit obligations:

The liabilities for earned leave and sick leave are not expected to be settled wholly within 12 months after the end of the period in which the
employees render the related service. They are therefore measured at the present value of expected future payments to be made in respect of
services provided by employees up to the end of the reporting period using the projected unit credit method. The benefits are discounted using the
market yields at the end of the reporting period that have terms approximating to the terms of the related obligations. Remeasurements as a result
of the experience adjustments and changes in actuarial assumptions are recognized in profit or loss.

iii) Post Employment obligations:

The Company operates the following post-employment schemes:

(a) Defined benefit plans such as gratuity; and

(b) Defined contribution plans such as provident fund.

Gratuity obligations

The liability or assets recognized in the balance sheet in respect of gratuity plans is the present value of the defined benefit obligation at the end of
the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by actuaries using the projected unit
credit method.

The present value of the defined benefit obligation denominated in is determined by discounting the estimated future cash outflows by reference
to market yields at the end of the reporting period on government bonds that have terms approximating to the terms of the related obligation.

The interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets.
This cost is included in employee benefit expense in the statement of profit and loss.

Remeasurements gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which
they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and in the
balance sheet.

Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in
profit or loss as past service cost.

93
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Defined contribution plans

The company pays provident fund contributions to publicly administered funds as per regulations. The Company has no further payment
obligations once the contributions have been paid. The contributions are accounted for as defined contribution plans and the contributions are
recognized as employee benefit expense when they are due.

Compensated Absences:

Liability toward earned leaves is provided on the basis of actual leaves earned outstanding for payment.

iv) Bonus plans

The Company recognizes a liability and an expense for bonuses. The Company recognizes a provision where contractually obliged or where there
is a past practice that has created a constructive obligation.

u) Cash and Cash Equivalents:

For the purpose of presentation in the statement of cash flows, cash and cash equivalents includes cash on hand, deposits held at call with
financial institutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to
known amounts of cash and which are subject to an insignificant risk of changes in value. Bank overdrafts are shown within borrowings in current
liabilities in the balance sheet.

v) Trade Receivables:

Trade receivables are recognized initially at fair value and subsequently measured at amortized cost using effective interest method, less provision
for impairment.

94
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

w) Trade and other payables:

These amounts represent liabilities for goods and services provided to the company prior to the end of financial year which are unpaid. The
amounts are unsecured and are usually paid within 30 days of recognition. Trade and other payables are presented as current liabilities unless
payment is not due within 12 months after the reporting period. They are recognized initially at their fair value and subsequently measured at
amortized cost using the effective interest method.

x) Research & Development Expenses:

Research and development expenditure, which is of revenue nature, is charged to the profit and loss account, while capital expenditure is added to
the cost of Fixed Assets in the year in which these are incurred.

y) Provisions, contingent liabilities and contingent assets:

Provision: A provision is recognized if, as a result of a past event, the Company has a present legal or constructive obligation that can be
estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation.

Contingent Liability: A disclosure for a contingent liability is made when there is a possible obligation or a present obligation that may, but
probably will not, require an outflow of resources. Where there is a possible obligation or a present obligation in respect of which the likelihood
of outflow of resources is remote, no provision or disclosure is made.

Contingent Asset: Contingent assets are not recognized in the financial statements. However, contingent assets are assessed continually and if it is
virtually certain that an outflow of economic benefits will arise, the asset and related income are recognized in the period in which the change
occurs.

95
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

z) Standards issued but not yet effective:

Recent Accounting Pronouncements issued but not yet effective:

Ministry of Corporate Affairs (“MCA”) through Companies (Indian Accounting Standards) Amendment Rules, 2019 and Companies (Indian
Accounting Standards) Second Amendment Rules, has notified the following new and amendments to Ind AS which the company has not applied
as they are effective from April 1, 2019:

Ind AS 116 – Leases

Ind AS 116 will replace the existing leases standard, Ind AS 17 Leases. Ind AS 116 sets out the principles for the recognition, measurement,
presentation and disclosure of leases for both lessees and lessors. It introduces a single, on-balance sheet lessee accounting model for lessees. A
lessee recognizes right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease
payments. The standard also contains enhanced disclosure requirements for lessees. Ind AS 116 substantially carries forward the lessor
accounting requirements in Ind AS 17.

[610200] Notes - Corporate information and statement of IndAs compliance


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of corporate information notes and other explanatory information
[TextBlock]
Textual information (47) Textual information (48)
Statement of Ind AS compliance [TextBlock] [See below] [See below]
Whether there is any departure from Ind AS No No
Whether there are reclassifications to comparative amounts No No
Description of reason why reclassification of comparative amounts is Textual information (49) Textual information (50)
impracticable [See below] [See below]
Description of nature of necessary adjustments to provide comparative Textual information (51) Textual information (52)
information [See below] [See below]
Textual information (53)
Disclosure of significant accounting policies [TextBlock] [See below]

96
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (47)

Statement of Ind AS compliance [Text Block]


The financial statements of the company have been prepared and presented in accordance with the Indian Accounting Standards (“Ind AS”)
notified under the Companies ( Indian Accounting Standards) Rules, 2015 and as amended from time to time.

These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:

· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;

· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.

Textual information (48)

Statement of Ind AS compliance [Text Block]


The financial statements of the company have been prepared and presented in accordance with the Indian Accounting Standards (“Ind AS”)
notified under the Companies ( Indian Accounting Standards) Rules, 2015 and as amended from time to time.

These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:

· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;

· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.

97
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (49)

Description of reason why reclassification of comparative amounts is impracticable


a) Current and Non- Current classification: The Company presents assets and liabilities in the balance sheet based on current/ non-current
classification. An asset is treated as current when it is: • Expected to be realized or intended to be sold or consumed in normal operating cycle
• Held primarily for the purpose of trading • Expected to be realized within twelve months after the reporting period or • Cash or cash
equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period All other assets
are classified as non-current. A liability is current when: • It is expected to be settled in normal operating cycle • It is due to be settled within
twelve months after the reporting period, or • There is no unconditional right to defer the settlement of the liability for at least twelve months
after the reporting period The Company classifies all other liabilities as non-current. Deferred tax assets and liabilities are classified as
non-current assets and liabilities. The operating cycle is the time between the acquisition of assets for processing and their realization in cash and
cash equivalents. The Company has identified twelve months as its operating cycle.

Textual information (50)

Description of reason why reclassification of comparative amounts is impracticable


a) Current and Non- Current classification: The Company presents assets and liabilities in the balance sheet based on current/ non-current
classification. An asset is treated as current when it is: • Expected to be realized or intended to be sold or consumed in normal operating cycle
• Held primarily for the purpose of trading • Expected to be realized within twelve months after the reporting period or • Cash or cash
equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period All other assets
are classified as non-current. A liability is current when: • It is expected to be settled in normal operating cycle • It is due to be settled within
twelve months after the reporting period, or • There is no unconditional right to defer the settlement of the liability for at least twelve months
after the reporting period The Company classifies all other liabilities as non-current. Deferred tax assets and liabilities are classified as
non-current assets and liabilities. The operating cycle is the time between the acquisition of assets for processing and their realization in cash and
cash equivalents. The Company has identified twelve months as its operating cycle.

Textual information (51)

Description of nature of necessary adjustments to provide comparative information


a) Current and Non- Current classification: The Company presents assets and liabilities in the balance sheet based on current/ non-current
classification. An asset is treated as current when it is: • Expected to be realized or intended to be sold or consumed in normal operating cycle
• Held primarily for the purpose of trading • Expected to be realized within twelve months after the reporting period or • Cash or cash
equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period All other assets
are classified as non-current. A liability is current when: • It is expected to be settled in normal operating cycle • It is due to be settled within
twelve months after the reporting period, or • There is no unconditional right to defer the settlement of the liability for at least twelve months
after the reporting period The Company classifies all other liabilities as non-current. Deferred tax assets and liabilities are classified as
non-current assets and liabilities. The operating cycle is the time between the acquisition of assets for processing and their realization in cash and
cash equivalents. The Company has identified twelve months as its operating cycle.

Textual information (52)

Description of nature of necessary adjustments to provide comparative information


a) Current and Non- Current classification: The Company presents assets and liabilities in the balance sheet based on current/ non-current
classification. An asset is treated as current when it is: • Expected to be realized or intended to be sold or consumed in normal operating cycle
• Held primarily for the purpose of trading • Expected to be realized within twelve months after the reporting period or • Cash or cash
equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period All other assets
are classified as non-current. A liability is current when: • It is expected to be settled in normal operating cycle • It is due to be settled within
twelve months after the reporting period, or • There is no unconditional right to defer the settlement of the liability for at least twelve months
after the reporting period The Company classifies all other liabilities as non-current. Deferred tax assets and liabilities are classified as
non-current assets and liabilities. The operating cycle is the time between the acquisition of assets for processing and their realization in cash and
cash equivalents. The Company has identified twelve months as its operating cycle.

98
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (53)

Disclosure of significant accounting policies [Text Block]

NOTES FORMING PART OF FINANCIAL STATEMENTS

NOTE 1

DESCRIPTION OF THE COMPANY AND SINGNIFICANT ACCOUNTING POLICIES:

1. Background:

Virchow Laboratories Limited (“the company”) was Incorporated in 1982 and its registered office in Hyderabad, Telangana, India. Virchow
Laboratories Limited is the largest producer of Sulfamethoxazole in the world. Virchow also undertakes custom synthesis and manufacture of
drug intermediates and bulk chemicals.

2. Significant Accounting Policies:

This note provides a list of the significant accounting policies adopted in the preparation of these financial statements. These policies have been
consistently applied to all the years presented, unless otherwise stated.

a) Basis of preparation of financial statements:

The financial statements of the company have been prepared and presented in accordance with the Indian Accounting Standards (“Ind AS”)
notified under the Companies ( Indian Accounting Standards) Rules, 2015 and as amended from time to time.

99
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:

· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;

· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.

b) Use of Estimates and Judgments:

The preparation of financial statements in conformity with Ind AS required management to make judgments, estimates and assumptions that
affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Accounting estimates may
change from period to period. Actual results may differ from these estimates.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which
the estimates are revised and if material, their effects are disclosed in the notes to the standalone financial statements.

c) Functional and Presentation Currency:

Items included in the financial statements are measured using the currency of the primary economic environment in which the entity operates ('the
functional currency'). These financial statements are prepared in Indian rupee, which is also the functional currency of the Company. All financial
information presented in Indian rupees has been rounded to the nearest Lakhs.

100
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

d) Current and Non- Current classification:

The Company presents assets and liabilities in the balance sheet based on current/ non-current classification.

An asset is treated as current when it is:

• Expected to be realized or intended to be sold or consumed in normal operating cycle

• Held primarily for the purpose of trading

• Expected to be realized within twelve months after the reporting period or

• Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period

All other assets are classified as non-current.

A liability is current when:

• It is expected to be settled in normal operating cycle

• It is due to be settled within twelve months after the reporting period, or

• There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period

101
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

The Company classifies all other liabilities as non-current.

Deferred tax assets and liabilities are classified as non-current assets and liabilities.

The operating cycle is the time between the acquisition of assets for processing and their realization in cash and cash equivalents. The Company
has identified twelve months as its operating cycle.

e) Foreign Currency transactions:

Transactions in foreign currencies are translated to the functional currencies of the Company at exchange rates at the dates of the transactions.
Monetary assets and liabilities denominated in foreign currencies at the reporting date are translated into the functional currency at the exchange
rate at that date. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at that date when
the fair value was measured. Exchange differences arising on settlements of monetary items or on translating monetary items at rates difference
from those at which they were translated on initial recognition during the period or in the previous financial statements are recognized in the
statement of profit and loss in the period in which they arise with.

f) Revenue Recognition:

· Sale of Goods:

Revenue is recognized when significant risks and rewards of ownership have been transferred to the buyer, recovery of consideration is probable,
the associated costs and possible return of goods can be estimated reliably, there is no continuing management involvement with the goods and
the amount of revenue can be measured reliably. Revenue from the sale of goods is measured at fair value of the consideration received or
receivable, net of returns, Goods and Service tax (GST), applicable trade discounts, allowances and amounts collected on behalf of third parties.

Revenue from export sales and other sales outside of India is recognized when the significant risks and rewards of ownership of products are
transferred to the customers, which occurs upon delivery of the products to the customers unless the terms of the applicable contract provide
specific revenue generating activities to be completed, in which case revenue is recognized once all such activities are completed.

· Sales Returns:

102
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

The Company accounts for sales returns accrual by recording an allowance for sales returns concurrent with the recognition of revenue at the time
of a product sale.

Interest Income:

Interest income primarily comprises of interest from term deposits and electricity deposits. Interest income is recorded using the effective rate of
interest. Interest income is included in other income in the statement of profit and loss.

· Dividend Income:

Dividend income is recognized when the Company’s right to receive the payment is established, which is generally when shareholders approve
the dividend.

· Export incentives:

Export incentives are recognized as income when the right to receive credit as per the terms of the scheme is established in respect of the exports
made and where there is no significant uncertainty regarding the ultimate collection of the relevant export proceeds.

g) Government Grants:

Grants from the government are recognized at fair value where there is a reasonable assurance that the grant will be received and the company
will comply with the attached conditions.

h) Income tax:

The income tax expense or credit for the period is the tax payable on the current period's taxable income based on the applicable income tax rate
for each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses.

The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period.

103
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Deferred income tax provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities
and their carrying amounts in the financial statements. Deferred income tax is determined using tax rates (and laws) that have been enacted or
substantially enacted by the end of the reporting period and are expected to apply when the related deferred income tax asset is realized or the
deferred income tax liability is settled.

Deferred tax assets are recognized for all deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilize those temporary differences and losses.

Current and deferred tax is recognized in profit or loss, except to the extent that it relates to items recognized in other comprehensive income or
directly in equity, In this case, the tax is also recognized in other comprehensive income or directly in equity, respectively

i) Earnings per share:

The Company presents basic and diluted earnings per share (“EPS”) data for its ordinary shares.

Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of
ordinary shares outstanding during the period.

Diluted EPS is determined by adjusting the profit or loss attributable to ordinary shareholders and the weighted average number of ordinary
shares outstanding for the effects of all dilutive potential ordinary shares.

j) Property, Plant and equipment:

Items of property, plant and equipment are measured at cost less accumulated depreciation and accumulated impairment losses, if any.

Cost includes expenditures that are directly attributable to the asset. The cost of self- constructed assets includes the cost of materials and other
costs directly attributable to bringing the asset to a working condition for its intended use. General and Specific borrowing costs that are
attributable to the construction of a qualifying asset are capitalized as part of the cost of the asset during the period of time that is required to
complete and prepare the asset for its intended use or sale.

104
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Gains and losses upon disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the
carrying amount of property, plant and equipment and are recognized in the statement of profit and loss. The costs of repairs and maintenance are
recognized in the statement of profit and loss as incurred.

Advances paid towards the acquisition of property, plant and equipment outstanding at each reporting date is disclosed as Capital Advances under
other non-current assets.

k) Depreciation/Amortization methods, estimated useful lives and residual value

Depreciation is recognized in the statement of profit and loss on a Written Down Value (WDV) basis over the estimated useful lives of property,
plant and equipment. Leased assets are depreciated over the shorter of the lease term and their useful lives. Land is not depreciated.

Description of the Asset Useful Life in Years

Building 30 to 60 years

Plant & Machinery, Electrical Installations etc 10 to 20 years

Computers 3 years

Furniture 10 years

Office Equipment 5 years

Vehicles 8 to 10 years

The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period.

Gains or losses on disposal are determined by comparing proceeds with carrying amount.

105
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

l) Intangible assets:

i) Recognition:

In-tangible assets consist of software licenses etc. which are measured at cost on initial recognition and amortized over their estimated useful life.

ii) Amortization methods and periods:

The Company amortizes intangible assets on a straight line method over a period of six years.

m) Borrowings:

Borrowings are initially recognized at fair value, net of transaction cost incurred. Borrowings are subsequently measured at amortized cost. Any
difference between the proceeds (net of transaction costs) and the redemption amount is recognized in profit or loss over the period of the
borrowings using the effective interest method.

Borrowings are removed from the balance sheet when the obligation specified in the contract is discharged, cancelled or expired. The difference
between the carrying amount of a financial liability that has been extinguished or transferred to another party and the consideration paid,
including any non-cash assets transferred or liabilities assumed, is recognized in profit or loss.

Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least 12
months after the reporting period.

n) Borrowing Costs:

General and specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying asset are
capitalized during the period of time that is required to complete and prepare the asset for its intended use or sale. Qualifying assets are assets that
necessarily take a substantial period of time to get ready for their intended use or sale. Investment income earned on the temporary investment of
specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing cost eligible for capitalization. Other
borrowings costs are expensed in the period in which they are incurred.

o) Leases:

106
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

At the inception of each lease, the lease arrangement is classified as either a finance lease or operating lease, based on the substance of the lease
arrangement. A lease that transfers substantially all the risks and rewards incidental to ownership to the lessee is classified as a finance lease. All
other leases are classified as operating leases.

As a lessee:

Operating lease payments are recognized as an expense in the statement of profit & loss over lease term.

p) Inventories:

Inventories consists of raw materials, stores and spares, work-in-progress and finished goods and are measured at the lower of cost and net
realizable value. Net realizable value is the estimated selling price in the ordinary course of business less estimated costs of completion and the
estimated costs necessary to make the sale.

Cost includes expenditures incurred in acquiring the inventories, production or conversion costs and other costs incurred in bringing them to their
existing location and condition. In the case of finished goods and work-in-progress, cost includes an appropriate share of overheads based on
normal operating capacity. Stores and spares, that do not qualify to be recognized as property, plant and equipment, consists of packing materials,
engineering spares (such as machinery spare parts) and consumables which are used for operating machines are consumed as indirect materials in
the manufacturing process.

q) Investments and other financial assets:

107
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

i) Classification

The Company classifies its financial assets in the following measurement categories:

- Those to be measured subsequently at fair value (either through other comprehensive income, or through profit or loss), and

- those measured at amortized cost.

The classification depends on the entity's business model for managing the financial assets and the contractual terms of the cash flows. For assets
measured at fair value, gains and losses will either be recorded in profit or loss or other comprehensive income.

ii) Measurement

At initial recognition, the company measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit
or loss, transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at fair
value through profit or loss are expensed in profit or loss.

Debt instruments: Subsequent measurement of debt instruments depends on the Company's business model for managing the asset and the cash
flow characteristics of the asset. There are three measurement categories into which the Company classifies its debt instruments:

Amortized cost: Assets that are held for collection of contractual cash flows where those cash flows represent solely payments of principal and
interest are measured at amortized cost. A gain or loss on a debt investment that is subsequently measured at amortized cost and is not part of a
hedging relationship is recognized in profit or loss when the asset is derecognized or impaired. Interest income from these financial assets is
included in finance income using the effective interest rate method.

108
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Fair value through other comprehensive income (FVOCI): Assets that are held for collection of contractual cash flows and for selling the financial
assets, where the assets' cash flows represent solely payments of principal and interest, are measured at fair value through other comprehensive
income (FVOCI). Movements in the carrying amount are taken through OCI, except for the recognition of impairment gains or losses, interest
revenue and foreign exchange gains and losses which are recognized in profit and loss. When the financial asset is derecognized, the cumulative
gain or loss previously recognized in OCI is reclassified from equity to profit or loss and recognized in other gains/(losses). Interest income from
these financial assets is included in other income using the effective interest rate method.

Fair value through profit or loss: Assets that do not meet the criteria for amortized cost or FVOCI are measured at fair value through profit or loss.
A gain or loss on a debt investment that is subsequently measured at fair value through profit or loss and is not part of a hedging relationship is
recognized in profit or loss and presented net in the statement of profit and loss within other gains/(losses) in the period in which it arises. Interest
income from these financial assets is included in other income.

Equity instruments: The Company subsequently measures all equity investments at fair value. Where the company's management has elected to
present fair value gains and losses on equity investments in other comprehensive income, there is no subsequent reclassification of fair value
gains and losses to profit or loss. Dividends from such investments are recognized in profit or loss as other income when the Company's right to
receive payments is established.

Changes in the fair value of financial assets at fair value through profit or loss are recognized in other gain/(losses) in the statement of profit and
loss. Impairment losses (and reversal of impairment losses) on equity investments measured at FVOCI are not reported separately from other
changes in fair value.

iii) Impairment of financial assets:

The Company assesses on a forward looking basis the expected credit losses associated with its assets carried at amortized cost and FVOCI debt
instruments. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The company applies
the simplified approach permitted by Ind AS 109 Financial Instruments, which requires expected lifetime losses to be recognized from initial
recognition of the receivables.

iv) De-recognition of financial assets:

A financial asset is derecognized only when

· the company has transferred the rights to receive cash flow from the financial asset or

· retains the contractual rights to receive the cash flows of the financial assets, but assumes a contractual obligation to pay cash flows to one
or more recipients.

109
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Where the entity has transferred an asset, the Company evaluates whether it has transferred substantially all risks and rewards of ownership of the
financial asset. In such cases, the financial asset is derecognized. Where the entity has not transferred substantially all risks and rewards of
ownership of the financial asset is not derecognized.

Where the entity has neither transferred a financial asset nor retains substantially all risks and rewards of ownership of the financial asset, the
financial asset is derecognized if the Company has not retained control of the financial asset. Where the Company retains control of the financial
asset, the asset is continued to be recognized to the extent of continuing involvement in the financial asset.

r) Impairment of non-financial assets:

The carrying amounts of the Company’s non-financial assets, other than inventories and deferred tax assets are reviewed at each reporting date to
determine whether there is any indication of impairment.

s) Offsetting financial instruments:

Financial assets and liabilities are offset and the net amount is reported in the balance sheet where there is a legally enforceable right to offset the
recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously. The legally
enforceable right must not be contingent on future events and must be enforceable in the normal course of business and in the event of default,
insolvency or bankruptcy of the Company or the counterparty.

t) Employee benefits:

i) Short-term employee benefits:

Liabilities for wages and salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after the end of the
period in which the employees render the related service are recognized in respect of employees’ services up to the end of the reporting period
and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit
obligations in the balance sheet.

110
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

ii) Other long-term employee benefit obligations:

The liabilities for earned leave and sick leave are not expected to be settled wholly within 12 months after the end of the period in which the
employees render the related service. They are therefore measured at the present value of expected future payments to be made in respect of
services provided by employees up to the end of the reporting period using the projected unit credit method. The benefits are discounted using the
market yields at the end of the reporting period that have terms approximating to the terms of the related obligations. Remeasurements as a result
of the experience adjustments and changes in actuarial assumptions are recognized in profit or loss.

iii) Post Employment obligations:

The Company operates the following post-employment schemes:

(a) Defined benefit plans such as gratuity; and

(b) Defined contribution plans such as provident fund.

Gratuity obligations

The liability or assets recognized in the balance sheet in respect of gratuity plans is the present value of the defined benefit obligation at the end of
the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by actuaries using the projected unit
credit method.

The present value of the defined benefit obligation denominated in is determined by discounting the estimated future cash outflows by reference
to market yields at the end of the reporting period on government bonds that have terms approximating to the terms of the related obligation.

The interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets.
This cost is included in employee benefit expense in the statement of profit and loss.

Remeasurements gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which
they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and in the
balance sheet.

Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in
profit or loss as past service cost.

111
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Defined contribution plans

The company pays provident fund contributions to publicly administered funds as per regulations. The Company has no further payment
obligations once the contributions have been paid. The contributions are accounted for as defined contribution plans and the contributions are
recognized as employee benefit expense when they are due.

Compensated Absences:

Liability toward earned leaves is provided on the basis of actual leaves earned outstanding for payment.

iv) Bonus plans

The Company recognizes a liability and an expense for bonuses. The Company recognizes a provision where contractually obliged or where there
is a past practice that has created a constructive obligation.

u) Cash and Cash Equivalents:

For the purpose of presentation in the statement of cash flows, cash and cash equivalents includes cash on hand, deposits held at call with
financial institutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to
known amounts of cash and which are subject to an insignificant risk of changes in value. Bank overdrafts are shown within borrowings in current
liabilities in the balance sheet.

v) Trade Receivables:

Trade receivables are recognized initially at fair value and subsequently measured at amortized cost using effective interest method, less provision
for impairment.

112
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

w) Trade and other payables:

These amounts represent liabilities for goods and services provided to the company prior to the end of financial year which are unpaid. The
amounts are unsecured and are usually paid within 30 days of recognition. Trade and other payables are presented as current liabilities unless
payment is not due within 12 months after the reporting period. They are recognized initially at their fair value and subsequently measured at
amortized cost using the effective interest method.

x) Research & Development Expenses:

Research and development expenditure, which is of revenue nature, is charged to the profit and loss account, while capital expenditure is added to
the cost of Fixed Assets in the year in which these are incurred.

y) Provisions, contingent liabilities and contingent assets:

Provision: A provision is recognized if, as a result of a past event, the Company has a present legal or constructive obligation that can be
estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation.

Contingent Liability: A disclosure for a contingent liability is made when there is a possible obligation or a present obligation that may, but
probably will not, require an outflow of resources. Where there is a possible obligation or a present obligation in respect of which the likelihood
of outflow of resources is remote, no provision or disclosure is made.

Contingent Asset: Contingent assets are not recognized in the financial statements. However, contingent assets are assessed continually and if it is
virtually certain that an outflow of economic benefits will arise, the asset and related income are recognized in the period in which the change
occurs.

113
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

z) Standards issued but not yet effective:

Recent Accounting Pronouncements issued but not yet effective:

Ministry of Corporate Affairs (“MCA”) through Companies (Indian Accounting Standards) Amendment Rules, 2019 and Companies (Indian
Accounting Standards) Second Amendment Rules, has notified the following new and amendments to Ind AS which the company has not applied
as they are effective from April 1, 2019:

Ind AS 116 – Leases

Ind AS 116 will replace the existing leases standard, Ind AS 17 Leases. Ind AS 116 sets out the principles for the recognition, measurement,
presentation and disclosure of leases for both lessees and lessors. It introduces a single, on-balance sheet lessee accounting model for lessees. A
lessee recognizes right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease
payments. The standard also contains enhanced disclosure requirements for lessees. Ind AS 116 substantially carries forward the lessor
accounting requirements in Ind AS 17.

[610300] Notes - Accounting policies, changes in accounting estimates and errors


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of changes in accounting policies, accounting estimates and errors
[TextBlock]
Disclosure of initial application of standards or interpretations
[TextBlock]
Whether initial application of an Ind AS has an effect on the
No No
current period or any prior period
Disclosure of voluntary change in accounting policy [TextBlock]
Whether there is any voluntary change in accounting policy No No
Disclosure of changes in accounting estimates [TextBlock]
Whether there are changes in acounting estimates during the year No No

114
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[400600] Notes - Property, plant and equipment

Disclosure of additional information about property plant and equipment [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 0 0
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount

Disclosure of additional information about property plant and equipment [Table] ..(2)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Buildings [Member] Factory building [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child Refer to child
Refer to child member Refer to child member
equipment member member
Useful lives or depreciation rates, property, Refer to child Refer to child
Refer to child member Refer to child member
plant and equipment member member
Whether property, plant and equipment are
No No No No
stated at revalued amount

Disclosure of additional information about property plant and equipment [Table] ..(3)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory building [Member] Plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
SLM SLM Refer to child member
equipment member
Useful lives or depreciation rates, property, Refer to child
30 30 Refer to child member
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount

115
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of additional information about property plant and equipment [Table] ..(4)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 15 15
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount

Disclosure of additional information about property plant and equipment [Table] ..(5)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 15 15
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount

Disclosure of additional information about property plant and equipment [Table] ..(6)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 10 10
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount

116
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of additional information about property plant and equipment [Table] ..(7)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 10 10
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount

Disclosure of additional information about property plant and equipment [Table] ..(8)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Vehicles [Member] Motor vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child Refer to child
Refer to child member Refer to child member
equipment member member
Useful lives or depreciation rates, property, Refer to child Refer to child
Refer to child member Refer to child member
plant and equipment member member
Whether property, plant and equipment are
No No No No
stated at revalued amount

Disclosure of additional information about property plant and equipment [Table] ..(9)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Motor vehicles [Member] Office equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
SLM SLM Refer to child member
equipment member
Useful lives or depreciation rates, property, Refer to child
10 10 Refer to child member
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount

117
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of additional information about property plant and equipment [Table] ..(10)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Office equipment [Member] Computer equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
SLM SLM Refer to child member
equipment member
Useful lives or depreciation rates, property, Refer to child
5 5 Refer to child member
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount

Disclosure of additional information about property plant and equipment [Table] ..(11)
Unless otherwise specified, all monetary values are in Lakhs of INR
Other property, plant and equipment
Classes of property, plant and equipment [Axis] Computer equipments [Member]
[Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
SLM SLM Refer to child member
equipment member
Useful lives or depreciation rates, property, Refer to child
3 3 Refer to child member
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount

Disclosure of additional information about property plant and equipment [Table] ..(12)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment, others [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information about
property plant and equipment [Abstract]
Disclosure of additional information about
property plant and equipment [Line items]
Depreciation method, property, plant and Refer to child
Refer to child member SLM SLM
equipment member
Useful lives or depreciation rates, property, Refer to child
Refer to child member 3 3
plant and equipment member
Whether property, plant and equipment are
No No No No
stated at revalued amount

118
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Property, plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2018 01/04/2017
31/03/2019 31/03/2018 to to
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 149.13 651.5
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.5 10.17
equipment
Total disposals and retirements,
2.5 10.17
property, plant and equipment
Total increase (decrease) in property,
146.63 641.33
plant and equipment
Property, plant and equipment at end of
4,223.02 4,577.9 12,089.99 11,943.36
period

Disclosure of detailed information about property, plant and equipment [Table] ..(2)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Property, plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
501.87 480.56
loss
Total Depreciation property plant and
501.87 480.56
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
0.36 7.77
equipment
Total disposals and retirements,
0.36 7.77
property, plant and equipment
Total increase (decrease) in property,
501.51 472.79
plant and equipment
Property, plant and equipment at end of
11,302.03 7,866.97 7,365.46 6,892.67
period

119
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(3)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Carrying amount [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 3.3
equipment
Total increase (decrease) in property,
0 3.3 0
plant and equipment
Property, plant and equipment at end of
930.04 930.04 926.74 930.04
period

Disclosure of detailed information about property, plant and equipment [Table] ..(4)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 3.3
equipment
Total increase (decrease) in property,
3.3 0 0
plant and equipment
Property, plant and equipment at end of
930.04 926.74 0 0
period

120
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(5)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 3.3
equipment
Total increase (decrease) in property,
0 3.3
plant and equipment
Property, plant and equipment at end of
0 930.04 930.04 926.74
period

Disclosure of detailed information about property, plant and equipment [Table] ..(6)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 3.3
equipment
Total increase (decrease) in property,
0 3.3 0
plant and equipment
Property, plant and equipment at end of
930.04 930.04 926.74 0
period

121
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(7)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Land [Member] Buildings [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-105.01 -115.96
loss
Total Depreciation property plant and
-105.01 -115.96
equipment
Total increase (decrease) in property,
0 -105.01 -75.54
plant and equipment
Property, plant and equipment at end of
0 0 1,007.8 1,112.81
period

Disclosure of detailed information about property, plant and equipment [Table] ..(8)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Buildings [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Total increase (decrease) in property,
0 40.42
plant and equipment
Property, plant and equipment at end of
1,188.35 2,375.31 2,375.31 2,334.89
period

122
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(9)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Buildings [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
105.01 115.96
loss
Total Depreciation property plant and
105.01 115.96
equipment
Total increase (decrease) in property,
105.01 115.96 0
plant and equipment
Property, plant and equipment at end of
1,367.51 1,262.5 1,146.54 2,375.31
period

Disclosure of detailed information about property, plant and equipment [Table] ..(10)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Buildings [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
105.01 115.96
loss
Total Depreciation property plant and
105.01 115.96
equipment
Total increase (decrease) in property,
40.42 105.01 115.96
plant and equipment
Property, plant and equipment at end of
2,375.31 2,334.89 1,367.51 1,262.5
period

123
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(11)
Unless otherwise specified, all monetary values are in Lakhs of INR
Buildings
Classes of property, plant and equipment [Axis] Factory building [Member]
[Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-105.01 -115.96
loss
Total Depreciation property plant and
-105.01 -115.96
equipment
Total increase (decrease) in property,
-105.01 -75.54
plant and equipment
Property, plant and equipment at end of
1,146.54 1,007.8 1,112.81 1,188.35
period

Disclosure of detailed information about property, plant and equipment [Table] ..(12)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory building [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
105.01
loss
Total Depreciation property plant and
105.01
equipment
Total increase (decrease) in property,
0 40.42 105.01
plant and equipment
Property, plant and equipment at end of
2,375.31 2,375.31 2,334.89 1,367.51
period

124
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(13)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory building [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
115.96 -105.01 -115.96
loss
Total Depreciation property plant and
115.96 -105.01 -115.96
equipment
Total increase (decrease) in property,
115.96 -105.01 -75.54
plant and equipment
Property, plant and equipment at end of
1,262.5 1,146.54 1,007.8 1,112.81
period

Disclosure of detailed information about property, plant and equipment [Table] ..(14)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory building [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 40.42
equipment
Total increase (decrease) in property,
0 40.42
plant and equipment
Property, plant and equipment at end of
1,188.35 2,375.31 2,375.31 2,334.89
period

125
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(15)
Unless otherwise specified, all monetary values are in Lakhs of INR
Plant and
Classes of property, plant and equipment [Axis] Factory building [Member] equipment
[Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Accumulated depreciation and impairment [Member]
[Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 136.51
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
105.01 115.96 -277.7
loss
Total Depreciation property plant and
105.01 115.96 -277.7
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.14
equipment
Total disposals and retirements,
2.14
property, plant and equipment
Total increase (decrease) in property,
105.01 115.96 -143.33
plant and equipment
Property, plant and equipment at end of
1,367.51 1,262.5 1,146.54 1,847.94
period

126
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(16)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 227.53 136.51 227.53
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-278.54
loss
Total Depreciation property plant and
-278.54
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.5
equipment
Total disposals and retirements,
2.5
property, plant and equipment
Total increase (decrease) in property,
-51.01 134.01 227.53
plant and equipment
Property, plant and equipment at end of
1,991.27 2,042.28 6,928.22 6,794.21
period

127
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(17)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
277.7 278.54
loss
Total Depreciation property plant and
277.7 278.54
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
0.36
equipment
Total disposals and retirements,
0.36
property, plant and equipment
Total increase (decrease) in property,
277.34 278.54
plant and equipment
Property, plant and equipment at end of
6,566.68 5,080.28 4,802.94 4,524.4
period

128
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(18)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 136.51 227.53
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
277.7
loss
Total Depreciation property plant and
277.7
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.5 0.36
equipment
Total disposals and retirements,
2.5 0.36
property, plant and equipment
Total increase (decrease) in property,
134.01 227.53 277.34
plant and equipment
Property, plant and equipment at end of
6,928.22 6,794.21 6,566.68 5,080.28
period

129
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(19)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Plant and equipment [Member] Factory equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 127.71 171.45
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
278.54 -238.91 -244.26
loss
Total Depreciation property plant and
278.54 -238.91 -244.26
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.14
equipment
Total disposals and retirements,
2.14
property, plant and equipment
Total increase (decrease) in property,
278.54 -113.34 -72.81
plant and equipment
Property, plant and equipment at end of
4,802.94 4,524.4 1,629.37 1,742.71
period

Disclosure of detailed information about property, plant and equipment [Table] ..(20)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 127.71 171.45
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.5
equipment
Total disposals and retirements,
2.5
property, plant and equipment
Total increase (decrease) in property,
125.21 171.45
plant and equipment
Property, plant and equipment at end of
1,815.52 6,432.14 6,306.93 6,135.48
period

130
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(21)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory equipments [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Accumulated depreciation and impairment [Member]
[Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 127.71
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
238.91 244.26 -238.91
loss
Total Depreciation property plant and
238.91 244.26 -238.91
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
0.36 2.14
equipment
Total disposals and retirements,
0.36 2.14
property, plant and equipment
Total increase (decrease) in property,
238.55 244.26 -113.34
plant and equipment
Property, plant and equipment at end of
4,802.77 4,564.22 4,319.96 1,629.37
period

131
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(22)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 171.45 127.71 171.45
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-244.26
loss
Total Depreciation property plant and
-244.26
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.5
equipment
Total disposals and retirements,
2.5
property, plant and equipment
Total increase (decrease) in property,
-72.81 125.21 171.45
plant and equipment
Property, plant and equipment at end of
1,742.71 1,815.52 6,432.14 6,306.93
period

132
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(23)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Factory equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
238.91 244.26
loss
Total Depreciation property plant and
238.91 244.26
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
0.36
equipment
Total disposals and retirements,
0.36
property, plant and equipment
Total increase (decrease) in property,
238.55 244.26
plant and equipment
Property, plant and equipment at end of
6,135.48 4,802.77 4,564.22 4,319.96
period

Disclosure of detailed information about property, plant and equipment [Table] ..(24)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Carrying amount [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 31.39
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-29.47 -29.49
loss
Total Depreciation property plant and
-29.47 -29.49
equipment
Total increase (decrease) in property,
-29.47 1.9 0
plant and equipment
Property, plant and equipment at end of
182.91 212.38 210.48 323.22
period

133
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(25)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 31.39
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
29.47 29.49
loss
Total Depreciation property plant and
29.47 29.49
equipment
Total increase (decrease) in property,
31.39 29.47 29.49
plant and equipment
Property, plant and equipment at end of
323.22 291.83 140.31 110.84
period

Disclosure of detailed information about property, plant and equipment [Table] ..(26)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 31.39
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-29.47 -29.49
loss
Total Depreciation property plant and
-29.47 -29.49
equipment
Total increase (decrease) in property,
-29.47 1.9
plant and equipment
Property, plant and equipment at end of
81.35 182.91 212.38 210.48
period

134
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(27)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 31.39
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
29.47
loss
Total Depreciation property plant and
29.47
equipment
Total increase (decrease) in property,
0 31.39 29.47
plant and equipment
Property, plant and equipment at end of
323.22 323.22 291.83 140.31
period

Disclosure of detailed information about property, plant and equipment [Table] ..(28)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Emission reduction equipment [Member] Other plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.8 24.69
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
29.49 -9.32 -4.79
loss
Total Depreciation property plant and
29.49 -9.32 -4.79
equipment
Total increase (decrease) in property,
29.49 -0.52 19.9
plant and equipment
Property, plant and equipment at end of
110.84 81.35 35.66 36.18
period

135
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(29)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.8 24.69
equipment
Total increase (decrease) in property,
8.8 24.69
plant and equipment
Property, plant and equipment at end of
16.28 172.86 164.06 139.37
period

Disclosure of detailed information about property, plant and equipment [Table] ..(30)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other plant and equipment [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Accumulated depreciation and impairment [Member]
[Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.8
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
9.32 4.79 -9.32
loss
Total Depreciation property plant and
9.32 4.79 -9.32
equipment
Total increase (decrease) in property,
9.32 4.79 -0.52
plant and equipment
Property, plant and equipment at end of
137.2 127.88 123.09 35.66
period

136
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(31)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 24.69 8.8 24.69
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-4.79
loss
Total Depreciation property plant and
-4.79
equipment
Total increase (decrease) in property,
19.9 8.8 24.69
plant and equipment
Property, plant and equipment at end of
36.18 16.28 172.86 164.06
period

Disclosure of detailed information about property, plant and equipment [Table] ..(32)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
9.32 4.79
loss
Total Depreciation property plant and
9.32 4.79
equipment
Total increase (decrease) in property,
9.32 4.79
plant and equipment
Property, plant and equipment at end of
139.37 137.2 127.88 123.09
period

137
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(33)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Carrying amount [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-1.31 -1.82
loss
Total Depreciation property plant and
-1.31 -1.82
equipment
Total increase (decrease) in property,
-1.31 -1.82 0
plant and equipment
Property, plant and equipment at end of
5.96 7.27 9.09 79.42
period

Disclosure of detailed information about property, plant and equipment [Table] ..(34)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
1.31 1.82
loss
Total Depreciation property plant and
1.31 1.82
equipment
Total increase (decrease) in property,
0 1.31 1.82
plant and equipment
Property, plant and equipment at end of
79.42 79.42 73.46 72.15
period

138
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(35)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-1.31 -1.82
loss
Total Depreciation property plant and
-1.31 -1.82
equipment
Total increase (decrease) in property,
-1.31 -1.82
plant and equipment
Property, plant and equipment at end of
70.33 5.96 7.27 9.09
period

Disclosure of detailed information about property, plant and equipment [Table] ..(36)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
1.31
loss
Total Depreciation property plant and
1.31
equipment
Total increase (decrease) in property,
0 0 1.31
plant and equipment
Property, plant and equipment at end of
79.42 79.42 79.42 73.46
period

139
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(37)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Furniture and fixtures [Member] Vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
1.82 -36.33 -30.6
loss
Total Depreciation property plant and
1.82 -36.33 -30.6
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.4
equipment
Total disposals and retirements,
2.4
property, plant and equipment
Total increase (decrease) in property,
1.82 -36.33 64.35
plant and equipment
Property, plant and equipment at end of
72.15 70.33 88.33 124.66
period

Disclosure of detailed information about property, plant and equipment [Table] ..(38)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
10.17
equipment
Total disposals and retirements,
10.17
property, plant and equipment
Total increase (decrease) in property,
0 87.18
plant and equipment
Property, plant and equipment at end of
60.31 357.5 357.5 270.32
period

140
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(39)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Vehicles [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
36.33 30.6
loss
Total Depreciation property plant and
36.33 30.6
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
7.77
equipment
Total disposals and retirements,
7.77
property, plant and equipment
Total increase (decrease) in property,
36.33 22.83 0
plant and equipment
Property, plant and equipment at end of
269.17 232.84 210.01 357.5
period

141
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(40)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
36.33 30.6
loss
Total Depreciation property plant and
36.33 30.6
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
10.17 7.77
equipment
Total disposals and retirements,
10.17 7.77
property, plant and equipment
Total increase (decrease) in property,
87.18 36.33 22.83
plant and equipment
Property, plant and equipment at end of
357.5 270.32 269.17 232.84
period

142
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(41)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Vehicles [Member] Motor vehicles [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-36.33 -30.6
loss
Total Depreciation property plant and
-36.33 -30.6
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
2.4
equipment
Total disposals and retirements,
2.4
property, plant and equipment
Total increase (decrease) in property,
-36.33 64.35
plant and equipment
Property, plant and equipment at end of
210.01 88.33 124.66 60.31
period

143
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(42)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Motor vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
36.33
loss
Total Depreciation property plant and
36.33
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
10.17
equipment
Total disposals and retirements,
10.17
property, plant and equipment
Total increase (decrease) in property,
0 87.18 36.33
plant and equipment
Property, plant and equipment at end of
357.5 357.5 270.32 269.17
period

144
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(43)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Motor vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
30.6 -36.33 -30.6
loss
Total Depreciation property plant and
30.6 -36.33 -30.6
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
7.77 2.4
equipment
Total disposals and retirements,
7.77 2.4
property, plant and equipment
Total increase (decrease) in property,
22.83 -36.33 64.35
plant and equipment
Property, plant and equipment at end of
232.84 210.01 88.33 124.66
period

Disclosure of detailed information about property, plant and equipment [Table] ..(44)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Motor vehicles [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 97.35
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
10.17
equipment
Total disposals and retirements,
10.17
property, plant and equipment
Total increase (decrease) in property,
0 87.18
plant and equipment
Property, plant and equipment at end of
60.31 357.5 357.5 270.32
period

145
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(45)
Unless otherwise specified, all monetary values are in Lakhs of INR
Office equipment
Classes of property, plant and equipment [Axis] Motor vehicles [Member]
[Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Accumulated depreciation and impairment [Member]
[Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 2.52
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
36.33 30.6 -5.74
loss
Total Depreciation property plant and
36.33 30.6 -5.74
equipment
Disposals and retirements, property,
plant and equipment [Abstract]
Disposals, property, plant and
7.77
equipment
Total disposals and retirements,
7.77
property, plant and equipment
Total increase (decrease) in property,
36.33 22.83 -3.22
plant and equipment
Property, plant and equipment at end of
269.17 232.84 210.01 13.69
period

Disclosure of detailed information about property, plant and equipment [Table] ..(46)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Office equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 2.52
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-10.96
loss
Total Depreciation property plant and
-10.96
equipment
Total increase (decrease) in property,
-10.96 2.52 0
plant and equipment
Property, plant and equipment at end of
16.91 27.87 137.46 134.94
period

146
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(47)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Office equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
5.74 10.96
loss
Total Depreciation property plant and
5.74 10.96
equipment
Total increase (decrease) in property,
5.74 10.96
plant and equipment
Property, plant and equipment at end of
134.94 123.77 118.03 107.07
period

Disclosure of detailed information about property, plant and equipment [Table] ..(48)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Office equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Carrying amount [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 2.52 2.52
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-5.74 -10.96
loss
Total Depreciation property plant and
-5.74 -10.96
equipment
Total increase (decrease) in property,
-3.22 -10.96 2.52
plant and equipment
Property, plant and equipment at end of
13.69 16.91 27.87 137.46
period

147
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(49)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Office equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Gross carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
5.74 10.96
loss
Total Depreciation property plant and
5.74 10.96
equipment
Total increase (decrease) in property,
0 5.74 10.96
plant and equipment
Property, plant and equipment at end of
134.94 134.94 123.77 118.03
period

Disclosure of detailed information about property, plant and equipment [Table] ..(50)
Unless otherwise specified, all monetary values are in Lakhs of INR
Office equipment
Classes of property, plant and equipment [Axis] Computer equipments [Member]
[Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.64 3.05
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-6.1 -3.68
loss
Total Depreciation property plant and
-6.1 -3.68
equipment
Total increase (decrease) in property,
2.54 -0.63
plant and equipment
Property, plant and equipment at end of
107.07 14.56 12.02 12.65
period

148
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(51)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Computer equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.64 3.05
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
6.1
loss
Total Depreciation property plant and
6.1
equipment
Total increase (decrease) in property,
8.64 3.05 6.1
plant and equipment
Property, plant and equipment at end of
159.43 150.79 147.74 144.87
period

Disclosure of detailed information about property, plant and equipment [Table] ..(52)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Computer equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.64 3.05
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
3.68 -6.1 -3.68
loss
Total Depreciation property plant and
3.68 -6.1 -3.68
equipment
Total increase (decrease) in property,
3.68 2.54 -0.63
plant and equipment
Property, plant and equipment at end of
138.77 135.09 14.56 12.02
period

149
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(53)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Computer equipments [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 8.64 3.05
equipment
Total increase (decrease) in property,
8.64 3.05
plant and equipment
Property, plant and equipment at end of
12.65 159.43 150.79 147.74
period

Disclosure of detailed information about property, plant and equipment [Table] ..(54)
Unless otherwise specified, all monetary values are in Lakhs of INR
Other property,
plant and
Classes of property, plant and equipment [Axis] Computer equipments [Member]
equipment
[Member]
Owned and leased
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Accumulated depreciation and impairment [Member]
[Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 1.46
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
6.1 3.68 -69.68
loss
Total Depreciation property plant and
6.1 3.68 -69.68
equipment
Total increase (decrease) in property,
6.1 3.68 -68.22
plant and equipment
Property, plant and equipment at end of
144.87 138.77 135.09 314.7
period

150
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(55)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 279.85 1.46 279.85
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-39
loss
Total Depreciation property plant and
-39
equipment
Total increase (decrease) in property,
240.85 1.46 279.85
plant and equipment
Property, plant and equipment at end of
382.92 142.07 1,122.61 1,121.15
period

Disclosure of detailed information about property, plant and equipment [Table] ..(56)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Gross carrying
Accumulated depreciation and impairment [Member]
[Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
69.68 39
loss
Total Depreciation property plant and
69.68 39
equipment
Total increase (decrease) in property,
69.68 39
plant and equipment
Property, plant and equipment at end of
841.3 807.91 738.23 699.23
period

151
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(57)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Accumulated
Carrying amount accumulated depreciation and gross carrying amount depreciation and
Gross carrying amount [Member]
[Axis] impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 1.46 279.85
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
69.68
loss
Total Depreciation property plant and
69.68
equipment
Total increase (decrease) in property,
1.46 279.85 69.68
plant and equipment
Property, plant and equipment at end of
1,122.61 1,121.15 841.3 807.91
period

Disclosure of detailed information about property, plant and equipment [Table] ..(58)
Unless otherwise specified, all monetary values are in Lakhs of INR
Other property, plant and equipment Other property, plant and equipment,
Classes of property, plant and equipment [Axis]
[Member] others [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying Accumulated depreciation and
Carrying amount [Member]
amount [Axis] impairment [Member]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Nature of other property plant and equipment Refer to child
Refer to child member
others member
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 1.46 279.85
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
39 -69.68 -39
loss
Total Depreciation property plant and
39 -69.68 -39
equipment
Total increase (decrease) in property,
39 -68.22 240.85
plant and equipment
Property, plant and equipment at end of
738.23 699.23 314.7 382.92
period

152
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(59)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment, others [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount Carrying amount
Gross carrying amount [Member]
[Axis] [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Nature of other property plant and equipment
Refer to child member Refer to child member
others
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 1.46 279.85
equipment
Total increase (decrease) in property,
1.46 279.85
plant and equipment
Property, plant and equipment at end of
142.07 1,122.61 1,121.15 841.3
period

Disclosure of detailed information about property, plant and equipment [Table] ..(60)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment, others [Member]
Owned assets
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
[Member]
Carrying amount accumulated depreciation and gross carrying Carrying amount
Accumulated depreciation and impairment [Member]
amount [Axis] [Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Lab Equipment,Fire
Extinguisher,Weighing
Nature of other property plant and equipment
Refer to child member Refer to child member Machine,R&D
others Equipment,Safety
Equipment and Boiler
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 1.46
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
69.68 39 -69.68
loss
Total Depreciation property plant and
69.68 39 -69.68
equipment
Total increase (decrease) in property,
69.68 39 -68.22
plant and equipment
Property, plant and equipment at end of
807.91 738.23 699.23 314.7
period

153
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of detailed information about property, plant and equipment [Table] ..(61)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment, others [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying
Carrying amount [Member] Gross carrying amount [Member]
amount [Axis]
01/04/2017 01/04/2018 01/04/2017
to 31/03/2017 to to
31/03/2018 31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Lab Equipment,Fire Lab Equipment,Fire
Lab Equipment,Fire
Extinguisher,Weighing Extinguisher,Weighing
Nature of other property plant and equipment Extinguisher,Weighing
Machine,R&D Machine,R&D
others Machine,R&D Equipment,Safety
Equipment,Safety Equipment,Safety
Equipment and Boiler
Equipment and Boiler Equipment and Boiler
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Additions other than through business
combinations, property, plant and 279.85 1.46 279.85
equipment
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
-39
loss
Total Depreciation property plant and
-39
equipment
Total increase (decrease) in property,
240.85 1.46 279.85
plant and equipment
Property, plant and equipment at end of
382.92 142.07 1,122.61 1,121.15
period

Disclosure of detailed information about property, plant and equipment [Table] ..(62)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of property, plant and equipment [Axis] Other property, plant and equipment, others [Member]
Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Carrying amount accumulated depreciation and gross carrying Gross carrying
Accumulated depreciation and impairment [Member]
amount [Axis] amount [Member]
01/04/2018 01/04/2017
31/03/2017 to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of detailed information about property,
plant and equipment [Abstract]
Disclosure of detailed information about
property, plant and equipment [Line items]
Lab Equipment,Fire Lab Equipment,Fire
Extinguisher,Weighing Extinguisher,Weighing
Nature of other property plant and equipment
Machine,R&D Machine,R&D
others Equipment,Safety Equipment,Safety Equipment
Equipment and Boiler and Boiler
Reconciliation of changes in property, plant
and equipment [Abstract]
Changes in property, plant and equipment
[Abstract]
Depreciation, property, plant and
equipment [Abstract]
Depreciation recognised in profit or
69.68 39
loss
Total Depreciation property plant and
69.68 39
equipment
Total increase (decrease) in property,
69.68 39
plant and equipment
Property, plant and equipment at end of
841.3 807.91 738.23 699.23
period

154
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[612100] Notes - Impairment of assets


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Textual information (54)
Disclosure of impairment of assets [TextBlock] [See below]
Disclosure of impairment loss and reversal of impairment loss [TextBlock]
Whether there is any impairment loss or reversal of impairment loss
No No
during the year
Disclosure of information for impairment loss recognised or reversed
for individual Assets or cash-generating unit [TextBlock]
Whether impairment loss recognised or reversed for individual Assets
No No
or cash-generating unit

Textual information (54)

Disclosure of impairment of assets [Text Block]

i) Impairment of financial assets:

The Company assesses on a forward looking basis the expected credit losses associated with its assets carried at amortized cost and FVOCI debt
instruments. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The company applies
the simplified approach permitted by Ind AS 109 Financial Instruments, which requires expected lifetime losses to be recognized from initial
recognition of the receivables.

[400700] Notes - Investment property


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of investment property [TextBlock]
Textual information (55) Textual information (56)
Depreciation method, investment property, cost model [See below] [See below]
Textual information (57) Textual information (58)
Useful lives or depreciation rates, investment property, cost model [See below] [See below]

Textual information (55)

Depreciation method, investment property, cost model


a) Depreciation/Amortization methods, estimated useful lives and residual value Depreciation is recognized in the statement of profit and
loss on a Written Down Value (WDV) basis over the estimated useful lives of property, plant and equipment. Leased assets are depreciated over
the shorter of the lease term and their useful lives. Land is not depreciated. Description of the Asset Useful Life in Years Building 30 to 60 years
Plant & Machinery, Electrical Installations etc 10 to 20 years Computers 3 years Furniture 10 years Office Equipment 5 years Vehicles 8 to 10
years The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period. Gains or losses on disposal are determined by comparing proceeds
with carrying amount.

155
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (56)

Depreciation method, investment property, cost model


a) Depreciation/Amortization methods, estimated useful lives and residual value Depreciation is recognized in the statement of profit and
loss on a Written Down Value (WDV) basis over the estimated useful lives of property, plant and equipment. Leased assets are depreciated over
the shorter of the lease term and their useful lives. Land is not depreciated. Description of the Asset Useful Life in Years Building 30 to 60 years
Plant & Machinery, Electrical Installations etc 10 to 20 years Computers 3 years Furniture 10 years Office Equipment 5 years Vehicles 8 to 10
years The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period. Gains or losses on disposal are determined by comparing proceeds
with carrying amount.

Textual information (57)

Useful lives or depreciation rates, investment property, cost model


a) Depreciation/Amortization methods, estimated useful lives and residual value Depreciation is recognized in the statement of profit and
loss on a Written Down Value (WDV) basis over the estimated useful lives of property, plant and equipment. Leased assets are depreciated over
the shorter of the lease term and their useful lives. Land is not depreciated. Description of the Asset Useful Life in Years Building 30 to 60 years
Plant & Machinery, Electrical Installations etc 10 to 20 years Computers 3 years Furniture 10 years Office Equipment 5 years Vehicles 8 to 10
years The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period. Gains or losses on disposal are determined by comparing proceeds
with carrying amount.

Textual information (58)

Useful lives or depreciation rates, investment property, cost model


a) Depreciation/Amortization methods, estimated useful lives and residual value Depreciation is recognized in the statement of profit and
loss on a Written Down Value (WDV) basis over the estimated useful lives of property, plant and equipment. Leased assets are depreciated over
the shorter of the lease term and their useful lives. Land is not depreciated. Description of the Asset Useful Life in Years Building 30 to 60 years
Plant & Machinery, Electrical Installations etc 10 to 20 years Computers 3 years Furniture 10 years Office Equipment 5 years Vehicles 8 to 10
years The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period. Gains or losses on disposal are determined by comparing proceeds
with carrying amount.

[400900] Notes - Other intangible assets

Disclosure of detailed information about other intangible assets [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Company other intangible assets
Classes of other intangible assets [Axis]
[Member]
Internally generated and other than
Sub classes of other intangible assets [Axis] internally generated intangible assets
[Member]
Carrying amount accumulated amortization and impairment and gross carrying amount [Axis] Carrying amount [Member]
31/03/2019 31/03/2018
Disclosure of detailed information about other intangible assets [Abstract]
Disclosure of detailed information about other intangible assets [Line items]
Reconciliation of changes in other intangible assets [Abstract]
Other intangible assets at end of period 0 0

156
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of other intangible assets [TextBlock]
Disclosure of detailed information about other intangible assets
[TextBlock]
Disclosure of intangible assets with indefinite useful life [TextBlock]
Whether there are intangible assets with indefinite useful life No No

[401000] Notes - Biological assets other than bearer plants


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of biological assets, agriculture produce at point of
harvest and government grants related to biological assets
[TextBlock]
Textual information (59) Textual information (60)
Depreciation method, biological assets other than bearer plants, at cost [See below] [See below]
Useful lives or depreciation rates, biological assets other than bearer Textual information (61) Textual information (62)
plants, at cost [See below] [See below]

Textual information (59)

Depreciation method, biological assets other than bearer plants, at cost


a) Depreciation/Amortization methods, estimated useful lives and residual value Depreciation is recognized in the statement of profit and
loss on a Written Down Value (WDV) basis over the estimated useful lives of property, plant and equipment. Leased assets are depreciated over
the shorter of the lease term and their useful lives. Land is not depreciated. Description of the Asset Useful Life in Years Building 30 to 60 years
Plant & Machinery, Electrical Installations etc 10 to 20 years Computers 3 years Furniture 10 years Office Equipment 5 years Vehicles 8 to 10
years The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period. Gains or losses on disposal are determined by comparing proceeds
with carrying amount.

Textual information (60)

Depreciation method, biological assets other than bearer plants, at cost


a) Depreciation/Amortization methods, estimated useful lives and residual value Depreciation is recognized in the statement of profit and
loss on a Written Down Value (WDV) basis over the estimated useful lives of property, plant and equipment. Leased assets are depreciated over
the shorter of the lease term and their useful lives. Land is not depreciated. Description of the Asset Useful Life in Years Building 30 to 60 years
Plant & Machinery, Electrical Installations etc 10 to 20 years Computers 3 years Furniture 10 years Office Equipment 5 years Vehicles 8 to 10
years The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period. Gains or losses on disposal are determined by comparing proceeds
with carrying amount.

Textual information (61)

Useful lives or depreciation rates, biological assets other than bearer plants, at cost
a) Depreciation/Amortization methods, estimated useful lives and residual value Depreciation is recognized in the statement of profit and
loss on a Written Down Value (WDV) basis over the estimated useful lives of property, plant and equipment. Leased assets are depreciated over
the shorter of the lease term and their useful lives. Land is not depreciated. Description of the Asset Useful Life in Years Building 30 to 60 years
Plant & Machinery, Electrical Installations etc 10 to 20 years Computers 3 years Furniture 10 years Office Equipment 5 years Vehicles 8 to 10
years The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period. Gains or losses on disposal are determined by comparing proceeds
with carrying amount.

157
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (62)

Useful lives or depreciation rates, biological assets other than bearer plants, at cost
a) Depreciation/Amortization methods, estimated useful lives and residual value Depreciation is recognized in the statement of profit and
loss on a Written Down Value (WDV) basis over the estimated useful lives of property, plant and equipment. Leased assets are depreciated over
the shorter of the lease term and their useful lives. Land is not depreciated. Description of the Asset Useful Life in Years Building 30 to 60 years
Plant & Machinery, Electrical Installations etc 10 to 20 years Computers 3 years Furniture 10 years Office Equipment 5 years Vehicles 8 to 10
years The useful lives have been determined based on the estimated useful life of assets and in the manner laid down under Schedule II of the
Companies Act, 2013. The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are
reviewed, and adjusted if appropriate, at the end of each reporting period. Gains or losses on disposal are determined by comparing proceeds
with carrying amount.

[611100] Notes - Financial instruments

Disclosure of financial assets [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Financial assets at amortised cost, class
Classes of financial assets [Axis] Trade receivables [Member]
[Member]
Categories of financial assets [Axis] Financial assets, category [Member] Financial assets, category [Member]
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of financial assets [Abstract]
Disclosure of financial assets [Line items]
Financial assets 0 0 0 0
Financial assets, at fair value 14,799.95 15,907.21 14,799.95 15,907.21

Disclosure of financial assets [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of financial assets [Axis] Trade receivables [Member]
Financial assets at fair value through
Financial assets at fair value through profit or loss, designated upon initial
Categories of financial assets [Axis]
profit or loss, category [Member] recognition or subsequently, category
[Member]
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of financial assets [Abstract]
Disclosure of financial assets [Line items]
Financial assets 0 0 0 0
Financial assets, at fair value 14,799.95 15,907.21 14,799.95 15,907.21

Disclosure of financial liabilities [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of financial liabilities [Axis] Financial liabilities at fair value, class [Member]
Financial liabilities at fair value through
Categories of financial liabilities [Axis] Financial liabilities, category [Member]
profit or loss, category [Member]
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of financial liabilities [Abstract]
Disclosure of financial liabilities [Line items]
Financial liabilities 0 0 0 0
Financial liabilities, at fair value 2,548.85 2,297.93 2,548.85 2,297.93

158
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of financial liabilities [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Financial liabilities at fair value, class
Classes of financial liabilities [Axis]
[Member]
Financial liabilities at fair value through
profit or loss, designated upon initial
Categories of financial liabilities [Axis]
recognition or subsequently, category
[Member]
31/03/2019 31/03/2018
Disclosure of financial liabilities [Abstract]
Disclosure of financial liabilities [Line items]
Financial liabilities 0 0
Financial liabilities, at fair value 2,548.85 2,297.93

[611300] Notes - Regulatory deferral accounts


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of regulatory deferral accounts [TextBlock]
Other comprehensive income, net of tax, net
movement in regulatory deferral account
0 0
balances related to items that will not be
reclassified to profit or loss

[400400] Notes - Non-current investments

Details of non-current investments [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of non-current investments [Axis] 1 2
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Non-current investments [Abstract]
Disclosure of details of non-current investments
[Abstract]
Details of non-current investments [Line items]
Investment in Investment in Investment in Investment in
Type of non-current investments subsidiaries equity subsidiaries equity subsidiaries equity subsidiaries equity
instruments instruments instruments instruments
Class of non-current investments Other investments Other investments Other investments Other investments
Investment in Equity Investment in Equity Investment in Equity Investment in Equity
Instruments in Instruments in Instruments in Instruments in
Nature of non-current investments Subsidiary Subsidiary Companies Subsidiary Subsidiary Companies
Companies (at cost) (at cost) Companies (at cost) (at cost)
Non-current investments 451.1 451.1 170 170
Name of body corporate in whom investment has Andhra Organics Andhra Organics Virchow Healthcare Virchow Healthcare
been made Limited Limited Private Limited Private Limited
Number of shares of non-current investment
[shares] 45,10,990 [shares] 45,10,990 [shares] 1,70,000 [shares] 1,70,000
made in body corporate

159
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Details of non-current investments [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of non-current investments [Axis] 3 4
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Non-current investments [Abstract]
Disclosure of details of non-current investments
[Abstract]
Details of non-current investments [Line items]
Investment in Investment in Investment in other Investment in other
Type of non-current investments subsidiaries equity subsidiaries equity Indian companies Indian companies
instruments instruments equity instruments equity instruments
Class of non-current investments Other investments Other investments Other investments Other investments
Investment in Equity Investment in Equity Investment in Equity Investment in Equity
Instruments in Instruments in Instruments in Instruments in
Nature of non-current investments Subsidiary Subsidiary Companies A s s o c i a t e Associate Companies
Companies (at cost) (at cost) Companies (at cost) (at cost)
Non-current investments 320.36 320.36 2,078.63 2,078.63
Name of body corporate in whom investment has Virchow Drugs Virchow Drugs Virchow Biotech Virchow Biotech
been made Limited Limited Private Limited Private Limited
Number of shares of non-current investment
[shares] 62,44,899 [shares] 62,44,899 [shares] 83,46,210 [shares] 83,46,210
made in body corporate

Details of non-current investments [Table] ..(3)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of non-current investments [Axis] 5
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Non-current investments [Abstract]
Disclosure of details of non-current investments [Abstract]
Details of non-current investments [Line items]
Investment in other Investment in other
Type of non-current investments Indian companies Indian companies
equity instruments equity instruments
Class of non-current investments Other investments Other investments
Investment in Equity Investment in Equity
Intruments in Other Intruments in Other
Nature of non-current investments Companies (at fair Companies (at fair
value) value)
Non-current investments 37.04 34.15
Jeedimetla Effluent Jeedimetla Effluent
Name of body corporate in whom investment has been made Limited Limited
Number of shares of non-current investment made in body corporate [shares] 5,762 [shares] 5,762

Unless otherwise specified, all monetary values are in Lakhs of INR


31/03/2019 31/03/2018
Disclosure of notes on non-current investments explanatory [TextBlock]
Aggregate amount of quoted non-current investments 0 0
Market value of quoted non-current investments 0 0
Aggregate amount of unquoted non-current investments 3,057.13 3,054.24
Aggregate provision for diminution in value of non-current investments 0 0

160
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[400500] Notes - Current investments

Details of current investments [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of current investments [Axis] 1 2
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Current investments [Abstract]
Disclosure of details of current investments
[Abstract]
Details of current investments [Line items]
Investments in Investments in mutual Investments in Investments in mutual
Type of current investments mutual funds funds mutual funds funds
Class of current investments Current investments Current investments Current investments Current investments
HDFC Liquid HDFC Liquid Canara Robeco
Canara Robeco
Nature of current investments fund-direct fund-direct
Mutual Fund
Savings Fund-Direct
plan-growth option plan-growth option Growth
Current investments 921.98 250.55 458.44 1,289.88
Investments Investments
Investments measured Investments measured
measured at fair measured at fair
Basis of valuation of current investments value through profit
at fair value through
value through profit
at fair value through
profit and loss (FVPL) profit and loss (FVPL)
and loss (FVPL) and loss (FVPL)
HDFC Liquid HDFC Liquid Canara Robeco
Name of body corporate in whom investment has Canara Robeco
fund-direct fund-direct Savings Fund-Direct
been made Mutual Fund
plan-growth option plan-growth option Growth
Number of shares of current investment made
[shares] 0 [shares] 0 [shares] 0 [shares] 0
in body corporate

Details of current investments [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of current investments [Axis] 3 4
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Current investments [Abstract]
Disclosure of details of current investments
[Abstract]
Details of current investments [Line items]
Investments in Investments in mutual Investments in Investments in mutual
Type of current investments mutual funds funds mutual funds funds
Class of current investments Current investments Current investments Current investments Current investments
ICICI Prudential ABSL Internal
ABSL Floating Rate
Nature of current investments ABSL Liquid Fund
Fund STP Gr-Direct
Liquid Fund-Direct I n c o m e -
Plan-Gr Qtrly-S1-Gr-Direct
Current investments 1,166.24 422.74 710.89 503.97
Investments Investments
Investments measured Investments measured
measured at fair measured at fair
Basis of valuation of current investments value through profit
at fair value through
value through profit
at fair value through
profit and loss (FVPL) profit and loss (FVPL)
and loss (FVPL) and loss (FVPL)
ICICI Prudential ABSL Internal
Name of body corporate in whom investment has ABSL Floating Rate
ABSL Liquid Fund Liquid Fund-Direct I n c o m e -
been made Fund STP Gr-Direct
Plan-Gr Qtrly-S1-Gr-Direct
Number of shares of current investment made
[shares] 0 [shares] 0 [shares] 0 [shares] 0
in body corporate

161
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Details of current investments [Table] ..(3)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of current investments [Axis] 5 6
01/04/2018 01/04/2017 01/04/2017
to to to
31/03/2019 31/03/2018 31/03/2018
Current investments [Abstract]
Disclosure of details of current investments [Abstract]
Details of current investments [Line items]
Investments in Investments in mutual Investments in
Type of current investments mutual funds funds mutual funds
Class of current investments Current investments Current investments Current investments
ICICI Prudential HDFC Floating Rate
Nature of current investments Ultra Short Term IDFC Growth Funds Debt Fund- Direct
Fund Plan
Current investments 306.99 1,102.18 720.34
Investments Investments
Investments measured
measured at fair measured at fair
Basis of valuation of current investments value through profit
at fair value through
value through profit
profit and loss (FVPL)
and loss (FVPL) and loss (FVPL)
ICICI Prudential HDFC Floating Rate
Name of body corporate in whom investment has been made Ultra Short Term IDFC Growth Funds Debt Fund- Direct
Fund Plan
Number of shares of current investment made in body corporate [shares] 0 [shares] 0 [shares] 0

Unless otherwise specified, all monetary values are in Lakhs of INR


31/03/2019 31/03/2018
Disclosure of notes on current investments explanatory [TextBlock]
Aggregate amount of quoted current investments 3,564.54 4,289.66
Market value of quoted current investments 0 0
Aggregate amount of unquoted current investments 0 0
Aggregate provision for diminution in value of current investments 0 0

[611600] Notes - Non-current asset held for sale and discontinued operations
Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of non-current assets held for sale and discontinued operations
[TextBlock]
Net cash flows from (used in) operating activities, continuing
6,232.42 7,199.61
operations
Net cash flows from (used in) operating activities, discontinued
0 0
operations
Net cash flows from (used in) operating activities 6,232.42 7,199.61
Net cash flows from (used in) investing activities, continuing
248.11 -676.2
operations
Net cash flows from (used in) investing activities, discontinued
0 0
operations
Net cash flows from (used in) investing activities 248.11 -676.2
Net cash flows from (used in) financing activities, continuing
-5,060.25 -7,768.13
operations
Net cash flows from (used in) financing activities, discontinued
0 0
operations
Net cash flows from (used in) financing activities -5,060.25 -7,768.13

162
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[400100] Notes - Equity share capital

Disclosure of shareholding more than five per cent in company [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Name of shareholder [Member] Shareholder 1 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Type of share Equity Equity Equity Equity
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share Equity Equity Equity Equity
Refer to child Sri M. Narayana Sri M. Narayana
Name of shareholder member
Refer to child member
Reddy Reddy
Permanent account number of shareholder AEMPM4585Q AEMPM4585Q
Country of incorporation or residence of
INDIA INDIA
shareholder
Number of shares held in company [shares] 63,784 [shares] 82,899 [shares] 6,017 [shares] 7,917
Percentage of shareholding in company 68.00% 67.00% 6.00% 6.00%

Disclosure of shareholding more than five per cent in company [Table] ..(2)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 2 [Member] Shareholder 3 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Type of share Equity Equity Equity Equity
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share Equity Equity Equity Equity
Sri D. Ravindra Sri D. Ravindra Dr L.V. Subba
Name of shareholder Reddy Reddy Reddy
Dr L.V. Subba Reddy

Permanent account number of shareholder AKLPK4260D AKLPK4260D AAVPL5579L AAVPL5579L


Country of incorporation or residence of
INDIA INDIA INDIA INDIA
shareholder
Number of shares held in company [shares] 6,379 [shares] 8,394 [shares] 6,922 [shares] 8,080
Percentage of shareholding in company 7.00% 7.00% 7.00% 6.00%

163
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of shareholding more than five per cent in company [Table] ..(3)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 4 [Member] Shareholder 5 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Type of share Equity Equity Equity Equity
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share Equity Equity Equity Equity
Dr Nandigala Dr Nandigala Sri Nandigala Sri Nandigala
Name of shareholder Hemanth Hemanth Prasanth Prasanth
Permanent account number of shareholder ACAPN0908Q ACAPN0908Q ABYPN4171A ABYPN4171A
Country of incorporation or residence of
INDIA INDIA INDIA INDIA
shareholder
Number of shares held in company [shares] 7,419 [shares] 9,762 [shares] 7,419 [shares] 9,762
Percentage of shareholding in company 8.00% 8.00% 8.00% 8.00%

Disclosure of shareholding more than five per cent in company [Table] ..(4)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 6 [Member] Shareholder 7 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Type of share Equity Equity Equity Equity
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share Equity Equity Equity Equity
Name of shareholder Sri M. Maha Vishnu Sri M. Maha Vishnu Smt. M. Sudha Smt. M. Sudha
Permanent account number of shareholder AAAAA9999A AAAAA9999A AFXPM8911L AFXPM8911L
Country of incorporation or residence of
INDIA INDIA INDIA INDIA
shareholder
Number of shares held in company [shares] 8,322 [shares] 10,950 [shares] 8,322 [shares] 10,950
Percentage of shareholding in company 9.00% 9.00% 9.00% 9.00%

Disclosure of shareholding more than five per cent in company [Table] ..(5)
Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 8 [Member] Shareholder 9 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Type of share Equity Equity Equity Equity
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share Equity Equity Equity Equity
Name of shareholder Sri L.V. Sunil Sri L.V. Sunil Sri L.V. Subash Sri L.V. Subash
Permanent account number of shareholder BBBBB9999B BBBBB9999B ABNPL3249E ABNPL3249E
Country of incorporation or residence of
INDIA INDIA INDIA INDIA
shareholder
Number of shares held in company [shares] 6,734 [shares] 8,860 [shares] 6,250 [shares] 8,224
Percentage of shareholding in company 7.00% 7.00% 7.00% 7.00%

164
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of classes of equity share capital [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Equity shares 1
Classes of equity share capital [Axis] Equity shares [Member]
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of classes of equity share capital [Abstract]
Disclosure of classes of equity share capital [Line
items]
Type of share Equity
Number of shares authorised [shares] 1,50,000 [shares] 1,50,000 [shares] 1,50,000
Value of shares authorised 150 150 150
Number of shares issued [shares] 71,470 [shares] 89,337 [shares] 71,470
Value of shares issued 71.47 89.34 71.47
Number of shares subscribed and fully paid [shares] 71,470 [shares] 89,337 [shares] 71,470
Value of shares subscribed and fully paid 71.47 89.34 71.47
Number of shares subscribed but not fully paid [shares] 0 [shares] 0 [shares] 0
Value of shares subscribed but not fully paid 0 0 0
Total number of shares subscribed [shares] 71,470 [shares] 89,337 [shares] 71,470
Total value of shares subscribed 71.47 89.34 71.47
Value of shares paid-up [Abstract]
Number of shares paid-up [shares] 71,470 [shares] 89,337 [shares] 71,470
Value of shares called 71.47 89.34 71.47
Value of shares paid-up 71.47 89.34 71.47
Par value per share [INR/shares] 100
Amount per share called in case shares not fully
[INR/shares] 0
called
Reconciliation of number of shares outstanding
[Abstract]
Changes in number of shares outstanding
[Abstract]
Decrease in number of shares during period
[Abstract]
Number of shares bought back or treasury
[shares] 17,867 [shares] 28,210 [shares] 17,867
shares
Total decrease in number of shares during
[shares] 17,867 [shares] 28,210 [shares] 17,867
period
Total increase (decrease) in number of
[shares] -17,867 [shares] -28,210 [shares] -17,867
shares outstanding
Number of shares outstanding at end of period [shares] 71,470 [shares] 89,337 [shares] 1,17,547 [shares] 71,470
Reconciliation of value of shares outstanding
[Abstract]
Changes in equity share capital [Abstract]
Decrease in equity share capital during
period [Abstract]
Decrease in amount of treasury shares
17.87 28.21 17.87
or shares bought back
Total decrease in equity share capital
17.87 28.21 17.87
during period
Total increase (decrease) in share capital -17.87 -28.21 -17.87
Equity share capital at end of period 71.47 89.34 117.55 71.47
Details of application money received for
allotment of securities and due for refund and
interest accrued thereon [Abstract]
Application money received for allotment of
securities and due for refund and interest
accrued thereon [Abstract]
Total application money received for
allotment of securities and due for refund 0 0 0
and interest accrued thereon
Type of share Equity

165
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of classes of equity share capital [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classes of equity share capital [Axis] Equity shares 1 [Member]
01/04/2017
to 31/03/2017
31/03/2018
Disclosure of classes of equity share capital [Abstract]
Disclosure of classes of equity share capital [Line items]
Type of share Equity
Number of shares authorised [shares] 1,50,000
Value of shares authorised 150
Number of shares issued [shares] 89,337
Value of shares issued 89.34
Number of shares subscribed and fully paid [shares] 89,337
Value of shares subscribed and fully paid 89.34
Number of shares subscribed but not fully paid [shares] 0
Value of shares subscribed but not fully paid 0
Total number of shares subscribed [shares] 89,337
Total value of shares subscribed 89.34
Value of shares paid-up [Abstract]
Number of shares paid-up [shares] 89,337
Value of shares called 89.34
Value of shares paid-up 89.34
Par value per share [INR/shares] 100
Amount per share called in case shares not fully called [INR/shares] 0
Reconciliation of number of shares outstanding [Abstract]
Changes in number of shares outstanding [Abstract]
Decrease in number of shares during period [Abstract]
Number of shares bought back or treasury shares [shares] 28,210
Total decrease in number of shares during period [shares] 28,210
Total increase (decrease) in number of shares outstanding [shares] -28,210
Number of shares outstanding at end of period [shares] 89,337 [shares] 1,17,547
Reconciliation of value of shares outstanding [Abstract]
Changes in equity share capital [Abstract]
Decrease in equity share capital during period [Abstract]
Decrease in amount of treasury shares or shares bought back 28.21
Total decrease in equity share capital during period 28.21
Total increase (decrease) in share capital -28.21
Equity share capital at end of period 89.34 117.55
Details of application money received for allotment of securities and due for
refund and interest accrued thereon [Abstract]
Application money received for allotment of securities and due for refund and
interest accrued thereon [Abstract]
Total application money received for allotment of securities and due for
0
refund and interest accrued thereon
Type of share Equity

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of notes on equity share capital explanatory [TextBlock]
Whether there are any shareholders holding more than five per cent
Yes Yes
shares in company
Whether money raised from public offering during year No No

166
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[400300] Notes - Borrowings

Classification of borrowings [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification based on current non-current [Axis] Current [Member]
Classification of borrowings [Axis] Borrowings [Member]
Secured/Unsecured borrowings
Subclassification of borrowings [Axis] Secured borrowings [Member]
[Member]
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Borrowings notes [Abstract]
Details of borrowings [Abstract]
Details of borrowings [Line items]
Borrowings 2,187.04 1,761.99 2,187.04 1,761.99

Classification of borrowings [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification based on current non-current [Axis] Current [Member]
Working capital loans from banks
Classification of borrowings [Axis]
[Member]
Subclassification of borrowings [Axis] Secured borrowings [Member]
31/03/2019 31/03/2018
Borrowings notes [Abstract]
Details of borrowings [Abstract]
Details of borrowings [Line items]
Borrowings 2,187.04 1,761.99

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018
to
31/03/2019
Textual information (63)
Disclosure of notes on borrowings explanatory [TextBlock] [See below]

Textual information (63)

Disclosure of notes on borrowings explanatory [Text Block]


a) Borrowings:

Borrowings are initially recognized at fair value, net of transaction cost incurred. Borrowings are subsequently measured at amortized cost. Any
difference between the proceeds (net of transaction costs) and the redemption amount is recognized in profit or loss over the period of the
borrowings using the effective interest method.

Borrowings are removed from the balance sheet when the obligation specified in the contract is discharged, cancelled or expired. The difference
between the carrying amount of a financial liability that has been extinguished or transferred to another party and the consideration paid,
including any non-cash assets transferred or liabilities assumed, is recognized in profit or loss.

Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least 12
months after the reporting period.

167
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[612700] Notes - Income taxes

Disclosure of temporary difference, unused tax losses and unused tax credits [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Depreciation
amortisation
Temporary difference, unused tax losses and unused tax credits [Axis] Temporary differences [Member]
impairment
[Member]
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of temporary difference, unused tax
losses and unused tax credits [Abstract]
Disclosure of temporary difference, unused
tax losses and unused tax credits [Line items]
Deferred tax assets and liabilities [Abstract]
Deferred tax liabilities 86.01 173.53 86.01
Net deferred tax liability (assets) 86.01 173.53 173.53 86.01
Deferred tax expense (income) [Abstract]
Deferred tax expense (income)
Deferred tax expense (income)
-87.52 0 -87.52
recognised in profit or loss
Reconciliation of changes in deferred tax
liability (assets) [Abstract]
Changes in deferred tax liability (assets)
[Abstract]
Deferred tax expense (income)
-87.52 0 -87.52
recognised in profit or loss
Total increase (decrease) in deferred
-87.52 0 -87.52
tax liability (assets)
Deferred tax liability (assets) at end of
86.01 173.53 173.53 86.01
period

Disclosure of temporary difference, unused tax losses and unused tax credits [Table] ..(2)
Unless otherwise specified, all monetary values are in Lakhs of INR
Depreciation amortisation impairment
Temporary difference, unused tax losses and unused tax credits [Axis]
[Member]
01/04/2017
to 31/03/2017
31/03/2018
Disclosure of temporary difference, unused tax losses and unused tax credits [Abstract]
Disclosure of temporary difference, unused tax losses and unused tax credits [Line
items]
Deferred tax assets and liabilities [Abstract]
Deferred tax liabilities 173.53
Net deferred tax liability (assets) 173.53 173.53
Deferred tax expense (income) [Abstract]
Deferred tax expense (income)
Deferred tax expense (income) recognised in profit or loss 0
Reconciliation of changes in deferred tax liability (assets) [Abstract]
Changes in deferred tax liability (assets) [Abstract]
Deferred tax expense (income) recognised in profit or loss 0
Total increase (decrease) in deferred tax liability (assets) 0
Deferred tax liability (assets) at end of period 173.53 173.53

168
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Textual information (64)
Disclosure of income tax [TextBlock] [See below]
Major components of tax expense (income) [Abstract]
Current tax expense (income) and adjustments for current tax of prior
periods [Abstract]
Current tax expense (income) 1,648.24 1,257.33
Total current tax expense (income) and adjustments for current tax
1,648.24 1,257.33
of prior periods
Other components of deferred tax expense (income) -96.54 -51.99
Total tax expense (income) 1,551.7 1,205.34
Disclosure of temporary difference, unused tax losses and unused tax
credits [TextBlock]
Disclosure of temporary difference, unused tax losses and unused tax
credits [Abstract]
Deferred tax assets and liabilities [Abstract]
Deferred tax expense (income) [Abstract]
Reconciliation of changes in deferred tax liability (assets)
[Abstract]
Changes in deferred tax liability (assets) [Abstract]
Reconciliation of accounting profit multiplied by applicable tax rates
[Abstract]
Tax expense (income) at applicable tax rate 1,551.7 1,205.34
Total tax expense (income) 1,551.7 1,205.34

169
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (64)

Disclosure of income tax [Text Block]


a) Income tax:

The income tax expense or credit for the period is the tax payable on the current period's taxable income based on the applicable income tax rate
for each jurisdiction adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses.

The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period.

Deferred income tax provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities
and their carrying amounts in the financial statements. Deferred income tax is determined using tax rates (and laws) that have been enacted or
substantially enacted by the end of the reporting period and are expected to apply when the related deferred income tax asset is realized or the
deferred income tax liability is settled.

Deferred tax assets are recognized for all deductible temporary differences and unused tax losses only if it is probable that future taxable amounts
will be available to utilize those temporary differences and losses.

Current and deferred tax is recognized in profit or loss, except to the extent that it relates to items recognized in other comprehensive income or
directly in equity, In this case, the tax is also recognized in other comprehensive income or directly in equity, respectively

[611000] Notes - Exploration for and evaluation of mineral resources


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of exploration and evaluation assets [TextBlock]
Whether there are any exploration and evaluation activities No No

[611900] Notes - Accounting for government grants and disclosure of government assistance
Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of accounting for government grants and disclosure of government
assistance [TextBlock]
Whether company has received any government grant or government assistance No No

170
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[401100] Notes - Subclassification and notes on liabilities and assets

Disclosure of breakup of provisions [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification based on current non-current [Axis] Non-current [Member] Current [Member]
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Provisions notes [Abstract]
Disclosure of breakup of provisions [Abstract]
Disclosure of breakup of provisions [Line items]
Provisions [Abstract]
Provisions for employee benefits
[Abstract]
Provision gratuity 274.84 264.15 27.79 34.17
Provision leave encashment 103.24 84.72
Total provisions for employee benefits 378.08 348.87 27.79 34.17
CSR expenditure provision 0 0 0 0
Total provisions 378.08 348.87 27.79 34.17

Other non-current financial assets, others [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of other non-current financial assets others [Axis] 1
01/04/2017
to
31/03/2018
Subclassification and notes on liabilities and assets [Abstract]
Other non-current financial assets notes [Abstract]
Other non-current financial assets [Abstract]
Other non-current financial assets, others 599.74
Other non-current financial assets, others [Abstract]
Other non-current financial assets, others [Line items]
Description other non-current financial assets, others Claims on VAT
Other non-current financial assets, others 599.74

Other current financial liabilities, others [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Other current financial liabilities, others [Axis] 1
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets [Abstract]
Disclosure of other current financial liabilities notes [Abstract]
Other current financial liabilities [Abstract]
Other current financial liabilities, others 217.7 373.9
Other current financial liabilities, others [Abstract]
Other current financial liabilities, others [Line items]
Creditors for Creditors for
Description of other current financial liabilities, others Expenses Expenses
Other current financial liabilities, others 217.7 373.9

171
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Other non-current assets, others [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Other non-current assets, others [Axis] 1 2
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Other non-current assets notes [Abstract]
Other non-current assets [Abstract]
Other non-current assets, others 132 15.6 213.51 128.18
Other non-current assets, others [Abstract]
Other non-current assets, others [Line items]
Description of other non-current assets, Security & Other Security & Other
Capital Advances Capital Advances
others Deposits Deposits
Other non-current assets, others 132 15.6 213.51 128.18

Classification of inventories [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of inventories [Axis] Company inventories [Member] Raw materials [Member]
01/04/2018 01/04/2017
31/03/2019 31/03/2018 to to
31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Inventories notes [Abstract]
Classification of inventories [Abstract]
Classification of inventories [Line items]
Inventories 2,979.53 2,603.06 1,002.91 755.77
Mode of valuation FIFO FIFO

Classification of inventories [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of inventories [Axis] Work-in-progress [Member] Finished goods [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Inventories notes [Abstract]
Classification of inventories [Abstract]
Classification of inventories [Line items]
Inventories 263.94 243.63 16.67 194.86
Mode of valuation FIFO FIFO FIFO FIFO

Classification of inventories [Table] ..(3)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of inventories [Axis] Stock-in-trade [Member] Stores and spares [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Inventories notes [Abstract]
Classification of inventories [Abstract]
Classification of inventories [Line items]
Inventories 149.85 127.35 1,245.54 1,030.54
Mode of valuation FIFO FIFO FIFO FIFO

172
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Classification of inventories [Table] ..(4)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of inventories [Axis] Other inventories [Member] Other inventories, others [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Inventories notes [Abstract]
Classification of inventories [Abstract]
Classification of inventories [Line items]
Inventories 300.62 250.91 300.62 250.91
Refer to child
Mode of valuation member
Refer to child member FIFO FIFO
Refer to child Packing Material, Packing Material,
Nature of other inventories member
Refer to child member
Coal and Diesel Coal and Diesel

Other current financial assets others [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Other current financial assets others [Axis] 1 2
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Other current financial assets [Abstract]
Other current financial assets others 29.2 13.05 5.21 3.58
Other current financial assets others [Abstract]
Other current financial assets others [Line
items]
Description other current financial assets
Staff Advances Staff Advances Interest receivable Interest receivable
others
Other current financial assets others 29.2 13.05 5.21 3.58

Other current financial assets others [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Other current financial assets others [Axis] 3
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets [Abstract]
Other current financial assets [Abstract]
Other current financial assets others 100.1 148.7
Other current financial assets others [Abstract]
Other current financial assets others [Line items]
Other amounts Other amounts
Description other current financial assets others receivable receivable
Other current financial assets others 100.1 148.7

Other current assets others [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Other current assets others [Axis] 1 2
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Other current assets notes [Abstract]
Other current assets [Abstract]
Other current assets, others 285.54 1,643.7 61.24 55.49
Other current assets others [Abstract]
Other current assets others [Line items]
Balances with Balances with
Description of other current assets others Statutory Authorities Statutory Authorities
Pre-paid expenses Pre-paid expenses

Other current assets, others 285.54 1,643.7 61.24 55.49

173
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Other current assets others [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Other current assets others [Axis] 3
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets [Abstract]
Other current assets notes [Abstract]
Other current assets [Abstract]
Other current assets, others 311.42 461.76
Other current assets others [Abstract]
Other current assets others [Line items]
Advance to A d v a n c e to
Description of other current assets others suppliers/expenses suppliers/expenses
Other current assets, others 311.42 461.76

Subclassification of trade receivables [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification based on current non-current [Axis] Current [Member]
Classification of assets based on security
Classification of assets based on security [Axis] Unsecured considered good [Member]
[Member]
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Disclosure of notes on trade receivables [Abstract]
Subclassification of trade receivables [Abstract]
Subclassification of trade receivables [Line
items]
Breakup of trade receivables [Abstract]
Trade receivables, gross 6,596.83 7,771.59 6,596.83 7,771.59
Allowance for bad and doubtful debts 0 0 0 0
Total trade receivables 6,596.83 7,771.59 6,596.83 7,771.59
Details of trade receivables due by
directors, other officers or others
[Abstract]
Trade receivables due by directors 0 0
Trade receivables due by other officers 0 0
Total trade receivables due by
0 0
directors, other officers or others
Details of trade receivables due by firms
or companies in which any director is
partner or director [Abstract]
Trade receivables due by firms in
0 0
which any director is partner
Trade receivables due by private
companies in which any director is 0 0
director
Trade receivables due by private
companies in which any director is 0 0
member
Total trade receivables due by
firms or companies in which any 0 0
director is partner or director

174
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in Lakhs of INR


31/03/2019 31/03/2018
Disclosure of subclassification and notes on liabilities and assets
explanatory [TextBlock]
Total other non-current financial assets 0 599.74
Advances, non-current 0 0
Total other non-current assets 345.51 143.78
Disclosure of notes on cash and bank balances explanatory [TextBlock]
Fixed deposits with banks 0 0
Other balances with banks 1,434.97 19.51
Total balance with banks 1,434.97 19.51
Cash on hand 11.97 7.15
Total cash and cash equivalents 1,446.94 26.66
Total cash and bank balances 1,446.94 26.66
Total balances held with banks to extent held as
margin money or security against borrowings, 0 0
guarantees or other commitments
Bank deposits with more than 12 months maturity 0 0
Total other current financial assets 134.51 165.33
Total other current assets 658.2 2,160.95
Security deposits refundable, Non-current 45.36 43.96
Total other non-current financial liabilities 45.36 43.96
Interest accrued on borrowings 0 0
Interest accrued on public deposits 0 0
Interest accrued others 0 0
Unpaid dividends 0 0
Unpaid matured deposits and interest accrued thereon 0 0
Unpaid matured debentures and interest accrued thereon 0 0
Debentures claimed but not paid 0 0
Public deposit payable, current 0 0
Total other current financial liabilities 217.7 373.9
Advance received from customers 52.49 151.06
Total other advance 52.49 151.06
Current liabilities portion of share application money pending
0 0
allotment
Total other current liabilities 52.49 151.06

175
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[401200] Notes - Additional disclosures on balance sheet


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of additional balance sheet notes explanatory [TextBlock]
Additional balance sheet notes [Abstract]
Contingent liabilities and commitments [Abstract]
Classification of contingent liabilities [Abstract]
Total contingent liabilities 0 0
Total contingent liabilities and commitments 0 0
Details regarding dividends [Abstract]
Amount of dividends proposed to be distributed to equity shareholders 0 0
Amount of per share dividend proposed to be distributed to equity
[INR/shares] 0 [INR/shares] 0
shareholders
Details of deposits [Abstract]
Deposits accepted or renewed during period 0 0
Deposits matured and claimed but not paid during period 0 0
Deposits matured and claimed but not paid 0 0
Deposits matured but not claimed 0 0
Interest on deposits accrued and due but not paid 0 0
Details of share application money received and paid [Abstract]
Share application money received during year 0 0
Share application money paid during year 0 0
Amount of share application money received back during year 0 0
Amount of share application money repaid returned back during year 0 0
Number of person share application money paid during year [pure] 0 [pure] 0
Number of person share application money received during year [pure] 0 [pure] 0
Number of person share application money paid as at end of year [pure] 0 [pure] 0
Number of person share application money received as at end of year [pure] 0 [pure] 0
Share application money received and due for refund 0 0
Details regarding cost records and cost audit[Abstract]
Details regarding cost records [Abstract]
Whether maintenance of cost records by company has been
mandated under Companies (Cost Records and Audit) Rules, Yes Yes
2014
If yes, Central Excise Tariff Act, heading in which product/
29350011
service is covered under cost records 29350011
Details regarding cost audit [Abstract]
Whether audit of cost records of company has been mandated
Yes Yes
under Rules specified in SN 1
If yes, Central Excise Tariff Act, heading in which product/
29350011
service is covered under cost audit 29350011
Net worth of company 0 0
Details of unclaimed liabilities [Abstract]
Unclaimed share application refund money 0 0
Unclaimed matured debentures 0 0
Unclaimed matured deposits 0 0
Interest unclaimed amount 0 0
Financial parameters balance sheet items [Abstract]
Investment in subsidiary companies 0 0
Investment in government companies 0 0
Amount due for transfer to investor education and protection fund
0 0
(IEPF)
Gross value of transactions with related parties 0 0
Number of warrants converted into equity shares during period [pure] 0 [pure] 0
Number of warrants converted into preference shares during period [pure] 0 [pure] 0
Number of warrants converted into debentures during period [pure] 0 [pure] 0
Number of warrants issued during period (in foreign currency) [pure] 0 [pure] 0
Number of warrants issued during period (INR) [pure] 0 [pure] 0

176
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[611800] Notes - Revenue


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018
to
31/03/2019
Textual information (65)
Disclosure of revenue [TextBlock] [See below]

177
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (65)

Disclosure of revenue [Text Block]


a) Revenue Recognition:

· Sale of Goods:

Revenue is recognized when significant risks and rewards of ownership have been transferred to the buyer, recovery of consideration is probable,
the associated costs and possible return of goods can be estimated reliably, there is no continuing management involvement with the goods and
the amount of revenue can be measured reliably. Revenue from the sale of goods is measured at fair value of the consideration received or
receivable, net of returns, Goods and Service tax (GST), applicable trade discounts, allowances and amounts collected on behalf of third parties.

Revenue from export sales and other sales outside of India is recognized when the significant risks and rewards of ownership of products are
transferred to the customers, which occurs upon delivery of the products to the customers unless the terms of the applicable contract provide
specific revenue generating activities to be completed, in which case revenue is recognized once all such activities are completed.

· Sales Returns:

The Company accounts for sales returns accrual by recording an allowance for sales returns concurrent with the recognition of revenue at the time
of a product sale.

Interest Income:

Interest income primarily comprises of interest from term deposits and electricity deposits. Interest income is recorded using the effective rate of
interest. Interest income is included in other income in the statement of profit and loss.

· Dividend Income:

Dividend income is recognized when the Company’s right to receive the payment is established, which is generally when shareholders approve
the dividend.

· Export incentives:

Export incentives are recognized as income when the right to receive credit as per the terms of the scheme is established in respect of the exports
made and where there is no significant uncertainty regarding the ultimate collection of the relevant export proceeds.

178
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[612400] Notes - Service concession arrangements


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of service concession arrangements [TextBlock]
Whether there are any service concession arrangments No No

[612000] Notes - Construction contracts


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of notes on construction contracts [TextBlock]
Whether there are any construction contracts No No

[612600] Notes - Employee benefits

Disclosure of defined benefit plans [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Defined benefit plans [Axis] Domestic defined benefit plans [Member]
Defined benefit plans categories [Axis] 1
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of defined benefit plans [Abstract]
Disclosure of defined benefit plans [Line items]
Description of type of plan Gratuity Gratuity
Surplus (deficit) in plan [Abstract]
Defined benefit obligation, at present value 302.63 298.32
Net surplus (deficit) in plan -302.63 -298.32
Actuarial assumption of discount rates 7.00% 7.00%

179
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of net defined benefit liability (assets) [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Defined benefit plans [Axis] Domestic defined benefit plans [Member]
Present value of
defined benefit
Net defined benefit liability (assets) [Axis] Net defined benefit liability (assets) [Member]
obligation
[Member]
Defined benefit plans categories [Axis] 1 1
01/04/2018 01/04/2017 01/04/2018
to to 31/03/2017 to
31/03/2019 31/03/2018 31/03/2019
Disclosure of net defined benefit liability
(assets) [Abstract]
Disclosure of net defined benefit liability
(assets) [Line items]
Description of type of plan Refer to child member Refer to child member Gratuity
Changes in net defined benefit liability
(assets) [Abstract]
Current service cost, net defined
31.33 34.09 31.33
benefit liability (assets)
Interest expense (income), net defined
21.47 21.14 21.47
benefit liability (assets)
Gain (loss) on remeasurement, net
defined benefit liability (assets)
[Abstract]
Actuarial losses (gains) arising from
changes in financial assumptions, net 22.92 33.72 22.92
defined benefit liability (assets)
Total loss (gain) on
remeasurement, net defined 22.92 33.72 22.92
benefit liability (assets)
Payments from plan, net defined benefit
25.57 13.45 25.57
liability (assets)
Total increase (decrease) in net
4.31 8.06 4.31
defined benefit liability (assets)
Net defined benefit liability (assets) at
302.63 298.32 290.26 302.63
end of period

Disclosure of net defined benefit liability (assets) [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Defined benefit plans [Axis] Domestic defined benefit plans [Member]
Present value of defined benefit
Net defined benefit liability (assets) [Axis]
obligation [Member]
Defined benefit plans categories [Axis] 1
01/04/2017
to 31/03/2017
31/03/2018
Disclosure of net defined benefit liability (assets) [Abstract]
Disclosure of net defined benefit liability (assets) [Line items]
Description of type of plan Gratuity
Changes in net defined benefit liability (assets) [Abstract]
Current service cost, net defined benefit liability (assets) 34.09
Interest expense (income), net defined benefit liability (assets) 21.14
Gain (loss) on remeasurement, net defined benefit liability (assets)
[Abstract]
Actuarial losses (gains) arising from changes in financial
33.72
assumptions, net defined benefit liability (assets)
Total loss (gain) on remeasurement, net defined benefit liability
33.72
(assets)
Payments from plan, net defined benefit liability (assets) 13.45
Total increase (decrease) in net defined benefit liability (assets) 8.06
Net defined benefit liability (assets) at end of period 298.32 290.26

180
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Textual information (66)
Disclosure of employee benefits [TextBlock] [See below]
Textual information (67)
Disclosure of defined benefit plans [TextBlock] [See below]
Whether there are any defined benefit plans Yes Yes
Disclosure of net defined benefit liability (assets) [TextBlock]

181
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (66)

Disclosure of employee benefits [Text Block]


a) Employee benefits:

i) Short-term employee benefits:

Liabilities for wages and salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after the end of the
period in which the employees render the related service are recognized in respect of employees’ services up to the end of the reporting period
and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit
obligations in the balance sheet.

ii) Other long-term employee benefit obligations:

The liabilities for earned leave and sick leave are not expected to be settled wholly within 12 months after the end of the period in which the
employees render the related service. They are therefore measured at the present value of expected future payments to be made in respect of
services provided by employees up to the end of the reporting period using the projected unit credit method. The benefits are discounted using the
market yields at the end of the reporting period that have terms approximating to the terms of the related obligations. Remeasurements as a result
of the experience adjustments and changes in actuarial assumptions are recognized in profit or loss.

iii) Post Employment obligations:

The Company operates the following post-employment schemes:

(a) Defined benefit plans such as gratuity; and

(b) Defined contribution plans such as provident fund.

Gratuity obligations

The liability or assets recognized in the balance sheet in respect of gratuity plans is the present value of the defined benefit obligation at the end of
the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by actuaries using the projected unit
credit method.

The present value of the defined benefit obligation denominated in is determined by discounting the estimated future cash outflows by reference
to market yields at the end of the reporting period on government bonds that have terms approximating to the terms of the related obligation.

182
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

The interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets.
This cost is included in employee benefit expense in the statement of profit and loss.

Remeasurements gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which
they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and in the
balance sheet.

Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in
profit or loss as past service cost.

Defined contribution plans

The company pays provident fund contributions to publicly administered funds as per regulations. The Company has no further payment
obligations once the contributions have been paid. The contributions are accounted for as defined contribution plans and the contributions are
recognized as employee benefit expense when they are due.

Compensated Absences:

Liability toward earned leaves is provided on the basis of actual leaves earned outstanding for payment.

183
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (67)

Disclosure of defined benefit plans [Text Block]


a) Employee benefits:

i) Short-term employee benefits:

Liabilities for wages and salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after the end of the
period in which the employees render the related service are recognized in respect of employees’ services up to the end of the reporting period
and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit
obligations in the balance sheet.

ii) Other long-term employee benefit obligations:

The liabilities for earned leave and sick leave are not expected to be settled wholly within 12 months after the end of the period in which the
employees render the related service. They are therefore measured at the present value of expected future payments to be made in respect of
services provided by employees up to the end of the reporting period using the projected unit credit method. The benefits are discounted using the
market yields at the end of the reporting period that have terms approximating to the terms of the related obligations. Remeasurements as a result
of the experience adjustments and changes in actuarial assumptions are recognized in profit or loss.

iii) Post Employment obligations:

The Company operates the following post-employment schemes:

(a) Defined benefit plans such as gratuity; and

(b) Defined contribution plans such as provident fund.

Gratuity obligations

The liability or assets recognized in the balance sheet in respect of gratuity plans is the present value of the defined benefit obligation at the end of
the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by actuaries using the projected unit
credit method.

The present value of the defined benefit obligation denominated in is determined by discounting the estimated future cash outflows by reference
to market yields at the end of the reporting period on government bonds that have terms approximating to the terms of the related obligation.

184
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

The interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets.
This cost is included in employee benefit expense in the statement of profit and loss.

Remeasurements gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which
they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and in the
balance sheet.

Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in
profit or loss as past service cost.

Defined contribution plans

The company pays provident fund contributions to publicly administered funds as per regulations. The Company has no further payment
obligations once the contributions have been paid. The contributions are accounted for as defined contribution plans and the contributions are
recognized as employee benefit expense when they are due.

Compensated Absences:

Liability toward earned leaves is provided on the basis of actual leaves earned outstanding for payment.

[612800] Notes - Borrowing costs


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Textual information (68)
Disclosure of borrowing costs [TextBlock] [See below]
Whether any borrowing costs has been capitalised during the year No No

Textual information (68)

Disclosure of borrowing costs [Text Block]


a) Borrowing Costs:

General and specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying asset are
capitalized during the period of time that is required to complete and prepare the asset for its intended use or sale. Qualifying assets are assets that
necessarily take a substantial period of time to get ready for their intended use or sale. Investment income earned on the temporary investment of
specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing cost eligible for capitalization. Other
borrowings costs are expensed in the period in which they are incurred.

185
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[700100] Notes - Key managerial personnels and directors remuneration and other information

Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Key managerial personnels and directors [Axis] 1 2 3 4
01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of key managerial personnels and directors and
remuneration to key managerial personnels and directors
[Abstract]
Disclosure of key managerial personnels and directors
and remuneration to key managerial personnels and
directors [LineItems]
RAVINDRA
VENKATA REDDY NARAYANA REDDY VENGA
Name of key managerial personnel or director SUDHA MUNDLA
ALLA REDDY MUNDLA R E D D Y
KUTAGULLA
Director identification number of key managerial
00054013 07701625 00064392 00083986
personnel or director
Permanent account number of key managerial
AFXPM8911L AMFPA4063J AEMPM4585Q AKLPK4260D
personnel or director
Date of birth of key managerial personnel or
19/04/1982 05/01/1940 01/06/1951 19/04/1942
director
Designation of key managerial personnel or director Director Director Managing Director Director
Qualification of key managerial personnel or
B. Tech & MBA Graduate M.SC Graduate
director
Shares held by key managerial personnel or director [shares] 8,322 [shares] 0 [shares] 6,017 [shares] 0
Key managerial personnel or director remuneration
[Abstract]
Gross salary to key managerial personnel or
director [Abstract]
Salary key managerial personnel or director 0 0 12 0
Perquisites key managerial personnel or
0 0 0 0
director
Profits in lieu of salary key managerial
0 0 2.45 0
personnel or director
Gross salary to key managerial personnel or
0 0 14.45 0
director
Sitting fees key managerial personnel or
0 0 0 0
director
Stock option key managerial personnel or
0 0 0 0
director
Sweat equity key managerial personnel or
0 0 0 0
director
Commission as percentage of profit key
0 0 0 0
managerial personnel or director
Other commission key managerial personnel or
0 0 0 0
director
Other compensation key managerial personnel or
0 0 0 0
director
Total key managerial personnel or director
0 0 14.45 0
remuneration

186
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table] ..(2)
Unless otherwise specified, all monetary values are in Lakhs of INR
Key managerial personnels and directors [Axis] 5 6 7 8
01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of key managerial personnels and directors and
remuneration to key managerial personnels and directors
[Abstract]
Disclosure of key managerial personnels and directors
and remuneration to key managerial personnels and
directors [LineItems]
VENKATA LINGAREDDY
HEMANTH NANDIGALA
Name of key managerial personnel or director SUBASH SUBBA REDDY
NANDIGALA VENKATA REDDY
LINGAREDDY VENKATA
Director identification number of key managerial
00125240 00135847 01561731 01740424
personnel or director
Permanent account number of key managerial
ABNPL3249E AAVPL5579L ACAPN0908Q ABNPN2622B
personnel or director
Date of birth of key managerial personnel or
09/12/1971 01/07/1941 02/01/1974 01/07/1943
director
Designation of key managerial personnel or director Director Director Director Managing Director
Qualification of key managerial personnel or
B. Tech & MBA Graduate MBBS & MBA MBBS
director
Shares held by key managerial personnel or director [shares] 6,250 [shares] 6,922 [shares] 7,419 [shares] 3,779
Key managerial personnel or director remuneration
[Abstract]
Gross salary to key managerial personnel or
director [Abstract]
Salary key managerial personnel or director 0 0 0 12
Perquisites key managerial personnel or
0 0 0 0
director
Profits in lieu of salary key managerial
0 0 0 2.57
personnel or director
Gross salary to key managerial personnel or
0 0 0 14.57
director
Sitting fees key managerial personnel or
0 0 0 0
director
Stock option key managerial personnel or
0 0 0 0
director
Sweat equity key managerial personnel or
0 0 0 0
director
Commission as percentage of profit key
0 0 0 0
managerial personnel or director
Other commission key managerial personnel or
0 0 0 0
director
Other compensation key managerial personnel or
0 0 0 0
director
Total key managerial personnel or director
0 0 0 14.57
remuneration

187
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table] ..(3)
Unless otherwise specified, all monetary values are in Lakhs of INR
Key managerial personnels and directors [Axis] 9 10
01/04/2018 01/04/2018
to to
31/03/2019 31/03/2019
Disclosure of key managerial personnels and directors and remuneration to key
managerial personnels and directors [Abstract]
Disclosure of key managerial personnels and directors and remuneration to key
managerial personnels and directors [LineItems]
PRASANTH
Name of key managerial personnel or director NANDIGALA
GARGI PAMMI

Director identification number of key managerial personnel or director 01740471 01744011


Permanent account number of key managerial personnel or director ABYPN4171A ADYPP6863B
Date of birth of key managerial personnel or director 14/04/1972 01/04/1947
Designation of key managerial personnel or director Director Director
B.Tech (IIT) &
Qualification of key managerial personnel or director MBA
MBBS

Shares held by key managerial personnel or director [shares] 7,419 [shares] 2,256
Key managerial personnel or director remuneration [Abstract]
Gross salary to key managerial personnel or director [Abstract]
Salary key managerial personnel or director 0 0
Perquisites key managerial personnel or director 0 0
Profits in lieu of salary key managerial personnel or director 0 0
Gross salary to key managerial personnel or director 0 0
Sitting fees key managerial personnel or director 0 0
Stock option key managerial personnel or director 0 0
Sweat equity key managerial personnel or director 0 0
Commission as percentage of profit key managerial personnel or director 0 0
Other commission key managerial personnel or director 0 0
Other compensation key managerial personnel or director 0 0
Total key managerial personnel or director remuneration 0 0

[612200] Notes - Leases


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Textual information (69)
Disclosure of leases [TextBlock] [See below]
Whether company has entered into any lease agreement No No
Whether any operating lease has been converted to financial lease or
No No
vice-versa

188
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (69)

Disclosure of leases [Text Block]


a) Leases:

At the inception of each lease, the lease arrangement is classified as either a finance lease or operating lease, based on the substance of the lease
arrangement. A lease that transfers substantially all the risks and rewards incidental to ownership to the lessee is classified as a finance lease. All
other leases are classified as operating leases.

As a lessee:

Operating lease payments are recognized as an expense in the statement of profit & loss over lease term.

[612300] Notes - Transactions involving legal form of lease


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of arrangements involving legal form of lease [TextBlock]
Whether there are any arrangements involving legal form of lease No No

[612900] Notes - Insurance contracts


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of insurance contracts [TextBlock]
Whether there are any insurance contracts as per Ind AS 104 No No

[613100] Notes - Effects of changes in foreign exchange rates


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of effect of changes in foreign exchange rates [TextBlock]
Whether there is any change in functional currency during the year No No
Description of presentation currency INR

189
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[500100] Notes - Subclassification and notes on income and expenses


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Subclassification and notes on income and expense explanatory [TextBlock]
Disclosure of revenue from operations [Abstract]
Disclosure of revenue from operations for other than finance company
[Abstract]
Revenue from sale of products 37,187.57 33,553.81
Revenue from sale of services 0 0
Total revenue from operations other than finance company 37,187.57 33,553.81
Total revenue from operations 37,187.57 33,553.81
Disclosure of other income [Abstract]
Interest income [Abstract]
Interest income on non-current investments [Abstract]
Interest on fixed deposits, non-current investments 6 5.48

Interest on other non-current investments (A) 66.64 (B) 137.83


Total interest income on non-current investments 72.64 143.31
Total interest income 72.64 143.31
Dividend income [Abstract]
Total dividend income 0 0
Other non-operating income [Abstract]
Net gain (loss) on foreign currency fluctuations treated as other
income [Abstract]
Net gain (loss) on foreign currency translation 571.33 368.42
Total net gain/loss on foreign currency fluctuations treated as
571.33 368.42
other income
Surplus on disposal, discard, demolishment and destruction of
0 0.05
depreciable property, plant and equipment
Gain on disposal of intangible Assets (C) 152.71 (D) 115.53
Miscellaneous other non-operating income 17.74 8.09
Total other non-operating income 741.78 492.09
Total other income 814.42 635.4
Disclosure of finance cost [Abstract]
Interest expense [Abstract]
Interest expense current loans [Abstract]
Interest expense current loans, banks 5.99 8.64

Interest expense current loans, others (E) 7.86 (F) 3.74


Total interest expense current loans 13.85 12.38

Other interest charges (G) 46.11 (H) 37.03


Total interest expense 59.96 49.41
Total finance costs 59.96 49.41
Employee benefit expense [Abstract]
Salaries and wages 2,008.87 1,854.21
Managerial remuneration [Abstract]
Remuneration to directors [Abstract]
Salary to directors 514 344
Total remuneration to directors 514 344
Total managerial remuneration 514 344
Contribution to provident and other funds [Abstract]
Contribution to provident and other funds for others 80.34 78.03
Total contribution to provident and other funds 80.34 78.03
Leave encashment expenses 41.7 25.66
Gratuity 27.23 41.78
Staff welfare expense 94.61 82.66

Other employee related expenses (I) 66.79 (J) 70.83


Total employee benefit expense 2,833.54 2,497.17

190
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Depreciation, depletion and amortisation expense [Abstract]


Depreciation expense 501.9 480.56
Total depreciation, depletion and amortisation expense 501.9 480.56
Breakup of other expenses [Abstract]
Consumption of stores and spare parts 464.64 603.83
Power and fuel 3,335.67 3,214.1
Rent 3.69 2.8
Repairs to building 77.37 91.32
Repairs to machinery 666.03 443.08
Insurance 41.44 42.84
Rates and taxes excluding taxes on income [Abstract]
Excise duty 0 152.96
Other cess taxes 24.14 39.17

Cost taxes other levies by government local authorities (K) 0.11 (L) 0.11
Provision wealth tax 0
(M) 0.02
Total rates and taxes excluding taxes on income 24.25 192.26
Research development expenditure 116.89 115.21
Electricity expenses 97.22 73.03
Telephone postage 38.02 32.53
Printing stationery 49.21 39.53
Travelling conveyance 58.18 64.45
Legal professional charges 28.39 36.85
Vehicle running expenses 8.91 13.63
Directors sitting fees 0 0
Donations subscriptions 11.82 1.82
Registration filing fees 57.8 59.17
Advertising promotional expenses 330.82 293.61

Transportation distribution expenses (N) 568.88 (O) 534.95


Guarantee commission (P) 258.41 (Q) 192.86
Cost transportation [Abstract]
Cost other transporting 54.07 209.81
Total cost transportation 54.07 209.81
Cost effluent disposal 284.03 292.88
Loss on disposal of intangible Assets 0 0
Loss on disposal, discard, demolishment and destruction of
0 0
depreciable property plant and equipment
Operating and maintenance cost of emission and other pollution
reduction equipments (R) 70.87 (S) 46.62
Payments to auditor [Abstract]
Payment for audit services 8 6
Total payments to auditor 8 6
CSR expenditure 91.74 67.98

Miscellaneous expenses (T) 19.06 (U) 34.15


Total other expenses 6,765.41 6,705.31
Current tax [Abstract]
Current tax pertaining to current year 1,648.24 1,257.33
Total current tax 1,648.24 1,257.33

191
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Footnotes
(A) Income from investments mandatorily measured at fair value through profit or loss
(B) Income from investments mandatorily measured at fair value through profit or loss
(C) Profit on redemption of investments
(D) Profit on redemption of investments
(E) Interest on others
(F) Interest on others
(G) Bank Charges
(H) Bank Charges
(I) Contribution to ESI - 18.77 Bonus - 48.02
(J) Contribution to ESI - 20.68 Bonus - 50.16
(K) Professional Tax
(L) Professional Tax
(M) Interest on TDS
(N) Clearing and Forward Charges - 567.64 Consignment Expenses - 1.24
(O) Clearing and Forward Charges - 528.49 Consignment Expenses - 6.46
(P) Sales Commission
(Q) Sales Commission
(R) Lab Maintenance
(S) Lab Maintenance
(T) Miscellaneous Expenses - 10.71 Office Expenses - 7.09 EMS Expenses - 1.28
(U) Miscellaneous Expenses - 22.73 Office Expenses - 7.27 EMS Expenses - 4.16

[613200] Notes - Cash flow statement


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to 31/03/2017
31/03/2019 31/03/2018
Disclosure of cash flow statement [TextBlock]
Cash and cash equivalents cash flow statement 1,446.94 26.66 1,271.38
Cash and cash equivalents 1,446.94 26.66
Income taxes paid (refund), classified as operating activities 1,648.23 1,225.24
Total income taxes paid (refund) 1,648.23 1,225.24

[500200] Notes - Additional information statement of profit and loss


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Additional information on profit and loss account explanatory [TextBlock]
Changes in inventories of stock-in-trade 135.37 863.28
Total changes in inventories of finished goods, work-in-progress and
135.37 863.28
stock-in-trade
Domestic sale traded goods 37,187.57 33,553.81
Total domestic turnover goods, gross 37,187.57 33,553.81
Total revenue from sale of products 37,187.57 33,553.81
Total revenue from sale of services 0 0
Gross value of transaction with related parties 0 0
Bad debts of related parties 0 0

192
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[611200] Notes - Fair value measurement


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Textual information (70)
Disclosure of fair value measurement [TextBlock] [See below]
Disclosure of fair value measurement of assets [TextBlock]
Whether assets have been measured at fair value No No
Disclosure of fair value measurement of liabilities [TextBlock]
Whether liabilities have been measured at fair value No No
Disclosure of fair value measurement of equity [TextBlock]
Whether equity have been measured at fair value No No

193
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (70)

Disclosure of fair value measurement [Text Block]


a) Investments and other financial assets:

i) Classification

The Company classifies its financial assets in the following measurement categories:

- Those to be measured subsequently at fair value (either through other comprehensive income, or through profit or loss), and

- those measured at amortized cost.

The classification depends on the entity's business model for managing the financial assets and the contractual terms of the cash flows. For assets
measured at fair value, gains and losses will either be recorded in profit or loss or other comprehensive income.

ii) Measurement

At initial recognition, the company measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit
or loss, transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at fair
value through profit or loss are expensed in profit or loss.

Debt instruments: Subsequent measurement of debt instruments depends on the Company's business model for managing the asset and the cash
flow characteristics of the asset. There are three measurement categories into which the Company classifies its debt instruments:

Amortized cost: Assets that are held for collection of contractual cash flows where those cash flows represent solely payments of principal and
interest are measured at amortized cost. A gain or loss on a debt investment that is subsequently measured at amortized cost and is not part of a

194
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

hedging relationship is recognized in profit or loss when the asset is derecognized or impaired. Interest income from these financial assets is
included in finance income using the effective interest rate method.

Fair value through other comprehensive income (FVOCI): Assets that are held for collection of contractual cash flows and for selling the financial
assets, where the assets' cash flows represent solely payments of principal and interest, are measured at fair value through other comprehensive
income (FVOCI). Movements in the carrying amount are taken through OCI, except for the recognition of impairment gains or losses, interest
revenue and foreign exchange gains and losses which are recognized in profit and loss. When the financial asset is derecognized, the cumulative
gain or loss previously recognized in OCI is reclassified from equity to profit or loss and recognized in other gains/(losses). Interest income from
these financial assets is included in other income using the effective interest rate method.

Fair value through profit or loss: Assets that do not meet the criteria for amortized cost or FVOCI are measured at fair value through profit or loss.
A gain or loss on a debt investment that is subsequently measured at fair value through profit or loss and is not part of a hedging relationship is
recognized in profit or loss and presented net in the statement of profit and loss within other gains/(losses) in the period in which it arises. Interest
income from these financial assets is included in other income.

Equity instruments: The Company subsequently measures all equity investments at fair value. Where the company's management has elected to
present fair value gains and losses on equity investments in other comprehensive income, there is no subsequent reclassification of fair value
gains and losses to profit or loss. Dividends from such investments are recognized in profit or loss as other income when the Company's right to
receive payments is established.

Changes in the fair value of financial assets at fair value through profit or loss are recognized in other gain/(losses) in the statement of profit and
loss. Impairment losses (and reversal of impairment losses) on equity investments measured at FVOCI are not reported separately from other
changes in fair value.

iii) Impairment of financial assets:

The Company assesses on a forward looking basis the expected credit losses associated with its assets carried at amortized cost and FVOCI debt
instruments. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The company applies
the simplified approach permitted by Ind AS 109 Financial Instruments, which requires expected lifetime losses to be recognized from initial
recognition of the receivables.

iv) De-recognition of financial assets:

A financial asset is derecognized only when

195
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

· the company has transferred the rights to receive cash flow from the financial asset or

· retains the contractual rights to receive the cash flows of the financial assets, but assumes a contractual obligation to pay cash flows to one
or more recipients.

Where the entity has transferred an asset, the Company evaluates whether it has transferred substantially all risks and rewards of ownership of the
financial asset. In such cases, the financial asset is derecognized. Where the entity has not transferred substantially all risks and rewards of
ownership of the financial asset is not derecognized.

Where the entity has neither transferred a financial asset nor retains substantially all risks and rewards of ownership of the financial asset, the
financial asset is derecognized if the Company has not retained control of the financial asset. Where the Company retains control of the financial
asset, the asset is continued to be recognized to the extent of continuing involvement in the financial asset.

[613300] Notes - Operating segments


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of entity's operating segments [TextBlock]
Disclosure of reportable segments [TextBlock]
Whether there are any reportable segments No No
Disclosure of major customers [TextBlock]
Whether there are any major customers No No

[610700] Notes - Business combinations


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of business combinations [TextBlock]
Whether there is any business combination No No
Disclosure of reconciliation of changes in goodwill [TextBlock]
Whether there is any goodwill arising out of business combination No No
Disclosure of acquired receivables [TextBlock]
Whether there are any acquired receivables from business combination No No
Disclosure of contingent liabilities in business combination [TextBlock]
Whether there are any contingent liabilities in business combination No No

196
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[611500] Notes - Interests in other entities

Disclosure of associates [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Associates [Axis] 1
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of associates [Abstract]
Disclosure of associates [Line items]
VIRCHOW BIOTECH VIRCHOW BIOTECH
Name of associate entity PRIVATE LIMITED PRIVATE LIMITED
Description of nature of entity's relationship with associate Associate Company Associate Company
Principal place of business of associate India India
Country of incorporation of associate INDIA INDIA
CIN of associate entity U24210TG2001PTC036520 U24210TG2001PTC036520
Latest audited balance sheet date 31/03/2018 31/03/2018
Whether associate has been considered in consolidation Yes Yes
Proportion of ownership interest in associate 49.00% 49.00%
Proportion of voting rights held in associate 49.00% 49.00%
Amount of investment in associate 834.62 834.62
Number of shares held of associate [shares] 83,46,210 [shares] 83,46,210
Latest audited balance sheet date 31/03/2018 31/03/2018

197
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of details of subsidiaries [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Subsidiaries [Axis] 1 2
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of subsidiaries [Abstract]
Disclosure of subsidiaries [Line
items]
ANDHRA ORGANICS ANDHRA ORGANICS VIRCHOW DRUGS VIRCHOW DRUGS
Name of subsidiary LIMITED LIMITED LIMITED LIMITED
Principal place of business of
India India India India
subsidiary
Country of incorporation or
residence of INDIA INDIA INDIA INDIA
subsidiary
CIN of subsidiary company U24116TG1991PLC012314 U24116TG1991PLC012314 U24239TG2004PLC042949 U24239TG2004PLC042949
Section under which company
Section 2(87)(ii) Section 2(87)(ii) Section 2(87)(ii) Section 2(87)(ii)
became subsidiary
Whether subsidiary has filed
No No No No
balance sheet
Reason if no filing has been made
by Shall file shortly Shall file shortly Shall file shortly Shall file shortly
subsidiary
Whether financial year of
subsidiary
No No No No
different from financial year of
holding company
Financial year of subsidiary
[Abstract]
Start date of accounting period of
01/04/2018 01/04/2017 01/04/2018 01/04/2017
subsidiary
End date of accounting period of
31/03/2019 31/03/2018 31/03/2019 31/03/2018
subsidiary
Percentage of shareholding in
100.00% 100.00% 51.00% 51.00%
subsidiary
Key information about subsidiary
[Abstract]
Reporting currency of subsidiary INR INR INR INR
Exchange rate as applicable for
INR INR INR INR
subsidiary
Share capital of subsidiary 451.17 451.17 1,224.49 1,224.49
Reserves and surplus of
49,509.04 42,257.38 10,627.23 7,226.64
subsidiary
Total assets of subsidiary 58,493.69 49,737.36 14,325.02 12,467.48
Total liabilities of subsidiary 58,613.56 3,822.19 14,004.64 4,016.35
Investment of subsidiary 0 0 0 0
Turnover of subsidiary 62,713.44 50,024.62 15,455.58 10,950.01
Profit before tax of subsidiary 9,337.29 8,955.86 3,450.65 2,635.3
Provision for tax of subsidiary -2,684.34 -2,485.15 -955.01 -832.58
Profit after tax of subsidiary 6,652.95 6,470.71 2,495.64 1,802.72
Proposed dividend of subsidiary 0 0 0 0
ANDHRA ORGANICS ANDHRA ORGANICS VIRCHOW DRUGS VIRCHOW DRUGS
Name of subsidiary LIMITED LIMITED LIMITED LIMITED
Principal place of business of
India India India India
subsidiary
Country of incorporation or
residence of INDIA INDIA INDIA INDIA
subsidiary
CIN of subsidiary company U24116TG1991PLC012314 U24116TG1991PLC012314 U24239TG2004PLC042949 U24239TG2004PLC042949

198
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of details of subsidiaries [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Subsidiaries [Axis] 3
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of subsidiaries [Abstract]
Disclosure of subsidiaries [Line items]
VIRCHOW VIRCHOW
Name of subsidiary HEALTHCARE PRIVATE HEALTHCARE PRIVATE
LIMITED LIMITED
Principal place of business of subsidiary India India
Country of incorporation or residence of subsidiary INDIA INDIA
CIN of subsidiary company U24230MH2007PTC176048 U24230MH2007PTC176048
Section under which company became subsidiary Section 2(87)(ii) Section 2(87)(ii)
Whether subsidiary has filed balance sheet No No
Reason if no filing has been made by subsidiary Shall file shortly Shall file shortly
Whether financial year of subsidiary different from financial year of holding
No No
company
Financial year of subsidiary [Abstract]
Start date of accounting period of subsidiary 01/04/2018 01/04/2017
End date of accounting period of subsidiary 31/03/2019 31/03/2018
Percentage of shareholding in subsidiary 85.00% 85.00%
Key information about subsidiary [Abstract]
Reporting currency of subsidiary INR INR
Exchange rate as applicable for subsidiary INR INR
Share capital of subsidiary 200 200
Reserves and surplus of subsidiary 879.74 502.59
Total assets of subsidiary 1,481.16 983.24
Total liabilities of subsidiary 1,311.16 280.64
Investment of subsidiary 0 0
Turnover of subsidiary 2,230.06 2,049
Profit before tax of subsidiary 458.59 322.35
Provision for tax of subsidiary -111.45 -87.12
Profit after tax of subsidiary 347.14 235.23
Proposed dividend of subsidiary 0 0
VIRCHOW VIRCHOW
Name of subsidiary HEALTHCARE PRIVATE HEALTHCARE PRIVATE
LIMITED LIMITED
Principal place of business of subsidiary India India
Country of incorporation or residence of subsidiary INDIA INDIA
CIN of subsidiary company U24230MH2007PTC176048 U24230MH2007PTC176048

199
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of interests in other entities [TextBlock]
Disclosure of interests in subsidiaries [TextBlock]
Disclosure of subsidiaries [TextBlock]
Whether company has subsidiary companies Yes Yes
Number of subsidiary companies [pure] 3 [pure] 3
Whether company has subsidiary companies which are yet to commence
No No
operations
Whether company has subsidiary companies liquidated or sold during
No No
year
Disclosure of interests in associates [TextBlock]
Disclosure of associates [TextBlock]
Whether company has invested in associates Yes Yes
Whether company has associates which are yet to commence operations No No
Whether company has associates liquidated or sold during year No No
Disclosure of interests in joint arrangements [TextBlock]
Disclosure of joint ventures [TextBlock]
Whether company has invested in joint ventures No No
Whether company has joint ventures which are yet to commence
No No
operations
Whether company has joint ventures liquidated or sold during year No No
Disclosure of interests in unconsolidated structured entities [TextBlock]
Disclosure of unconsolidated structured entities [TextBlock]
Whether there are unconsolidated structured entities No No
Disclosure of investment entities [TextBlock]
Disclosure of information about unconsolidated subsidiaries [TextBlock]
Whether there are unconsolidated subsidiaries No No
Disclosure of information about unconsolidated structured entities
controlled by investment entity [TextBlock]
Whether there are unconsolidated structured entities controlled by
No No
investment entity

[611400] Notes - Separate financial statements

Disclosure of subsidiaries [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Subsidiaries [Axis] 1 2
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of subsidiaries [Abstract]
Disclosure of subsidiaries [Line items]
ANDHRA ORGANICS ANDHRA ORGANICS VIRCHOW DRUGS VIRCHOW DRUGS
Name of subsidiary LIMITED LIMITED LIMITED LIMITED
CIN of subsidiary company U24116TG1991PLC012314 U24116TG1991PLC012314 U24239TG2004PLC042949 U24239TG2004PLC042949
Principal place of business of
India India India India
subsidiary
Country of incorporation or residence
of INDIA INDIA INDIA INDIA
subsidiary
Proportion of ownership interest in
100.00% 100.00% 51.00% 51.00%
subsidiary
Proportion of voting rights held in
100.00% 100.00% 51.00% 51.00%
subsidiary

200
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of subsidiaries [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Subsidiaries [Axis] 3
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of subsidiaries [Abstract]
Disclosure of subsidiaries [Line items]
VIRCHOW VIRCHOW
Name of subsidiary HEALTHCARE PRIVATE HEALTHCARE PRIVATE
LIMITED LIMITED
CIN of subsidiary company U24230MH2007PTC176048 U24230MH2007PTC176048
Principal place of business of subsidiary India India
Country of incorporation or residence of subsidiary INDIA INDIA
Proportion of ownership interest in subsidiary 85.00% 85.00%
Proportion of voting rights held in subsidiary 85.00% 85.00%

Disclosure of associates [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Associates [Axis] 1
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of associates [Abstract]
Disclosure of associates [Line items]
VIRCHOW BIOTECH VIRCHOW BIOTECH
Name of associate entity PRIVATE LIMITED PRIVATE LIMITED
CIN of associate entity U24210TG2001PTC036520 U24210TG2001PTC036520
Principal place of business of associate India India
Country of incorporation of associate INDIA INDIA
Proportion of ownership interest in associate 49.00% 49.00%
Proportion of voting rights held in associate 49.00% 49.00%

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of separate financial statements [TextBlock]
Disclosure of subsidiaries [TextBlock]
Disclosure of associates [TextBlock]
Method used to account for investments in subsidiaries INDas
INDas
Method used to account for investments in associates INDas INDas

201
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[610800] Notes - Related party

Disclosure of transactions between related parties [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Categories of related parties [Axis] Subsidiaries [Member]
Related party [Axis] 1 2
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of transactions between
related parties
[Abstract]
Disclosure of transactions between
related
parties [Line items]
ANDHRA ORGANICS ANDHRA ORGANICS VIRCHOW DRUGS VIRCHOW DRUGS
Name of related party LIMITED LIMITED LIMITED LIMITED
Country of incorporation or residence
of INDIA INDIA INDIA INDIA
related party
CIN of related party U24116TG1991PLC012314 U24116TG1991PLC012314 U24239TG2004PLC042949 U24239TG2004PLC042949
Description of nature of transactions
with Purchase/Sale Purchase/Sale Purchase/Sale Purchase/Sale
related party
Description of nature of related party
Subsidiary company Subsidiary company Subsidiary company Subsidiary company
relationship
Related party transactions [Abstract]
Purchases of goods related party
2,576.34 4,519.89 12.35 0.74
transactions
Revenue from sale of goods related
party 3,810.06 2,646.02 170.68 40.97
transactions
Other related party transactions
0 0 0 0
contribution received
Outstanding balances for related
party
transactions [Abstract]
Amounts payable related party
0 0 0 0
transactions
Amounts receivable related party
0 0 0 0
transactions
Outstanding commitments made by
entity, 0 0 0 0
related party transactions
Outstanding commitments made on
behalf 0 0 0 0
of entity, related party transactions
Provisions for doubtful debts related
to
0 0 0 0
outstanding balances of related party
transaction
Expense recognised during period for
bad
0 0 0 0
and doubtful debts for related party
transaction

202
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of transactions between related parties [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Categories of related parties [Axis] Subsidiaries [Member] Associates [Member]
Related party [Axis] 3 10
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of transactions between
related parties
[Abstract]
Disclosure of transactions between
related
parties [Line items]
VIRCHOW VIRCHOW
VIRCHOW BIOTECH VIRCHOW BIOTECH
Name of related party HEALTHCARE PRIVATE HEALTHCARE PRIVATE
PRIVATE LIMITED PRIVATE LIMITED
LIMITED LIMITED
Country of incorporation or
residence of INDIA INDIA INDIA INDIA
related party
CIN of related party U24230MH2007PTC176048 U24230MH2007PTC176048 U24210TG2001PTC036520 U24210TG2001PTC036520
Description of nature of transactions
with Purchase/Sale Purchase/Sale Purchase/Sale Purchase/Sale
related party
Description of nature of related
party Subsidiary company Subsidiary company Associate company Associate company
relationship
Related party transactions [Abstract]

Purchases of goods related party


16.69 4.59 468.35 339.87
transactions
Revenue from sale of goods
related party 16.16 0.09 3.62 0.42
transactions
Other related party transactions
0 0 0 0
contribution received
Outstanding balances for related
party
transactions [Abstract]
Amounts payable related party
0 0 0 0
transactions
Amounts receivable related party
0 0 0 0
transactions
Outstanding commitments made
by entity, 0 0 0 0
related party transactions
Outstanding commitments made
on behalf
0 0 0 0
of entity, related party transactions

Provisions for doubtful debts related


to
outstanding balances of related party 0 0 0 0

transaction
Expense recognised during period
for bad
0 0 0 0
and doubtful debts for related party
transaction

203
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of transactions between related parties [Table] ..(3)


Unless otherwise specified, all monetary values are in Lakhs of INR
Categories of related parties [Axis] Key management personnel of entity or parent [Member]
Related party [Axis] 4 5
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of transactions between related parties
[Abstract]
Disclosure of transactions between related
parties [Line items]
NANDIGALA
NARAYANA NARAYANA NANDIGALA
Name of related party REDDY MUNDLA REDDY MUNDLA
VENKATA
VENKATA REDDY
REDDY
Country of incorporation or residence of
INDIA INDIA INDIA INDIA
related party
Permanent account number of related party AEMPM4585Q AEMPM4585Q ABNPN2622B ABNPN2622B
Description of nature of transactions with
Remuneration Remuneration Remuneration Remuneration
related party
Description of nature of related party
Managing Director Managing Director Managing Director Managing Director
relationship
Related party transactions [Abstract]
Other related party transactions
0 0 0 0
contribution received
Outstanding balances for related party
transactions [Abstract]
Amounts payable related party transactions 257 197 257 147
Amounts receivable related party transactions 0 0 0 0
Outstanding commitments made by entity,
0 0 0 0
related party transactions
Outstanding commitments made on behalf
0 0 0 0
of entity, related party transactions
Provisions for doubtful debts related to
outstanding balances of related party 0 0 0 0
transaction
Expense recognised during period for bad
and doubtful debts for related party 0 0 0 0
transaction

204
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of transactions between related parties [Table] ..(4)


Unless otherwise specified, all monetary values are in Lakhs of INR
Categories of related parties [Axis] Other related parties [Member]
Related party [Axis] 6 7
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of transactions between
related parties
[Abstract]
Disclosure of transactions between
related
parties [Line items]
VIRCHOW VIRCHOW
VIRCHOW CHEMICALS VIRCHOW CHEMICALS
Name of related party PVT. LTD. PVT. LTD.
PETROCHEMICAL PETROCHEMICAL
PRIVATE LIMITED PRIVATE LIMITED
Country of incorporation or residence
of INDIA INDIA INDIA INDIA
related party
CIN of related party U65910TG1988PTC008596 U65910TG1988PTC008596 U23209TG2003PTC041101 U23209TG2003PTC041101
Description of nature of transactions
with Purchase/Sale Purchase/Sale Purchase/Sale Purchase/Sale
related party
Description of nature of related party
Other related party Other related party Other related party Other related party
relationship
Related party transactions [Abstract]
Purchases of goods related party
6,294.39 4,671.86 36.58 0.15
transactions
Revenue from sale of goods related
party 0.42 40.63 67.03 36.03
transactions
Other related party transactions
0 0 0 0
contribution received
Outstanding balances for related
party
transactions [Abstract]
Amounts payable related party
0 0 0 0
transactions
Amounts receivable related party
0 0 0 0
transactions
Outstanding commitments made by
entity, 0 0 0 0
related party transactions
Outstanding commitments made on
behalf 0 0 0 0
of entity, related party transactions
Provisions for doubtful debts related
to
0 0 0 0
outstanding balances of related party
transaction
Expense recognised during period for
bad
0 0 0 0
and doubtful debts for related party
transaction

205
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of transactions between related parties [Table] ..(5)


Unless otherwise specified, all monetary values are in Lakhs of INR
Categories of related parties [Axis] Other related parties [Member]
Related party [Axis] 8 9
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of transactions between
related parties
[Abstract]
Disclosure of transactions between
related
parties [Line items]
COVALENT COVALENT
IMEX ENGINEERING CO IMEX ENGINEERING CO
Name of related party LABORATORIES LABORATORIES
PVT LTD PVT LTD
PRIVATE LIMITED PRIVATE LIMITED
Country of incorporation or residence
of INDIA INDIA INDIA INDIA
related party
CIN of related party U24230TG2002PTC039606 U24230TG2002PTC039606 U74210TG1974PTC001733 U74210TG1974PTC001733
Description of nature of transactions
with Purchase/Sale Purchase/Sale Purchase/Sale Purchase/Sale
related party
Description of nature of related party
Other related party Other related party Other related party Other related party
relationship
Related party transactions [Abstract]
Purchases of goods related party
0 0.01 123.59 220.37
transactions
Revenue from sale of goods related
party 0.13
transactions
Other related party transactions
0 0 0 0
contribution received
Outstanding balances for related
party
transactions [Abstract]
Amounts payable related party
0 0 0 0
transactions
Amounts receivable related party
0 0 0 0
transactions
Outstanding commitments made by
entity, 0 0 0 0
related party transactions
Outstanding commitments made on
behalf 0 0 0 0
of entity, related party transactions
Provisions for doubtful debts related
to
0 0 0 0
outstanding balances of related party
transaction
Expense recognised during period for
bad
0 0 0 0
and doubtful debts for related party
transaction

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of related party [TextBlock]
Whether there are any related party transactions during year Yes Yes
Disclosure of transactions between related parties [TextBlock]
Whether entity applies exemption in Ind AS 24.25 No No
Whether company is subsidiary company No No

206
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[611700] Notes - Other provisions, contingent liabilities and contingent assets


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of other provisions, contingent liabilities and contingent assets Textual information (71)
[TextBlock] [See below]
Disclosure of contingent liabilities [TextBlock]
Whether there are any contingent liabilities No No

Textual information (71)

Disclosure of other provisions, contingent liabilities and contingent assets [Text Block]
a) Provisions, contingent liabilities and contingent assets:

Provision: A provision is recognized if, as a result of a past event, the Company has a present legal or constructive obligation that can be
estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation.

Contingent Liability: A disclosure for a contingent liability is made when there is a possible obligation or a present obligation that may, but
probably will not, require an outflow of resources. Where there is a possible obligation or a present obligation in respect of which the likelihood
of outflow of resources is remote, no provision or disclosure is made.

Contingent Asset: Contingent assets are not recognized in the financial statements. However, contingent assets are assessed continually and if it is
virtually certain that an outflow of economic benefits will arise, the asset and related income are recognized in the period in which the change
occurs.

[700200] Notes - Corporate social responsibility

Disclosure of net profits for last three financial years [Table] ..(1)
Unless otherwise specified, all monetary values are in Lakhs of INR
Financial year 1 Financial year 2 Financial year 3
Net profits for last three financial years [Axis]
[Member] [Member] [Member]
01/04/2018 01/04/2018 01/04/2018
to to to
31/03/2019 31/03/2019 31/03/2019
Disclosure of net profits for last three financial years [Abstract]
Disclosure of net profits for last three financial years [LineItems]
Description of financial year 2017-18 2016-17 2015-16
Profit before tax of financial year 3,449.01 7,514.41 6,910.85
Net profit computed u/s 198 and adjusted as per rule 2(1)(f)
3,449.01 7,514.41 6,910.85
of Companies (CSR Policy) Rules, 2014

207
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Classification of CSR spending [Table] ..(1)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of CSR spending [Axis] 1 2 3 4
01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of CSR spending [Abstract]
Details of CSR spent during financial year [Abstract]
Manner in which amount CSR spent during financial
year [Abstract]
Manner in which amount CSR spent during
financial year [Line items]
Promotion of Promotion of health Providing safe
CSR project or activity identified education care drinking water
Rural Development
Rural development
Sector in which project is covered Education Health care Safe drinking water
projects
Name of state or union territory where
Telangana Telangana Telangana Telangana
projects or programs was undertaken
Budget amount outlay project or program wise 32.92 28.42 4.87 18.33
Amount spent on projects or programs
[Abstract]
Direct expenditure on projects or programs 32.92 28.42 4.87 18.33
Overheads on projects or programs 0 0 0 0
Total amount spent on projects or programs 32.92 28.42 4.87 18.33
Other implementing Other implementing Other implementing Other implementing
Mode of amount spent agencies agencies agencies agencies

Classification of CSR spending [Table] ..(2)


Unless otherwise specified, all monetary values are in Lakhs of INR
Classification of CSR spending [Axis] 5
01/04/2018
to
31/03/2019
Disclosure of CSR spending [Abstract]
Details of CSR spent during financial year [Abstract]
Manner in which amount CSR spent during financial year [Abstract]
Manner in which amount CSR spent during financial year [Line items]
CSR project or activity identified Promotion of Sports
Training to promote
Sector in which project is covered sports
Name of state or union territory where projects or programs was undertaken Telangana
Budget amount outlay project or program wise 7.2
Amount spent on projects or programs [Abstract]
Direct expenditure on projects or programs 7.2
Overheads on projects or programs 0
Total amount spent on projects or programs 7.2
Other implementing
Mode of amount spent agencies

208
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in Lakhs of INR


01/04/2018
to
31/03/2019
Disclosure of corporate social responsibility explanatory [TextBlock]
Whether provisions of corporate social responsibility are applicable on
Yes
company
Textual information (72)
Disclosure of composition of CSR committee [TextBlock] [See below]
Whether company has written CSR policy Yes
Textual information (73)
Details CSR policy [TextBlock] [See below]
Average net profit for last three financial years 5,958.09
Prescribed CSR expenditure 119.16
Amount CSR to be spent for financial year 119.16
Amount CSR spent for financial year 91.74
Amount spent in local area 91.74
Amount unspent CSR 27.42
Implementation and
monitoring of CSR policy,
Details of implementing agency is in compliance with CSR
objectives and policy of
the company.

Textual information (72)

Disclosure of composition of CSR committee [Text Block]


2. Composition of CSR Committee:

The details of the composition of the committee are given below:

1. Mr. A. Venkata Reddy - Chairman

2. Mr. N. Prasanth - Member

3. Mr. M. Vishnu Mundla - Member

209
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (73)

Details CSR policy [Text Block]


1. A brief Outline of Company’s CSR Policy, including overview of projects or programmes undertaken/ proposed to be undertaken:

The CSR committee of the Board has developed CSR Policy consist of

a) Eradicating poverty, promoting health care & sanitation and making available safe drinking water

b) Promoting education

c) Rural development projects

d) Sports promotion

[610500] Notes - Events after reporting period


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of events after reporting period [TextBlock]
Disclosure of non-adjusting events after reporting period [TextBlock]
Whether there are non adjusting events after reporting period No No

[612500] Notes - Share-based payment arrangements


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of share-based payment arrangements [TextBlock]
Whether there are any share based payment arrangement No No

210
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[613000] Notes - Earnings per share


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of earnings per share [TextBlock]
Basic earnings per share [Abstract]
Diluted earnings per share [Abstract]
Profit (loss), attributable to ordinary equity holders of parent entity
[Abstract]
Profit (loss), attributable to ordinary equity holders of parent entity 0 0
Profit (loss), attributable to ordinary equity holders of parent
0 0
entity including dilutive effects
Weighted average shares and adjusted weighted average shares [Abstract]
Weighted average number of ordinary shares outstanding [shares] 0 [shares] 0

[610900] Notes - First time adoption


Unless otherwise specified, all monetary values are in Lakhs of INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Textual information (74) Textual information (75)
Disclosure of first-time adoption [TextBlock] [See below] [See below]
Whether company has adopted Ind AS first time No Yes
Disclosure of reconciliation of equity from previous GAAP to Ind AS
[TextBlock]
Equity as per Indian GAAP 71.47 89.34
Equity as per Ind AS 71.47 89.34
Disclosure of reconciliation of comprehensive income from previous GAAP
to Ind AS [TextBlock]
Comprehensive income as per Indian GAAP 3,112.77 2,269.71
Comprehensive income as per Ind AS 3,112.77 2,269.71
Disclosure of reconciliation of profit (loss) for the period from
previous GAAP to Ind AS [TextBlock]
Profit (loss) for the period as per Indian GAAP 3,095.98 2,243.67
Profit (loss) for the period as per Ind AS 3,095.98 2,243.67

211
VIRCHOW LABORATORIES LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (74)

Disclosure of first-time adoption [Text Block]


The financial statements of the company have been prepared and presented in accordance with the Indian Accounting Standards (“Ind AS”)
notified under the Companies ( Indian Accounting Standards) Rules, 2015 and as amended from time to time.

These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:

· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;

· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.

Textual information (75)

Disclosure of first-time adoption [Text Block]


The financial statements of the company have been prepared and presented in accordance with the Indian Accounting Standards (“Ind AS”)
notified under the Companies ( Indian Accounting Standards) Rules, 2015 and as amended from time to time.

These financial statements have been prepared on the historical cost convention and on an accrual basis, except for the following material items in
the balance sheet:

· Certain financial assets are measured either at fair value or at amortized cost depending on the classification;

· Employee defined benefit assets/(liabilities) are remeasured at the net total of the fair value of plan assets, plus actuarial losses, less
actuarial gains and the present value of the defined benefit obligation.

212

You might also like